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Thesis summary 
Urinary tract infections (UTIs) affect significant proportions of the population, particularly 
prevalent in elderly patients. Up to 40 % of healthcare associated infections are UTIs and 80% of 
those are associated with catheter use. CA-UTIs significantly effect patient’s health and are 
frequently associated with substantial morbidity and mortality. Furthermore, the financial 
implications are enormous as the high complication rate arising from catheterisation requires 
significant time and cost. In the UK, more than a million cases are reported each year accounting 
for annual economic burden of approximately £125 million. The aim of this study was to develop 
novel antimicrobial bioactive glasses that can be used to prevent and treat catheter associated 
urinary tract infections. This was achieved by assessing the antimicrobial efficacy of increasing 
cobalt or zinc content (1, 3, 5 and 10 mol %) in phosphate based glass system (P2O5-Na2O-CaO). 
Glass compositions with two metal oxides (cobalt, copper or zinc) were also studied to determine 
synergistic combinations against a panel of clinically relevant microorganisms. A decrease in the 
dissolution rates of cobalt glasses was seen with increasing cobalt content, however an increase 
in dissolution rate was observed with higher zinc content (5% and 10%). A strong antimicrobial 
activity was exhibited by 5 and 10 mol % cobalt or zinc doped glasses which was not only time 
dependent but also strain specific. Moreover, combinations such as Co/Cu, Co/Zn and Cu/Zn 
showed synergism against E. coli and S. aureus. Whilst a strong antimicrobial activity was seen, 
the cytotoxic studies demonstrated decrease in cell viability of mammalian cells when exposed 
to glasses directly and their dissolution products. Nevertheless, cobalt and/or zinc doped 
phosphate based glasses could potentially be used as a cartridge in drainage bags or to coat 
catheters with a decreasing amount to prevent cytotoxic effects.  
Keywords: Phosphate based glasses, antibacterial, cytotoxicity, cobalt and zinc. 
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1.1 Overview  
 
In most developed countries, as the life expectancy has increased there is an increased demand 
on the healthcare system. Medical devices are an integral part of modern medicine. Whilst this 
has been a huge success in improving the healthcare facilities, the occurrence and undesirable 
complications arising from such devices have well been recognized and continue to escalate [1]. 
Since the presence of a foreign body creates a favourable environment for microbial colonisation, 
device related infections therefore account for at least half of the healthcare associated infection 
[2]. One of the most commonly reported device related infection is catheter associated urinary 
tract infection (CA-UTI) due to the inability of the material to prevent microbial colonisation [3, 
4].   
 
Urinary catheters have long been used in hospitals and nursing homes. A number of patients who 
are admitted in hospital require urinary catheterisation at some stage during their stay. Urinary 
tract infections (UTIs) are the most common type of hospital - acquired infection accounting for 
up to 40% of all cases and 80% of those are associated with catheter use [5]. There are various 
reasons for catheterisation ranging from collecting a sterile urine sample to treating a long term 
underlying conditions such as urinary incontinence due to bladder weakness or nerve damage. In 
the latter case an indwelling catheter is inserted into the urinary tract via the urethra for an 
extended period of time thus predisposing the patient to urinary tract infection [3]. Since the 
catheters are made of different polymers, they provide favourable conditions for the growth and 
attachment of microorganisms thus leading to biofilm formation. These infections are difficult to 
treat as antibiotics fail to penetrate biofilms and thus can not only cause considerable morbidity 
but also can prove fatal. Therefore, due to the severity and the complications associated with 
catheter related urinary tract infections prevention of catheter related infections is an area that 
requires further investigation.  
 
 
23 
 
The aim of this chapter is to provide a brief overview of human urinary system, the need for 
urinary catheterisation and associated complications, mainly the infection, caused by it. The 
causative agents and their route of entry, pathogenesis of the infection will also be discussed in 
detail. Prevention of these infection by use of antimicrobial catheters, associated limitations and 
the concept of using bio-glasses as a potential alternative will be explored.  
 
1.2 Urinary System 
 
1.2.1 Components and Functions 
 
The urinary system is one of the major systems in the body that serves to maintain haemostatic 
balance of the body. It consists of two kidneys, two ureters, the bladder and urethra (Figure 1.1). 
Kidneys receive plasma portion of the blood and remove urea (nitrogenous waste product) from 
the body through millions of nephrons. Kidneys also play a central role in regulating water 
concentration, maintaining correct ionic composition (potassium, sodium, calcium, magnesium). 
The required components get selectively reabsorbed back into the blood to maintain proper 
balance whilst waste products that  
do not get filtered become secreted into the urine [6]. Other important functions include 
production of hormones and release of erythropoietin, which controls red blood cell production 
in the bone marrow.  
 
Urine produced by the kidneys is pushed down through ureters into urinary bladder by peristaltic 
movements. Ureters are narrow, muscular, thick walled tubes which are 25-30 cm in length and 
3-4 mm in diameter [6]. Smooth muscles in ureter walls continuously tighten and relax to avoid 
building up of urine in kidneys. Small amounts of urine are emptied into the bladder every 15-20 
seconds [7]. The ureters empty into urinary bladder, a triangular-shaped, hollow organ located 
in the lower abdomen. It serves to store urine until it is convenient to release it. The typical healthy 
adult bladder, on average can store up to 300-400 ml of urine before emptying however can hold 
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up 700 ml [8]. Three different types of muscles control the voiding of urine from bladder; internal 
sphincters, external sphincters and pelvic floor muscles that provide additional support to bladder 
[8]. When the bladder is full, stretch muscles send signals to parasympathetic nervous system and 
urination or micturition happens by voluntary relaxation of external sphincters muscles leading 
to opening of internal sphincters. Finally, during urination, urine is discharged from the body via 
urethra. Due to the innate mechanism of the human body, any bacteria (normally the endogenous 
species that colonize the periurethral area) that ascend the urinary tract are flushed out during 
micturition. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: The human urinary tract system [9]. 
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1.2.2 The Human Urothelium 
 
The urinary bladder like renal pelvis, ureters and upper urethra is lined by a tissue called 
uroepithelium or urothelium (Figure 1.2), which forms an interface between urinary space and 
the underlying tissues [10]. It is a transitional epithelium composed of three layers; basal, 
intermediate and superficial layer. The urothelium responds to stretch via large hexagonal cells 
present in the outermost layer called umbrella cells. In addition, these cells are coated with 
glycosaminoglycan mucin that act as the first line of defence against microbial invasion by 
preventing the adherence of bacteria [10, 11]. 
 
When the bladder starts to fill up, the cells in the outer layer begin to change their shape and can 
elongate ten times their original size, enabling the bladder to store urine. Other than allowing 
urine storage, urothelium serves as a barrier between the outer environment (excretory products 
i.e. urine) and the underlying tissues.  
 
Figure 1.2 – Transitional epithelium that lines urinary bladder [12]. 
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1.3 Urinary catheterisation  
 
The word catheter is derived from a Greek word kathiénai, which means “to thrust into or to send 
down” [8] and its use can be dated back to 1500 BC when bronze tubes or straws were used to 
treat urinary retention [13]. Up until the invention of modern day catheters the sole purpose of 
catheter was to treat urinary retention in the male [8]. However, in the later years, hollow tubes 
were not only used to drain bladder but also to insert pharmacological products into urinogenital 
tract. The development or improvement in the design of catheter was not seen until 1500s when 
the first wax-impregnated cloth catheter was made to lessen the severity of damage caused by 
inserting hard metallic tubes [14]. The modern-day catheters, termed as Foley catheters, were 
developed in 1929 and are described in section 1.3.1. 
 
Nowadays catheterisation is an invasive procedure, where a rubber tube is inserted into urinary 
bladder via urethra for a continuous flow of urine into a collecting system. It is frequently used 
in hospitals and nursing homes for management of several conditions. Many patients who are 
admitted in hospital require urinary catheterisation at some stage during their stay. There are 
various reasons for catheterisation ranging from collecting a sterile urine sample to treating long 
term underlying conditions such as urinary incontinence due to bladder weakness or nerve 
damage. Catheters are also used in patients undergoing surgery or suffering from conditions such 
as multiple sclerosis, enlarged prostate and spinal cord injury [15]. Urinary catheters are also 
indicated for measuring bladder residual volume, obtaining urine samples and delivering drugs 
[16, 17]. 
 
1.3.1 Types of catheters  
 
Depending upon the need there are variety of catheters available, however, the two main types of 
catheters are intermittent and indwelling catheters. Intermittent catheters are single use 
catheters that are used either to collect sterile urine samples or where patients are unable to empty 
their bladder properly therefore a catheter is inserted to drain urine. In such cases, once the bladder 
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is full, a catheter (typically a long plastic or rubber tube) is inserted aseptically into the urethra 
until the urine starts to flow [8]. Once the flow has stopped the catheter is removed and disposed 
of. The procedure needs to be repeated several times in a day. It is also used to manage patients 
with spinal cord injury or neuromuscular degeneration.  
 
Indwelling catheter is the most common type of catheter that is inserted in the same way as the 
intermittent catheter however left in the bladder for a long period. Indwelling catheters can be 
inserted via urethra into the bladder or by making a small incision in abdominal wall. Depending 
upon the underlying medical condition and the need, indwelling catheters are inserted for short 
or long term. When a catheter is inserted for few days i.e. less than 14 days, it is classed as short-
term catheterisation. On the other hand, long term catheterisation has been categorised differently 
by different studies, however majority of them classified catheterisation as long term if catheter 
is in body for more than 30 days and up to 90 days [4, 8, 16, 18]. 
 
The most widely used catheter these days is a Foley catheter (Figure 1.3), designed by American 
urologist, Frederick E.B. Foley [8]. Originally this catheter was designed to drain blood followed 
by prostatectomy, however soon it was used for management of urinary retention and 
incontinence. A Foley catheter is a thin, hollow tube made of soft, flexible material that is passed 
through the urethra into the bladder. The size of the catheter is measured in Charrierers or French 
Grade (1Ch =1/3mm diameter) and adult catheters are available in different sizes and lengths 
depending upon factors such as age, gender, purpose and the overall health of urinary tract [19, 
20]. A typical Foley catheter size is 16 Ch (between 10 and 24 Ch) and 220 - 380 mm in length 
[21]. It uses a retention device at proximal end such as a water filled balloon to keep the catheter 
in place. It has two or three different channels; one for inflating balloon and the other for draining 
urine or delivering medications. Once in situ the balloon is inflated/deflated with sterile water 
using a syringe. Historically buckets were used for collecting urine, however a closed drainage 
system such as a bag is attached to the urine outlet and is either hung beside the patient’s bed or 
strapped to the patient’s leg (Figure 1.4). Urine can either drain freely by gravity into the drainage 
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bag or a catheter valve can be fitted into the end of the catheter which may be switched on or off 
to allow for the urine to drain. 
 
 
 
Figure 1.3: A Foley catheter [22]. 
 
 
  
 
 
Figure 1.4: A Foley catheter inserted in situ – a closed drainage system [23]. 
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The first Foley catheter was made from latex, however nowadays they are made from many 
different materials to increase their biocompatibility and functionality. Like all devices 
biocompatibility of a catheter is highly dependent on the surface characteristics and its chemical 
nature. Whilst there is no ideal material for catheters some materials are more biocompatible than 
others.  Latex is inexpensive, has good elastic properties but tends to be more prone to bacterial 
adherence and have more allergic potential than some other materials [24, 25]. The cytotoxic 
effects of latex were reported due to eluted components from rubber [26]. PVC has been used in 
the past, however it elicits an acute inflammatory response in vivo due to which these catheters 
are outdated. Silicone on the other hand, is soft, non - irritating and clinically stable making it 
ideal for long - term use in the urinary tract. It is more expensive than latex catheters but is inert, 
putting patients at less risk of allergic reaction. Their surface properties make catheter insertion 
easy and lower rates of bacterial adhesion and encrustation have been reported compared to latex 
catheters. This has been attributed to the smoother surfaces of these catheters exhibiting less 
niches for microbial aggregation than latex catheters [27, 28]. 
 
1.4 Complications associated with catheterisation 
 
It was not until 1988 when an American physician Calvin M. Kunin published in the New 
England Journal of Medicine, that the use of Foley catheters was considered safe [29]. There are 
several complications associated with catheterisation that limit the use and effectiveness of 
catheters in healthcare. Discomfort, trauma, bladder spasm, overactive bladder, anaphylaxis due 
to latex allergy, cytotoxicity, hematuria, intravesical knotting, urethral fistulae, urosepsis, 
symptomatic infection and encrustation are among the most common complications due to 
catheterisation [30, 31]. The focus of the given study is prevention and treatment of infection due 
to urinary catheters. 
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1.4.1 Encrustation 
 
One of the major complications of urinary catheterisation is encrustation that causes blockage or 
obstruction of catheters causing retention of urine in the bladder. This subsequently causes reflux 
to upper urinary tract or leakage of urine. It occurs because of crystallisation of the ionic 
components in the urine on the surface of an indwelling catheter initiated by certain bacteria [32]. 
About 40 - 50% of the patients undergoing long term catheterisation experience blockage of the 
catheter [3, 4, 8, 33], which can occur outside or inside lumen of the catheter. The main cause of 
catheter encrustation is colonisation of urinary tract by urease producing bacteria and their 
activity is pH dependent. Urease is an enzyme, that catalyses the hydrolysis of urea in the urine 
to ammonia and carbon dioxide [34]. The production of ammonia increases the pH of the 
surrounding environment that initiates precipitation of magnesium and calcium salts within the 
urine to struvite and hydroxyapatite respectively [35]. Meanwhile bacterial biofilms are also 
formed and the crystals are deposited forming crystalline biofilms which continues until the eye 
hole of the catheter and lumen is blocked preventing the flow of urine through catheter to 
collecting bag.  
 
There are several species associated with CA-UTIs that are urease positive such as Pseudomonas 
aeruginosa, Klebsiella pneumoniae, Morganella morganii, Proteus species and some strains of 
Staphylococcus aureus [18, 36, 37], however the most commonly isolated microorganism from 
crystalline biofilms is Proteus mirabilis [35]. The enzyme produced by Proteus mirabilis is 
highly potent and has ability to cause crystallization several times faster than other bacteria. 
According to an analysis conducted by Sticker et al. other bacterial species (Pseudomonas 
aeruginosa, Klebsiella pneumoniae, Morganella morganii) are less capable of producing alkaline 
urine and hence failed to form crystallization on catheters compared to Proteus mirabilis and 
Proteus vulgaris. The former is shown to form crystalline biofilms on all types of indwelling 
catheters including silver and hydrogel coated catheters [33]. Even if the blocked catheters are 
changed, in some cases recurrent blockage occurs due to presence of Proteus mirabilis. A study 
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conducted by Sabbuba et al. [38] on bacterial strains isolated from urine samples, demonstrated 
recurrent bacterial infection and encrustation by Proteus mirabilis. The researchers identified a 
patient with persistent Proteus mirabilis, even though the patient had a course of antibiotics, eight 
catheters changed and 20 days without catheter, the infection continued for four months. 
 
 
 
Figure 1.5: A catheter that had been indwelling for 6 months (a). A cross section of silicone 
catheter removed after 8 weeks (b). A longitudinal section of a silver/hydrogel-coated latex 
catheter that had blocked after 11 days (c) [35]. 
 
 
 
1.4.2 Infections 
 
One of the most common complications of urinary catheterisation is catheter associated urinary 
tract infections. The infection is a microbial colonization of the urinary tract by pathogenic 
microorganisms causing signs and symptoms of inflammation when a catheter is present. The 
infection is said to be present if the urinary bacterial or fungal count is more than 103 CFU/ml 
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[39]. According to Foxman [40], the infections are classified according to the site of infection as 
the bladder (cystitis), kidney (pyelonephritis) and urine (bacteriuria). 
 
1.4.2.1 Epidemiology 
 
Urinary tract infections (UTI’s) have been reported as the most common health-care associated 
infections where 80% of these infections are due to insertion of a urinary catheter. Due to frequent 
and sometimes unnecessary use of catheters, CA-UTIs, equate for 8-35% of healthcare-related 
infections [27, 39], and are the second most common cause of septicaemia which is associated 
with substantially increased institutional death rates [41-43]. Studies have shown that about 15-
25% of the patients admitted in hospital require urinary catheterisation [27] which increases their 
risk of developing urinary tract infection by 5% per day [18, 39]. In about 30 - 40% of the patients 
suffering from CA-UTI microorganisms may enter blood and progress to septicaemia, which 
accounts for 8% of all nosocomial infections  [27]. 1 in 3 patients who acquire bacteraemia in 
blood will eventually die of the infection [44]. 
 
CA-UTIs are frequently associated with significant morbidity. A detailed review of the literature 
on morbidity and mortality associated with complications arising from catheter insertion was 
undertaken by Delimore and co-workers [21]. The study shows 100% morbidity rate in patients 
with CA-UTIs, when inserted for more than 30 days. The study also established symptomatic 
bacterial infection as the most fatal complication directly occurring due to catheter insertion. The 
high mortality rate, approximately 21%, was reported in older adults who required an indwelling 
urinary catheter. Another recent study conducted on patients suffering from nosocomial 
bacteraemia showed a high mortality associated with CA-UTIs. The authors compared central 
venous catheters (CVC) associated bacteraemia with catheter associated bacteraemia and found 
significant death rate within seven days of inserting a urinary catheter [45]. Similarly, a 
prospective study conducted by Platt et al. [46] on urinary catheterisation and associated mortality 
showed a 3-fold increase in the death rate, however many other studies argue on the association 
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of death with urinary catheterisation. Thus, the effect of catheter associated UTIs on mortality is 
unclear as patients requiring catheters are generally suffering from severe illness, therefore the 
death could be due to underlying conditions and not the CA-UTI.   
 
1.4.2.2 Financial costs  
 
Even though the problem of CA-UTIs is well recognised in health care settings, the full extent of 
the problem is not established. Nevertheless, the financial implications are enormous as the high 
complication rate arising from catheterisation requires significant time and cost. The cost is 
substantial due to extended length of stay at hospitals, nursing visits, antibiotics. In the UK,  in 
2000 it was estimated that the management of catheter associated infections cost £120 to £2600 
per patient for each quarter of a year [47]. The findings of Plowman in 1999, reported that an 
average increased stay of 5-6 days resulted in £1327 spent extra on each case [48]. More than a 
million cases are reported each year accounting for annual economic burden of approximately 
£125 million [3, 39]. The cost also includes extra expenses associated with diagnostic tests and 
treatment regimes.  
 
 
1.4.2.3 Risk factors 
 
Several factors play a key role in development of CA-UTI such as previous history of 
catheterisation, reason and the site of insertion [39]. Duration of catheterisation is a major risk 
factor associated with CA-UTI. The longer a patient requires catheterisation, the greater the 
chance of developing the associated infection [40]. According to Garibaldi et al., [49] the risk of 
developing bacteraemia increases 5% for each day the catheter is in body and by the tenth day, 
50% of the patients develop CA-UTI and 100% patients contract infection by the day 30. 
 
Among the other factors is increasing age and gender. The relative rate of CA-UTI is reported to 
be much higher in females than in males [39], and this is due to the relative ease with which 
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bacteria can travel to the urethra from the perineum. Estrogens promote growth of vaginal 
lactobacilli which prevent growth of enterococci [50], therefore the risk of CA-UTIs increases in 
menopausal women due to low levels of estrogens. Patients with other site infection, chronic 
health conditions such as diabetes, malnutrition and renal inefficiency are also at a risk of 
developing CA-UTI [39]. In addition, catheterisation in unsterile environment, use of unsuitable 
catheters and open drainage systems increase the incidence of CA-UTIs. 
 
1.4.2.4 Causative agents 
 
Catheter associated urinary tract infections are caused by a diverse range of microorganisms, both 
bacterial as well as fungal species. The spectrum of microorganisms isolated from the urine 
samples varies not only within patients but also some microbes are unique to each facility. 
Majority of the infections are caused either by endogenous skin microorganisms or faecal 
contaminants residing in periurethral area. The most common of the bacterial species is 
Escherichia coli [4, 51] whereas Candida albicans is also frequently isolated [52-54]. Among the 
other species that are commonly isolated from the samples are Proteus mirabilis, Klebsiella 
pneumoniae, Pseudomonas aeruginosa, Enterococcus spp (mostly E. faecalis and E. faecium), 
and Staphylococcus spp. (mostly S. aureus and Coagulase Negative Staphylococci). Proteus and 
Pseudomonas species are most commonly associated with biofilm formation on the catheter 
surface [4, 55]. These microorganisms especially Proteus mirabilis are not isolated following 
initial catheter colonisation and therefore not common in patients undergoing short term 
catheterisation. According to Nicolle, 50% of the infections in short term catheterised patients 
are due to Escherichia coli whereas long term catheter infections are mainly polymicrobial and 
up to 40% of infections are due to Proteus species [56].  
 
Melzer et al., conducted an analysis from October 2007 to September 2008 on patients with 
hospital acquired bacteraemia and established CA-UTIs as the second most common HAI [45]. 
35 
 
Among the patients with CA-UTI, 92.7% of the isolates were Gram negative and 7.2% were 
Gram positive. The proportion of each isolate is given in the chart below (Figure 1.6). 
 
 
 
Figure 1.6: Proportion of bacteraemic isolates causing catheter-associated urinary tract 
infections [45]. 
 
 
1.4.2.5 Routes of entry 
 
The urinary tract, like most internal organs is sterile (apart from the distal tip of the urethra), 
however under certain conditions microorganisms gain access to the bladder and kidneys. 
Insertion of a urinary catheter is the major route by which microorganisms may ascend the urinary 
tract and therefore cause infection. When a catheter is inserted microorganisms can enter the 
urinary tract by the contaminated hands of the person carrying out the procedure [39]. Most 
pathogens that cause CA-UTIs are faecal contaminants or skin residents of the patient’s own 
microflora that colonise the perianal area. Once a catheter is inserted, microorganisms travel 
along the surface of the catheter extraluminally or intraluminally into the bladder urethral meatus 
[57]. The preferred mechanism is extraluminal. In 66% of the cases microorganisms ascend via 
the urethral-catheter interface, whereas 34% of the cases are due to intraluminal migration 
0
5
10
15
20
25
30
35
40
45
50
36 
 
associated with manipulation of collecting systems or due to contamination of the drainage bag 
or disruption of the catheter tubing junction [3, 57]. Microorganisms gain access in the urinary 
tract using motility organs such as flagella and pilli, fimbriae or other adhesins, on the other hand 
microorganisms without such appendages use Brownian motion [58]. 
 
1.4.2.6 Pathogenesis/Biofilm formation 
 
Normal human urinary tract has innate protection against a variety of pathogens that enter the 
system, however once a foreign body such as a catheter is inserted, it increases the risk of 
developing UTI’s. Catheter surface provides an attachment site and favourable conditions for 
microorganism to colonise and infect the uroepithelial mucosa thus leading to biofilm formation. 
“A biofilm is an assemblage of microbial cells that is irreversibly associated (not removed by 
gentle rinsing) with a surface and enclosed in a matrix of primarily polysaccharide material” 
[59]. A detailed account of the pathogenesis and formation of biofilm is given below: 
 
Once a catheter is in situ, it is exposed urine. The urine contains a variety of components such as 
proteins, glycoproteins, electrolytes and other organic molecules, which adsorb onto the surface 
of catheter forming a conditioning film. According to Keane et al., [60] the conditioning film 
does not cover the catheter surface completely instead it forms a mesh like covering. The 
deposition of conditioning film is crucial as it not only masks the surface composition and 
properties of the catheter material but also contains host cell binding receptors which are primary 
attachment sites for microbial colonisation. In addition, the presence of urinary catheter impairs 
the normal host defences, such as physically damaging the protective uroepithelial mucosa 
leading to exposure of more binding sites. Likewise, normal mechanical defences of the bladder 
(urine flow) are also disrupted which results in an over distension and incomplete voiding that 
leaves residual urine in bladder hence enhancing microbial growth [61]. Once the conditioning 
film is formed, microbial colonisation begins by means of hydrophobic and electrostatic 
interactions and by means of adhesins. Microorganisms have special cell surface components 
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that facilitate anchorage of the cells to surfaces. Gram negative bacteria such as E. coli have a 
diverse range of adhesins such as flagella, pili and fimbriae, whereas P. mirabilis produce MR/K 
type fimbriae and haemagglutinins. MSCRAMM’s (microbial surface components recognizing 
adhesive matrix molecules) are the adhesion proteins that enable attachment of S. aureus on 
catheter surfaces. Even though the presence of a catheter surface is an advantage for 
microorganisms, certain other factors such as the host immune response and surrounding flow 
rate of the urine also play a key role in successful microbial colonisation. Initially the attachment 
is reversible, however irreversible attachment occurs when bacteria begin to change 
phenotypically by upregulating expression of certain genes [3] . Upregulation of these results in 
production of exopolysaccharides which protect not only bacteria from immune components but 
also antibiotics and shear force. These attached bacteria reproduce and form colonies that 
ultimately mature into biofilms (Figure 1.7 and 1.8). Channels are formed to permit exchange of 
nutrients and waste products [59]. The biofilms formed shed daughter cells that spread into other 
parts of catheter and form biofilms there.  
 
 
Figure 1.7: illustration of biofilm formation. Planktonic cells adhere onto the surface of catheter 
containing host cell proteins (within conditioning film) and secrete matrix components resulting 
in biofilm formation [62]. 
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Figure 1.8: Scanning electron micrograph of Staphylococcus aureus on the luminal surface of an 
indwelling catheter. The round cocci shaped bacterial cells are interwoven in a complex matrix 
of exopolysaccharides known as biofilm [63]. 
 
 
 
1.4.2.7 Symptoms 
 
Although the presence of bacteraemia is believed to induce an inflammatory response, most cases 
of CA-UTIs are asymptomatic i.e. 90% of patients suffering from CA-UTI did not show any 
symptoms [39]. These patients do not require any treatment unless the infection show symptoms 
or the patient is immunocompromised. However symptomatic cases range from mild fever and 
cystitis to severe cases of acute nephritis. The most common signs are abnormal urine colour, 
foul odour, dysuria (pain during urination) and urgency. Among other symptoms include pain in 
lower abdominal area, chills and confusion. If left untreated, CA-UITs can lead to abscess 
formation, renal obstruction, scarring and eventually will lead to septicaemia and possibly death 
[3]. 
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1.4.2.8 Treatment 
 
Asymptomatic infections are considered as clinically insignificant therefore treatment is unlikely 
to confer benefit. However, many patients are prescribed antibiotics unnecessarily which not only 
adds to antibiotics resistance but also inappropriate costs to the NHS. Symptomatic infections 
with one type of organism are treated with: 
 
• Trimethoprim – effective against most uro-pathogens except for Pseudomonas and 
Enterococcus species 
• Fluoroquinolones - effective against many Gram negative such as Pseudomonas and 
Proteus species 
• Nitrofurantoin - effective against most uro-pathogens except Pseudomonas and Proteus 
species 
 
Cephalosporin is used for patients with polymicrobial infection whereas a combination of drugs 
is prescribed for complicated infections. Biofilms are unlikely to clear with antibiotics, even if 
the catheter is changed there is always a risk of reoccurrence of infection and there remains a 
need to develop preventive strategy to reduce the occurrence of catheter associated infections. 
 
1.4.2.9 Prevention 
 
There is very little that can be done to prevent catheter associated urinary tract infections. The 
first and the foremost precautions is hand hygiene and aseptic technique while inserting a catheter 
in the bladder. Health care staff and clinicians should be trained to prevent transmission of 
infection by adopting the hygiene guidelines such as use of antiseptic soaps and alcohol hand 
rubs. Whilst the benefit of handwashing has been proven effective in many studies, lack of 
consistent hand washing practice, as demonstrated by Collins [1] where on average only 40% of 
healthcare staff adhered to recommended hand hygiene procedure, could aggravate the problem. 
In addition to hand hygiene a closed drainage system and minimising the duration of catheter 
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usage has been shown to reduce the infection rate. It is recommended to change the catheter as 
per clinical need or according to the manufacturer’s guidelines, which is usually at 10 - 12 week 
intervals [34]. Systemic antibiotics are advised in certain cases however have shown little or no 
benefit as it only delays the infection. The use of antibiotics however promotes antibiotic 
resistance and are not recommended even for the treatment of bacteriuria in the asymptomatic 
catheterised patient [64].  
 
 
Selective and limited use of catheters is critical in preventing CA-UTIs nevertheless under certain 
circumstances the use of catheters is inevitable. As adhesion to the catheter is crucial to the 
establishment of microorganisms and biofilms [3] therefore one of the prevention strategies is 
use of a catheter that prevents attachment of microorganisms onto the catheter surface. To prevent 
bacterial attachment on the surface of catheters an array of biomaterials such as C-Flex™, latex, 
nylon, Percuflex™, polyethylene, polyvinyl chloride, polyurethane, silicone, Tecoflex® have 
been developed in the past, however most of these materials were directed to reduce friction. 
While catheters are coated with a variety of materials such as hydrogel, silicone and hydrophilic 
coatings to reduce frictions and inhibit microbial growth, the inability of these materials to resist 
bacterial adhesion has led to the development of catheters with antimicrobial agents [21].  
 
1.5 Antimicrobial catheters 
 
Antimicrobial catheters were developed in the past to prevent bacterial colonisation on the surface 
of catheters. For instance, chlorhexidine containing catheters have shown in vitro activity against 
Escherichia coli, Proteus mirabilis and Staphylococcus epidermidis [65, 66]. Similarly, hydrogel 
coated catheters were loaded with bacteriophages to prevent bacterial growth. This was achieved 
by exposing the catheter segments to a phage culture such as lytic Staph. epidermidis 
bacteriophage 456 for a defined period. According to Carson et al., [67] hydrogel coated catheters 
containing bacteriophages reduced 99.9% of CA-UTIs caused by Escherichia coli. Similarly, 
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Staphylococcus epidermidis phage had been shown to reduce 4 logs over 24 hours [68]. While 
some successful cases have been reported, the ability of bacteria and viruses to mutate in short 
time, high phage specificity and immune response of the host are the factors that caused concerns 
over their usage. Among the other technologies that have been developed in the past is light 
activating antimicrobial agents (LAAA) [69]. These agents can produce reactive oxygen species 
(ROS) which bring about cell death by targeting several cell components. Methylene blue 
incorporated in polymers has also shown significant reduction in E. coli and MRSA within five 
minutes of irradiation [69]. 
 
Broad antimicrobial spectrum antimicrobials have been incorporated in urinary catheters to 
prevent catheter related infections and biofilm formation. The antimicrobial catheters that were 
developed and used in clinical practice included antiseptic coated catheters (silver oxide or silver 
alloy coated) and antibiotic-impregnated catheters containing nitrofurazone or a combination of 
the broad-spectrum antibiotics, minocycline and rifampin [70]. However, according to various 
studies these catheters, which initially showed promising results, did not significantly reduce the 
risk of CA-UTIs in large, well-controlled trials and are still the subject of considerable 
controversy [3].  
 
A detailed account of antimicrobial catheters is given below: 
 
1.5.1 Antibiotic containing catheters 
 
Antibiotic-impregnated catheters were developed to treat a broad range of microorganisms; 
however, these catheters did not show promising results due to development of resistant bacterial 
strains. Darouiche et al., [71] conducted a study on short term catheterisation of post-operative 
patients. An antibiotic impregnated catheter with minocycline and rifampicin was used. The 
catheter was shown to successfully reduce the rate of growth of Gram positive bacteria over a 
two-week period however failed to inhibit colonisation of Gram negative bacteria such as 
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Escherichia coli and Proteus mirabilis, which are majorly associated with infection and 
encrustation. Whilst the catheter showed some positive results, it was believed to linked with 
possible antibiotic resistance in Gram positive bacteria [71]. 
 
1.5.2 Nitrofurazone  
 
Nitrofurazone (NF) is an antimicrobial agent that belongs to nitrofurane group of antimicrobials 
and has a wide range of activity against microorganisms associated with CAUTIs. A 
nitrofurazone impregnated catheter called ReleaseNF was developed by Rochester Medical 
Corporation, USA. It is a 100% silicone, two way Foley catheter which works by eluting NF, 
both intraluminally and extraluminally, into the urinary tract [72]. The NF is impregnated in both 
sides of the catheter. The released NF acts as a bactericidal agent and kills planktonic bacteria 
before they develop into biofilm [72]. The efficacy of this type of catheter in reducing CAUTIs 
has been evaluated by several laboratory studies and clinical trials, of which a few are discussed 
here.  
 
 
Figure 1.9: ReleaseNF Foley catheter coated with nitrofurazone [72]. 
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An in vitro study to evaluate the effectiveness of NF containing catheter compared to a standard 
silicone catheter was conducted by Devak and co-workers in 2011 [73]. In the given study 
adherence of two pathogens; Escherichia coli and Enterococcus faecalis, on different catheter 
surfaces in broth was evaluated. The study showed significant decrease in Escherichia coli 
colonisation on the NF catheter compared to the silicone catheter as there were no bacteria found 
on the catheter material and surrounding environment. Even though statistically significant 
differences in the bacterial load were seen between NF catheter and standard silicone catheter, 
the inhibitory effect decreased with incubation time; 100%, 97%, 91%, 62%, 31% on day 0, 3, 5, 
7 and 10 respectively. On the other hand, NF catheter lost inhibitory effect against Enterococcus 
faecalis after 3 days. Among the other prominent study is one published by Johnson et al., [42] 
which demonstrated the effectiveness of NF catheter against 86 susceptible and multidrug-
resistant (MDR) clinical isolates (Escherichia coli, Klebsiella pneumoniae, Citrobacter freundii, 
Staphylococcus aureus, coagulase-negative staphylococci, and non-vancomycin resistant 
Enterococcus faecium [74, 75].  
 
A prospective double blind trial conducted by Maki et al., [39] showed a significant threefold 
reduction in the rate of CAUTI with a nitrofurazone impregnated catheter compared to standard 
silicone catheters for the first five days. In another study by Leclair [76] nitrofurazone catheters 
introduced in burns intensive care units reduced the catheter associated infections from 24.4 per 
1000 catheter to 7.5 per 1000 catheters. Similarly, Stensaballe et al., [77] conducted a double 
randomized controlled trail and showed significantly less infection rate in nitrofurazone group 
compared to control group. Whilst many clinical trials and in vitro analysis suggest effectiveness 
of nitrofurazone containing catheters, the data however show the use of catheter is only beneficial 
in the first five days of catheterisation [78].  
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1.5.3 Silver containing catheters  
 
Silver has been used for many decades for its antimicrobial properties, with a variety of 
applications ranging from treatment of conditions such as burns, abscesses and other types of 
infections and as part of wound dressings [79]. It has a broad antimicrobial spectrum and does 
not promote bacterial resistance. Silver exerts its activity by releasing silver ions in surrounding 
environment which have a bacteriostatic action at low concentrations (0.1µg/ml) and are 
bactericidal at high concentrations (1.6µg/ml) [80]. Silver has been used in a range of medical 
devices and in many ways to reduce CAUTIs. An in vitro analysis was undertaken by Veldhoen 
et al. [81], where silver was shown to inhibit colonisation of the urinary tract by Proteus mirabilis, 
Escherichia coli and Pseudomonas aeruginosa. The inhibition was only seen for the first 10 days 
of catheter insertion compared to experimental models with no silver where colonisation was seen 
approximately after five days. 
 
Silver containing catheters are available as silver alloy coatings or as silver oxide. Many studies; 
in vitro and clinical trials have been performed to evaluate the efficacy of silver containing 
catheters compared to standard catheters. Two commercially available silver containing catheter 
available in the UK are the Bardex IC and the Dover Silver catheter. The Bardex IC catheter is 
manufactured by Bard and contains silver with gold and palladium (Figure 1.10) whereas the 
Dover silver catheter is coated with hydrogel containing silver [82]. The Bardex IC catheter 
claims to have a precise balance of elements i.e. silver, gold and palladium that are released at a 
constant rate to prevent the microbial adherence and biofilm formation [83]. According to the 
manufacturers the catheter reduces the rate of CA-UTIs up to 47%. 
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Figure 1.10: Bardex IC [83]. 
 
Johnson et al. [42] conducted a clinical investigation on 482 acutely hospitalized patients to 
compare efficacy of silver oxide coated catheters with uncoated catheters. The study showed a 
reduce rate of CA-UTIs in female patients (19% for control verses 0 for silver oxide coated 
catheters) compared with a control silicone catheter. The efficacy of silver–alloy catheters has 
also been evaluated but showed conflicting results. Different results have been reported by 
various authors, for instance Rupp et al. [84] reported that use of silver alloy coated catheter 
decreased the rate of infection compared to the standard latex based catheter. They reported that 
the incidence of CA-UTIs decreased from 6.13/1000 to 2.6/1000 over a 2-year period. Similarly, 
Schumm and Lam [85] reported a significant decrease in the risk of asymptomatic bacteria when 
they used a silver alloy catheter, for up to two weeks. However, a randomized study conducted 
by Riley et al., [86] on 1,309 catheterised patients showed that 5% silver oxide coated catheter 
did not have antimicrobial effect compared to a standard catheter. Surprisingly silver oxide coated 
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catheters showed an inexplicable increased incident of bacteriuria in male patients with a high 
occurrence of Staphylococcus.  
 
Niel-Weise [87] reviewed seven clinical studies that compared silver oxide coated catheters with 
standard catheters, however did not find sufficient evidence to recommend the use of these 
catheter. Similarly, in a study conducted by Srinivasan et al [88] on silver-silicone hydrogel 
showed no benefit of silver in preventing bacteriuria. While some studies strongly suggest 
benefits of silver coated catheters, many others [89-91] question the quality of the trials. They 
criticised that the fundamental criterion for infection is inconsistent, lacking the distinction 
between UTI and asymptomatic bacteriuria, as symptomatic infection is of clinical interest not 
asymptomatic UTI. 
 
1.5.4 Limitations 
 
Several studies and reviews have been undertaken on efficacy of antimicrobial catheters, however 
the effectiveness of these catheters is still not proven. The lack of activity of antimicrobial 
catheters could be due to several reasons. 
 
1. Deposition of conditioning film on the catheter surface protect microorganisms from getting 
in direct contact with antimicrobial surface or components in the catheter. This was shown 
in studies where bacterial colonisation was seen shortly after deposition of a conditioning 
film [92, 93]. 
 
2. The release rate of the antimicrobial components from the catheters also plays a role. The 
antimicrobial efficacy of the coatings is highly dependent on the mechanism by which 
active components are incorporated in to the devices which subsequently affect the uniform 
dissolution of the ions into the surrounding aqueous environment. Thus, the lack of activity 
could be either antimicrobial components (e.g. Ag+) are not released from the coatings or 
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the coating itself is washed off relatively quickly hence provide the chance for bacterial 
colonisation [94, 95]. 
 
3. Furthermore, certain materials such as the hydrophobic silver-oxide coatings, discourage 
dissolution which explains the lack of antimicrobial activity of silver ions [96].  
 
4. The efficacy of the released antimicrobial ions can be affected by the presence of certain 
organic and inorganic components in the local environment. For instance, it has been shown 
that the effectiveness of silver is reduced in the presence serum, chloride ions and albumin 
[95]. 
 
Studies have been undertaken that provide sufficient evidence that antimicrobial catheters can 
delay or prevent colonisation in short term catheterised patients, however there is no proven 
benefit of using these catheters in long term catheterised patients. Proteus mirabilis has been 
shown to migrate across and form biofilms even on silver containing catheters when inserted for 
long term [3, 33, 97, 98]. To conclude, technological innovations have been introduced and 
evaluated in past two decades, however unsuccessful trials of antiseptic coated catheters and 
development of resistance in antibiotic impregnated catheters calls for development of new 
catheter coatings. Therefore to achieve clinically significant results there is still a need for 
development of an antimicrobial catheter, that will prevent bacterial adhesion for an extended 
period (>30 days) with a sustained release of antimicrobials.  
 
 
1.6  Bioactive glass -  A delivery system 
 
Glasses could potentially be used to provide a controlled release of antimicrobial ions. Bioactive 
material, as the name indicates, is one that elicits a specific biological response at the interface 
of the material which results in the formation of a bond between the tissues and the material [99-
101]. Structurally a glass is similar to a liquid but since they have high viscosity they are classified 
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as solid materials. Glass is defined as a solid that possesses a non-crystalline structure and 
exhibits a glass transition temperature when heated towards the liquid state [99].  Bioactive 
glasses therefore are a class of biomaterials that elicit a biological response at the interface of the 
material which stimulates cell proliferation, differentiation and forms a bond between living 
tissue and the material [101-103]. The first bioactive glass, later termed as 45S5, was invented 
by Professor Larry Hench in 1969 as an alternative to inert implants and since then many new 
materials with various glass compositions have been investigated. A brief account of glass 
synthesis, structure and applications is given below. 
 
1.6.1 Synthesis 
 
Bioactive glasses can be classified into two categories based on the method used to synthesize 
them; melt-quench and sol-gel. In the melt quench method the raw materials are heated up to high 
temperatures usually between 1200-1500°C, in a platinum crucible for a period [104]. This 
creates a melt which if cooled at a sufficiently high rate prevents crystal growth resulting in glass 
formation. To suppress crystallisation, the melt is poured in a pre-heated graphite mould or water 
and cooled slowly to room temperature to remove any residual stress. [105]. On the other hand, 
sol gel glasses are prepared by a chemical based process in which glasses are prepared by a 
polycondensation reaction from organic precursors (alkoxides) [105]. Sol-gel glasses, unlike 
conventional melt-quench glasses, require lower temperatures.  
 
The manufacturing process of the melt-quench and sol-gel glasses results in some differences in 
the glass structures. Sol-gel glasses have an inherent nanoporosity whereas melt-derived glasses 
are dense in nature [106, 107]. Sol-gel glasses tend to have higher dissolution rates due to higher 
surface area and hence higher bioactivity compared to the melt-quench glasses. The first bioactive 
glass, 45S5 was made using melt-quench method and since then most of the glasses to date are 
made using this method. This is because the technique is simple, low cost and requires less time 
to complete in contrast to sol-gel glasses. Additionally, the sol-gel application of Na2O-
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containing bioactive glasses is limited due the high hydrolytic reactivity of sodium alkoxide in 
water [108]. A schematic representation of glass synthesis via melt-quench and sol-gel method is 
given in Figure 1.11. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.11: Schematic representation of glass synthesis via melt-quench and sol-gel method. 
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1.6.2 Structure 
 
Glass is an amorphous solid that lacks a long range order or symmetry of atomic arrangement 
and exhibits time-dependent glass transformation behaviour [105]. Glass transition behaviour can 
be described based on a volume-temperature diagram (Figure 1.12). When a liquid is cooled to 
any temperature below the melting temperature, Tm, it will result in the conversion of the material 
to the crystalline state with long range periodic atomic arrangement [109]. However, if the 
cooling is quick enough, crystallization is inhibited and a glass will be formed. The glass 
transformation or glass transition occurs over a range of temperatures Tg and cannot be 
characterized by any single temperature [109]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.12: Schematic representation of glass or crystal formation from liquid melt. Tg (glass 
transition temperature), marks the transition of the super cooled liquid to a glassy state where as 
Tm represents the melting temperature. Adapted from [110].  
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A glass is a network of atoms bonded to oxygen via covalent bonds. Three different components 
are described within in glass structure; network former, network modifier and intermediate 
oxides. It is possible to make a glass with network former such as silica (SiO2), phosphorus 
pentoxide (P2O5), and boron trioxide (B2O3) without the need for additional components. For 
instance, silicate glass consists of silica tetrahedron (SiO2) as the building units, that are 
connected to each other by oxygen atoms (– Si – O – Si –), commonly termed as bridging oxygen 
atoms (BO). Thus, in a vitreous silica each tetrahedron is linked to another by each of its four 
corners corresponding to four BOs per tetrahedron. In other words, vitreous silica has a network 
connectivity (NC), defined as the average number of BO atoms bound to a network-forming 
cation, of four, that decreases when network modifiers are added.  
 
The addition of network modifiers, such as sodium and calcium oxides cause cleavage of covalent 
– Si – O – Si – bonds, which results in formation of non-bridging oxygen atoms (NBOs). Thus, 
the resulting glass structure not only contains covalent bonds but also ionic cross-links between 
NBOs (Figure 1.13). The third class of glass components is the intermediate oxides. These oxides 
can switch their role, depending upon the composition, as network former or modifier. Examples 
include magnesium, iron, aluminium, zinc and titanium etc.  
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Figure 1.13: (A) Two-dimensional structure of crystalline silica and (B) vitreous silica. The 
network periodicity and symmetry of crystal silica differs from the disorder seen in the glass 
network. (C) Two-dimensional glass structure with network modifiers [111].  
 
1.6.3 Bioactivity 
 
The bioactivity of glasses, as described earlier, is their ability to elicit a specific biological 
response in the human body. The bioactivity of glasses can be estimated based on their 
composition i.e. the content of glass formers and modifiers. For instance, in silicate glasses if the 
silica content is greater than 60 mol % a highly-connected network is formed which results in low 
dissolution and hence low bioactivity. However, addition of calcium and sodium ions opens the 
glass network allowing better penetration of water molecules thus facilitating glass dissolution 
and hence bioactivity. Bioactivity map of soda – lime – phosphosilicate glass is shown in Figure 
1.14, glasses in region A bond to bone and thus are bioactive whereas glasses in region B are bio-
inert and would result in scar tissue encapsulation upon transplantation. Glasses in region C are 
chemically unstable as the silica content is low and soda content is high hence degrade quickly 
when in aqueous environment (< 30 days). Region D contains composition with very low silica 
content such that it is not possible for it to form a glass network or crystallisation occurs.   
A C B 
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Figure 1.14: Bioactivity map of SiO2 – Na2O – CaO glass system showing regions of bioactivity 
[105].  
 
Bioactive glasses when immersed in aqueous solutions such as body fluids or simulated body 
fluids, dissolve slowly and release dissolution products such as calcium, sodium or phosphate 
ions, which are found within the body, particularly in bone. The dissolution products of bioactive 
glasses can form a carbonated hydroxyapatite layer on their surface [108, 112] which structurally 
and chemically is like the mineral phase of bone thus binds firmly with living bone and tissue 
[102, 112, 113]. Initially bioactive glasses were used as a material for bone regeneration and since 
the discovery of 45S5, bioactive glasses have been extensively investigated for their use in dental 
and orthopaedic fields. For instance, monolithic 45S5 was used as middle ear prostheses to restore 
the ossicular chain and to treat conductive hearing loss. It is also used as a synthetic bone graft to 
regenerate and heal bone defects [114]. Recently particulate bioactive glass can be found as the 
active ingredient of toothpaste to reduce sensitivity in teeth [105]. However, in recent years 
bioactive glasses have been shown to possess useful properties such as angiogenesis, 
remineralising potential and antimicrobial activity [112]. 
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1.6.4 Antimicrobial properties 
 
The ability of bioactive glasses to kill microorganisms has been investigated in the past two 
decades. It was not until 1998 that Stoor et al., investigated the antimicrobial effect of particulate 
bioactive glass on oral microorganisms [115]. In vitro S53P4 was shown to kill pathogens 
connected with enamel caries (Streptococcus mutans), root caries (Actinomyces naeslundii, S. 
mutans) and periodontitis (Actinobacillus actinomycetemcomitas) [116]. The same glass 
composition demonstrated antimicrobial effect against E. faecalis in dentinal tubules [117]. 
Similarly, 45S5 Bioglass was shown to reduce supragingival and subgingival bacteria [118] as 
well as persistent root canal infections due to enterococci [119].  
 
The exact mechanism of action of bioactive glasses is not yet clearly understood, however, initial 
studies on the antimicrobial efficacy attributed the killing of microbes due to changes in the pH 
of the solution. Like all cells, microorganism can tolerate changes in pH within an optimum range, 
however a significant change in the pH is detrimental to cells. According to Hu et al. [120], the 
alkali ions released from the bioactive glass alters the pH gradient of the cytoplasmic membrane 
which is required for the movement of organic nutrients and components into the cell. A higher, 
i.e. non-physiological concentration of dissolution products effects the osmotic pressure and thus 
cause cell death. While silica based bioglasses have shown some antimicrobial properties, the 
associated limitations such cytotoxic effects of prolonged silica exposure and slow degradation 
has led to the emergence of phosphate based glasses as potential alternatives [121].   
 
1.7 Phosphate glasses 
 
Glasses can be categorised based on the glass formers, those with phosphate as the network 
former are termed phosphate glasses. As discussed in section 1.6, silicate glasses have been 
extensively researched for many years for their tissue regeneration properties [121]. Many silicate 
glasses including 45S5 have shown success in dental and orthopaedic applications, however the 
long-term use of these glasses has been questioned due to their slow degradation in vivo which 
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can take up to two years [122, 123]. Due to this limitation, the search for new biomaterials has 
led to the emergence of phosphate glasses.        
 
Like silicate glasses, the building block of the phosphate glasses is a tetrahedral unit. The glass 
forming component is P2O5 and the basic unit is the orthophosphate (PO4 3-) tetrahedron (a 
phosphorus atom surrounded by four oxygen atoms). The PO4 unit is different from the SiO4 unit 
as phosphorus has a 5+ charge where one of the oxygen atoms share their two-unpaired electron 
with the P5+ ions and form a terminal double bond whereas silicon has 4+ where all oxygen atoms 
form single bonds (Figure 1.15). Whilst in a silica tetrahedral unit all oxygen atoms are equally 
shared and act as bridges, in phosphate tetrahedron only three oxygen atoms act as bridges, which 
limits the connectivity of phosphate glasses relative to their silicate counterparts [121]. This 
makes phosphate glasses less rigid or durable compared to silicate glasses [124]. 
 
 
 
 
 
 
 
 
Figure 1.15: Silicate and Phosphate tetrahedral structures. 
 
Unlike pure vitreous silica which is chemically and thermally stable, pure P2O5 glasses are very 
reactive and hygroscopic therefore modifiers such as calcium and sodium oxide are added to 
improve their durability [105]. Like all other bioactive glasses, the bioactivity of phosphate 
glasses is determined by their structure, i.e. content of P2O5 and network modifiers. Unlike 
silicate glasses, vitreous P2O5 is susceptible to hydrolysis as water or atmospheric humidity can 
disrupt the glass structure by creating POH groups instead of POP linkages [105].  
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Phosphate glasses belong to a class of materials known as controlled release glasses (CRG) which 
have several distinctive properties making them a unique group of materials. The most desirable 
characteristic is their complete dissolution in aqueous solutions, leaving no residues. The 
dissolution rate can be altered from hours to several weeks by adjusting the glass composition 
and thus a wide range of glasses can be prepared according to the end application. Not only does 
their dissolution remain constant for as long as the material remains in the body but also the 
components of the glass can be easily excreted as these are found naturally in human body [121]. 
The ability of phosphate glasses to dissolve at a constant rate and the non-toxic nature of the 
dissolution products makes them highly favourable for clinical applications. Like any bioactive 
glass the immersion of these glasses in aqueous solution results in glass degradation, as the glass 
degrades it affects not only the ionic composition of the environment but also the pH. Generally, 
with an increasing P2O5 content the pH decreases and vice versa.   
 
As stated earlier, the dissolution of glasses results in release of ions in the local environment, 
therefore biologically active elements such as metal ions can be incorporated and delivered at 
constant rate into surrounding aqueous environment. Phosphate glasses doped with antimicrobial 
ions can be used as localised antimicrobial delivery systems [121]. Whilst studies [125, 126] have 
shown the antimicrobial effect of phosphate glasses with only calcium and sodium as modifiers, 
the inclusion of antimicrobial ions such as copper, silver and gallium have shown additional 
benefits in killing microorganisms[127-129]. 
 
In recent years phosphate-based glasses have been prepared by incorporating antimicrobial 
components such as silver and copper for dental applications. Knowles et al. [130] investigated 
the antimicrobial effect of silver-doped phosphate-based glass on planktonic bacteria as well as 
the effect of increasing copper content in phosphate based glasses on biofilms of Streptococcus 
sanguinis [127]. Both studies demonstrated antimicrobial properties of the given glass 
compositions. 3 and 5% mol Ag significantly inhibited growth of both Gram positive and negative 
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bacteria as well as C. albicans. 10% and 15% Cu doped glasses also showed a considerable log 
reduction in bacterial count within 24 hours compared to the glass without copper ions. 
 
When considering bone tissue regeneration, antimicrobial efficacy or any other biological effects 
of bioactive glasses, it is essential to evaluate the cytotoxic effect of the glasses as well. Bioactive 
glasses have been extensively investigated for bone repair and regeneration as well as in dental 
field. Biocompatibility of bioactive glasses is a key element when it comes to their in vivo 
applications. The composition of bioactive glasses has a significant effect on their ability to 
support cell growth and proliferation. Phosphate glasses or bioactive glasses in general are 
believed to have non-cytotoxic effects on various cells [112, 131-133].  
 
To conclude, the higher incidence of CA-UTIs and unsuccessful clinical trials of currently 
available antimicrobial catheters highlights the need to investigate novel antimicrobial coatings 
for reducing the risk of infections caused by indwelling catheters. Previously glasses have been 
shown to be safe for inserting into bladder lining without causing major toxic and inflammatory 
responses [134]. Since the safety of Bioglass has been tested in vivo and in vitro therefore it can 
serve as a potential delivery system. 
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1.8 Aims of the study 
 
The aims of the current project were/are to 
 
• Manufacture and study the dissolution behaviour of 1, 3, 5 and 10 mol % cobalt 
phosphate glasses 
o Determine the changes in the pH and ionic concentration of the aqueous 
environment studied 
•  Manufacture and study the dissolution behaviour of 1, 3, 5 and 10 mol % zinc phosphate 
glasses 
o Determine the changes in the pH and ionic concentration of the aqueous 
environment studied 
 
• Determine the antimicrobial properties of 1, 3, 5 and 10 mol % cobalt phosphate glasses 
against microorganisms in planktonic growth mode. 
 
• Determine the antimicrobial properties of 1, 3, 5 and 10 mol % zinc phosphate glasses 
against microorganisms in planktonic growth mode.   
 
 
• Study the antimicrobial efficacy of 5 mol % copper, cobalt and zinc doped phosphate 
based glasses; alone and in combination against microorganisms in planktonic growth 
mode.  
  
• Undertake a cytotoxic evaluation of 3, 5 and 10 mol % cobalt doped phosphate glasses 
against uroepithelial cells 
 
• Undertake a cytotoxic evaluation of 3, 5 and 10 mol % zinc doped phosphate glasses 
against uroepithelial cells. 
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Chapter 2 
Manufacturing and study of dissolution 
behaviour of cobalt and zinc doped phosphate 
glasses 
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2.1 Introduction 
 
Phosphate glasses, due to lack of chemical stability, are soluble in aqueous media and thus can be 
used for a wide range of biomedical applications. The highly favoured characteristic of these 
glasses is the controlled release of the ions in to the surrounding media without toxic effects. 
Phosphate based glasses have long been in existence however, their application was limited by 
their lack of chemical durability. In the 1950s, the addition of 30% CaO to pure vitreous P2O5 
was shown to significantly improve the glass durability [1]. It is now well established that the rate 
of dissolution of phosphate glasses can be controlled by varying the composition of the glasses. 
In the past few decades these glasses have been widely studied as controlled release glasses that 
can be used to deliver specific ions in a local environment. Phosphate based glasses have uniform 
dissolution over a period within ten minutes of leaching and the system is believed to maintain 
the dissolution for over a year [2]. It has also been demonstrated that the dissolution is constant 
and non-selective leaching occurs. 
 
As previously stated, phosphate based glasses consist of PO4 tetrahedron which is connected to a 
maximum of three neighbouring tetrahedra forming a network. Addition of modifiers such as 
sodium or calcium leads to depolymerisation of the network and creates non-bridging oxygen 
atoms. The mechanical strength of the glass is thus increased due to the ionic cross-links between 
non-bridging oxygen atoms. Several theories have been proposed to elucidate and understand the 
dissolution mechanism of phosphate based glasses. According to the widely accepted theory, 
proposed by Bunker et al. [2] the glass dissolution occurs in two interdependent steps. In the first 
step a hydrated layer is formed on the surface of the glass due to exchange of sodium ions in glass 
with hydrogen ions in water, Figure 2.1 [2-4].  
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Figure 2.1: showing the dissolution mechanism of phosphate glasses; adapted from Gao et al.[3]. 
 
This step results in leaching of alkali or alkaline earth metals into water creating a P2O5 rich 
surface layer. In the second step the P-O-P bonds in the hydrated layer breaks and release 
phosphate chains of varying length into the solution [3]. However contrary to this theory Delahaye 
et al., argued that the dissolution of the glasses is controlled by ionic strength of the solution and 
not the ion exchange [5]. Throughout the whole process the phosphate glass dissolves congruently 
which means that the dissolution products that are in the solution have identical composition with 
that of the bulk glass [6]  
 
The solubility of phosphate glasses can be tailored by changing the compositions i.e. by the 
addition of various metal oxides. For instance, the addition of alkali oxides to phosphate glasses 
has been shown to increase the dissolution rate in aqueous environment whereas addition of 
alkaline earth metals increases the chemical stability. For this study, a ternary glass P2O5-Na2O-
CaO was selected as the delivery system. These glasses are not only biocompatible with low 
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toxicity and inflammatory response but also their solubility can be tailored by varying the amount 
of calcium oxide. An increase in CaO content decreases the glass solubility and vice versa [7-9]. 
Since the solubility of these glasses is linear with time therefore incorporating antimicrobials in 
such glass system will ensure constant delivery of the active ions as the glass dissolves. In the 
given study dissolution behaviour of sodium calcium phosphate glasses doped with cobalt and 
zinc was investigated.  
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2.2 Aims 
 
The aim of the given study was to manufacture cobalt and zinc doped phosphate based glasses 
and investigate various parameters associated with glass dissolution. This was achieved by 
studying: 
• Dissolution behaviour of glasses with increasing metal oxide content 
 
• Degradation rates of various glass compositions in different aqueous media such as 
distilled water, nutrient broth, synthetic urine and cell culture media 
 
• Changes in pH values of the surrounding media when glasses dissolve 
 
• The release of ionic species via inductively coupled plasma analysis as a function of 
time. 
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2.3 Methods and Materials 
 
 
2.3.1 Glass preparation 
 
The glasses were prepared using a melt quench method as the technique is simple, low cost and 
requires less time to complete compared to sol-gel glasses. The starting precursors were P2O5 
(99%, Fisher Scientific), NaH2PO4 (>99.0%, Sigma Aldrich, Dorset, UK) and CaCO3 (99.95%, 
Alfa Aesar, Lancashire, UK). To produce cobalt, copper and zinc containing phosphate based 
glasses CoO (99%, Sigma Aldrich, Dorset, UK), CuSO4 (99%, Sigma Aldrich, Dorset, UK) and 
ZnO (99%, Fisher Scientific) was used respectively. The glass prepared had a fixed concentration 
of P2O5 (50 mol %) along with a fixed Na2O content of 20 mol %. The remaining CaO (30-x) 
was substituted accordingly with X amount of CoO, CuSO4 or ZnO. The glass compositions 
investigated are given in the Tables 2.1a and 2.1b below: 
 
                          Mol % 
 P2O5 
 
CaO 
 
Na2O 
 
CoO 
 
0% mol Co 50 30 20 0 
1% mol Co 50 29 20 1 
3% mol Co 50 27 20 3 
5% mol Co 50 25 20 5 
10% mol Co 50 20 20 10 
 
Table 2.1a: Compositions of cobalt doped phosphate glasses investigated. 
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                          Mol % 
 P2O5 
 
CaO 
 
Na2O 
 
ZnO 
 
0% mol Zn 50 30 20 0 
1% mol Zn 50 29 20 1 
3% mol Zn 50 27 20 3 
5% mol Zn 50 25 20 5 
10% mol Zn 50 20 20 10 
 
Table 2.1b: Compositions of zinc doped phosphate glasses investigated 
 
To evaluate the effect of incorporating two different metal oxides in one glass, additional samples 
were prepared. These glasses had a fixed concentration of P2O5 (50 mol %) along with a fixed 
CaO and Na2O content, 20 mol % each. The remaining 10% was substituted accordingly with 5 
mol % of CoO, ZnO or CuO. The combinations investigated were Co/Zn, Co/Cu and Cu/Zn; as 
shown in the Table 2.2 
 
                          Mol %   
 P2O5 
 
CaO 
 
Na2O 
 
CoO 
 
CuO ZnO 
Co/Cu 50 20 20 5 5 0 
Co/Zn 50 20 20 5 0 5 
Cu/Zn 50 20 20 0 5 5 
 
Table 2.2: Glass compositions for evaluating synergistic potential of the glasses 
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The required chemicals were weighed out and placed into a 59 ml Pt - 10% Rh crucible (GLC 
alloys Ltd Middlesex, UK). After mixing the chemicals thoroughly the crucible was placed in a 
furnace at room temperature. The furnace was heated up to 300°C (10°C per minute) and dwelled 
for an hour. The temperature was then raised up to 600°C (60°C per minute) and after dwelling 
for 30 minutes, once again temperature was rapidly increased (60°C per minute) up to 1050°C and 
held at this temperature for 30 minutes. The molten glass was then poured into a split graphite 
mould, with 10 mm aperture (Figure 2.2), which had been preheated at 350°C.  
 
 
Figure 2.2: A split graphite mould (A – open, B – closed) with 10 mm aperture. 
 
The glass samples were allowed to slowly cool down to room temperature (inside furnace 
previously heated to 350°C) and the resulting glass rods were cut into 2.5 mm thick discs with an 
IsoMet™ 1000 Precision saw using Cool 2 cutting fluid as lubricant (Buehler). Discs were 
polished using MetaServ® (Buehler) polishing machine using a series of polishing cloths (30µ, 
15µ using lapping oil) followed by a final polish using 0.02µ colloidal silica. The discs were 
cleaned in acetone and air dried. To determine the effect of glasses in combinations, glass powders 
were used. Each glass composition was ground using mortar and pestle and sieved in the particle 
size range from 40-60 microns. Prior to undertaking the experiments, glass discs and powders 
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were sterilised using dry heat at 180°C for 2 hours. Samples were stored in a desiccator between 
stages of preparation to reduce exposure to atmospheric moisture. 
 
2.3.2 Glass characterisation using High Energy X-ray Diffraction 
High energy X-ray diffraction was carried out to determine the amorphous nature of the 
manufactured glasses. The experiments were carried out at I-15 beamline at Diamond Light 
Source, Harwell, UK. The instrument was set up to collect data in a 2θ geometry with a Si 
monochromatic, the energy of the X-ray beam was 76.7 KeV, λ = 0.162 Å. Finely ground glass 
powders were loaded in to 1.17 mm x 1.5 x 40 mm SiO2 glass capillaries at room temperature and 
mounted on sample changer (placed at right angles to incident X-ray beam). An empty capillary 
was measured to account for background corrections. Data corrections and normalizations were 
carried out using GudrunX [10].  
 
Degradation studies 
Glass rods with 10 mm diameter were cut into 2.5 mm thick discs and polished to 400 grit finish. 
To determine the surface area of the discs their exact thickness was measured using Vernier 
callipers (Fisher Scientific Loughborough, Leicestershire). The discs were then placed in 60 ml 
plastic containers with an internal diameter of 37 mm (Fisher Scientific Loughborough, 
Leicestershire) filled with 25 ml of standard distilled water (SDW). The containers were then 
placed on an orbital shaker in a 37°C incubator at 200 rpm. At various time intervals, i.e. every 
24 hours for 7 days glass discs were taken out of their respective containers and weighed after 
removing the excess moisture using paper towel. To determine the degradation rate, weight loss 
was calculated, as shown below. 
 
Weight loss = (M0 - Mt)/A  ……...     (2.1) 
 
83 
 
where,  M0 – initial weight in mg  
Mt – weight at time t in mg  
A is the surface area, cm2 
Weight loss was plotted against time and the slope of the graph gave a degradation value (mgcm-
2 h-1). Degradation analysis was also conducted in nutrient broth (NB), Surine™ (SU- synthetic 
urine) and in urothelial cell culture media (CM) supplemented with 10% FBS and 1% 
penicillin/streptomycin. Nutrient broth, Surine™ and Urothelial cell media were purchased from 
Oxoid, Sigma Aldrich and ScienCell laboratories respectively. Each measurement was carried out 
in triplicate. 
 
2.3.3  pH analysis 
 
pH measurements of the degradation media were taken at every time point using pH meter 
(Mettler Toledo, Switzerland). Three-point calibration of the pH electrode was achieved using pH 
calibration standards; 4.0, 7.0 and 10 (Fisher Scientific, Loughborough, UK) at 25°C. 
 
2.3.4 Ion release study 
 
The medium obtained at each time point from degradation studies was analysed for the presence 
of cation (Na+, Ca2+, Co2+) and anion (PO43-) using inductively coupled plasma optical emission 
spectrometry, ICP-OES (iCAPTM 7000 Plus Series). ICP-OES is an analytical technique that is 
used for quantification of trace metal ions in a sample. Three ml of each samples was initially 
passed through a nebuliser to create aerosols which are then passed through inductively coupled 
plasma at high temperatures to produce excited ions. The resulting species were then separated 
and detected with an optical emission spectrometer (OES). The dissolution products were filtered 
prior to measurements using 0.2µm Minisart filters (Fisher Scientific, UK) and the concentration 
of each ion was calculated from the linear portion of the generated standard curve as ppm. A 
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standard curve is the relationship between instrument response and known concentration in the 
analyte. The curves were produced using a blank and a five-point calibration (0.1, 0.5, 1.0, 5.0 
and 10.0 ppm) of the elements investigated in the study. The calibration samples along with 
quality control samples were diluted in 1 N nitric acid.  
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2.4 Results  
 
2.4.1 Cobalt doped phosphate glasses 
 
2.4.1.1 Glass characterisation using High Energy X-ray Diffraction 
The amorphicity of the cobalt doped phosphate glasses was determined by using high energy X-
ray diffraction analysis. Figure 2.3 shows data from the phosphate based glasses doped with 1, 3, 
5 and 10 mol% cobalt doped along with an un-doped glass. Crystalline solids reveal significant 
and sharp peak when characterised whereas the broad peaks are indicative of amorphous    
structure. The HEXRD pattern shows broad peaks suggesting that the glasses obtained were 
amorphous.     
 
 
Figure 2.3: High Energy X-ray diffraction pattern of synthesised cobalt doped phosphate based 
glasses (1, 3, 5 and 10 mol %) measured at I-15 beamline at Diamond Light Source, Harwell, UK. 
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2.4.1.2 Degradation analysis  
 
 
Degradation data for each glass composition, shown in Figure 2.4, was obtained by applying a 
line of best fit through the weight loss per unit area against time. A linear increase in weight loss 
as a function of time is observed for all samples in all solutions. The control glass (un-doped 
phosphate glass) has the largest weight loss and this weight loss decreases with increasing CoO 
content for all the solutions tested. Nutrient broth and cell culture media displayed broadly similar 
dissolution profiles of ~ 2.3 - 2.6 mg/cm2 for the control glass, with the dissolution reducing by 
an order of magnitude for the 10% doped CoO glass. Values of 2.1, 1.4 and 1.1 mg/cm2 were 
observed for the 1%, 3% and 5% CoO respectively.  
 
Whilst the dissolution of glasses in all media followed the same trend of decrease in dissolution 
with an increase in cobalt oxide content, the rate of degradation was however significantly 
different. The dissolution rates were approximately twice as high when the samples were placed 
in distilled water compared to nutrient broth and cell culture media. For instance, the degradation 
value at day 7 for 1% cobalt glass in distilled water was 27 mg/cm2 whereas the degradation rate 
was 14 mg/cm2 and 15 mg/cm2 in nutrients broth and cell culture media respectively. Glass 
degradation was significantly higher when immersed in synthetic urine, for example the control 
and 1% CoO glasses weight loss was ~7.5 times greater in synthetic urine compared to nutrient 
broth and cell culture media. 
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Figure 2.4: The degradation profiles obtained for 0, 1, 3, 5 and 10 mol % Co compositions, 
investigated in distilled water (A), nutrient broth (B), synthetic urine (C) and cell culture media 
(D). The data shows variable degradation rate in different media. (Error bars = ±SD for triplicate 
samples.
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2.4.1.3 pH studies 
 
The pH analysis displayed a sharp decrease in the pH value of the distilled water for all 
compositions within 24 hours where the values dropped from 6.7 to ~ 3.9 - 4.5 for the remaining 
duration of the study, as seen in the Table 2.1. Cobalt free composition showed the maximum 
decrease in the pH value followed by 1 mol % cobalt glass. The pH values observed for 3 and 5 
mol % cobalt glasses were similar from day 0 to 7. 10 mol % cobalt compositions however had 
slightly higher pH values than 3 and 5 mol % compositions.  
 
On the other hand, nutrient broth, cell culture media and synthetic urine appeared to have a 
buffering capacity as the pH values remained within a narrow range. The pH of nutrient broth and 
cell culture media were in the optimum range for the duration of the study between 6.3-6.9 and 
7.8-8.3. However, the pH values in synthetic urine was highly alkaline due to the initial alkaline 
pH of the synthetic urine. 
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Distilled water 
 
Nutrient broth 
Day 0 1% 3% 5% 10% 0 1% 3% 5% 10% 
0 6.72±0.0 6.72±0.0 6.72±0.0 6.72±0.0 6.72±0.0 6.5±0.0 6.5±0.0 6.5±0.0 6.5±0.0 6.5±0.0 
1 5.13±0.22 4.72±0.05 4.8±0.02 4.85±0.02 5.04±0.02 6.84±0.04 6.82±0.0 6.93±0.04 6.93±0.04 6.88±0.03 
2 4.56±0.02 4.44±0.14 4.46±0.01 4.48±0.01 4.6±0.02 6.78±0.01 6.78±0.01 6.78±0.01 6.78±0.01 6.89±0.01 
3 4.15±0.09 4.20±0.09 4.31±0.04 4.32±0.06 4.54±0.03 6.25±0.01 6.70±0.01 6.73±0.04 6.73±0.01 6.77±0.02 
4 4.18±0.03 4.20±0.01 4.35±0.01 4.37±0.02 4.55±0.21 6.48±0.0 6.57±0.04 6.69±0.04 6.69±0.02 6.73±0.01 
5 4.16±0.04 4.15±0.014 4.25±0.03 4.29±0.01 4.50±0.03 6.72±0.01 6.42±0.06 6.5±0.02 6.5±0.01 6.71±0.11 
6 3.93±.007 4.02±0.05 4.12±0.02 4.08±0.01 4.21±0.04 6.48±0.0 6.56±0.05 6.69±0.04 6.69±0.02 6.73±0.014 
7 3.93±0.014 3.95±0.05 4.10±0.02 4.02±0.01 4.10±0.01 6.28±0.0 6.30±0.01 6.45±0.01 6.48±0.02 6.73±0.19 
 
Continued next page 
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Synthetic urine 
 
Cell Culture media 
Day 0 1% 3% 5% 10% 0 1% 3% 5% 10% 
0 9.54±0.0 9.54±0.0 9.54±0.0 9.54±0.0 9.54±0.0 7.86±0.0 7.86±0.0 7.86±0.0 7.86±0.0 7.86±0.0 
1 9.48±0.01 9.47±0.04 9.54±0.01 9.44±0.01 9.54±0.01 7.84±0.0 7.91±0.0 7.94±0.0 7.9±0.0 7.87±0.0 
2 9.37±0.02 9.38±0.02 9.47±0.03 9.49±0.01 9.54±0.01 7.90±0.0 7.91±.0 7.85±0.0 7.85±0.0 8.02±0.0 
3 9.27±0.03 9.25±0.02 9.43±0.02 9.47±0.03 9.50±0.01 7.89±0.0 7.93±0 7.85±0.0 7.85±0.0 8.09±0.0 
4 9.20±0.02 9.19±0.03 9.33±0.03 9.39±0.01 9.41±0.01 7.69±0.0 7.74±0.0 7.92±0.0 7.92±0.0 8.06±0.0 
5 9.12±0.01 9.17±0.02 9.23±0.02 9.31±0.02 9.37±0.01 7.72±0.0 7.81±0.0 7.96±0.0 7.96±0.0 8.12±0.0 
6 9.06±0.00 9.09±0.03 9.14±0.03 9.25±0.01 9.31±0.01 7.61±0.0 7.72±0.0 7.88±0.0 7.88±0.0 8.19±0.0 
7 9.10±0.03 9.17±0.01 9.24±0.01 9.26±0.01 9.32±0.01 7.73±0.0 7.83±0.0 7.98±0.0 7.98±0.0 8.34±0.0 
 
Table 2.2: shows the pH values of cobalt doped glasses (0, 1, 3, 5 and 10 mol % Co compositions), investigated in distilled water, nutrient broth, synthetic 
urine and cell culture media (Mean ± SD for triplicate sample).
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2.4.1.4 Ion release study (ICP-OES) 
 
Figure 2.5 shows the cumulative ion release profile of cobalt doped phosphate glasses in distilled 
water. The data correlated with the weight loss profiles of the glass compositions. The study 
showed the highest anion (PO43-) and cation (Ca+2 and Na+) release for the compositions with the 
highest dissolution rate, i.e. the cobalt free composition released the greatest number of ions and 
cobalt doped glasses ion release profile was in the order 1 > 3 > 5 > 10 mol %. The result showed 
that the rate of cobalt ion release is also correlated to the rate of degradation with a considerable 
difference between the 1, 3 and 5 mol % compositions, however no substantial difference was 
detected between 5 and 10 mol % cobalt glasses. 
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Figure 2.5: Cumulative ion release (A) phosphorus, (B) calcium, (C) sodium and (D) cobalt as a 
function of time for 0, 1, 3, 5 and 10 mol% cobalt doped glasses in distilled water. (Error bars = 
±SD for triplicate samples).
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2.4.2 Zinc doped phosphate glasses 
 
2.4.2.1 Glass characterisation using High Energy X-ray Diffraction 
High energy X – ray diffraction was performed to confirm the amorphicity of zinc doped 
phosphate glasses. Figure 2.6 shows data from the phosphate based glasses doped with 1, 3, 5 and 
10 mol% zinc doped along with an un-doped glass. Crystalline solids reveal significant and sharp 
peak when characterised whereas the broad peaks shown in Figure 2.6 suggest that the glasses 
obtained were amorphous.       
 
 
 
Figure 2.6: High energy x ray diffraction data on zinc doped phosphate based glasses (0, 1, 3, 5 
and 10 mol %) measured at I-15 beamline at Diamond Light Source, Harwell, UK.  
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2.4.2.2 Degradation analysis 
 
Figure 2.7 shows weight loss per unit area measured (mg/cm2) over a week. Unlike cobalt doped 
glasses where the weight loss was observed to decrease with an increasing cobalt oxide content, 
zinc also showed a mixed dissolution behaviour. Glass degradation decreased with an increasing 
zinc oxide content up to 3 mol % Zn, however an increase in dissolution/weight loss was observed 
for 5 mol % Zn and 10 mol % Zn compared to 3 mol % Zn. The order of weight loss observed 
was 0 > 1 > 3 < 5 < 10 mol %. The weight loss for 10 mol % Zn was similar to zinc free 
composition, for example at day 7 the weight loss for zinc free glass was 33 mg/cm2 and 31mg/cm2 
for 10 mol % Zn glass, whereas 3 mol % Zn was least soluble composition (24 mg/cm2) of the 
glasses analysed. The dissolution trend described above was also observed in other media; 
nutrients broth, synthetic urine and cell culture media (Figure 2.7) however, the cumulative mass 
loss observed in nutrient broth and cell culture media was almost half that of distilled water and 
four times that in synthetic urine.  
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Figure 2.7: The degradation profiles obtained for 0, 3, 5 and 10 mol % Zn compositions, 
investigated in distilled water (A), nutrient broth (B), synthetic urine (C) and cell culture media 
(D). The data shows variable degradation rate in different media. (Error bars = ±SD for triplicate 
samples).
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2.4.2.3 pH studies 
 
The pH values of the zinc doped glasses in different media are given in Table 2.3. The pH values 
of the zinc free glass composition, in distilled water, decreased sharply in the first 24 hours. A 
gradual increase was seen in the remaining period with the lowest value 3.8 on day 7 of the 
analysis. Similarly, the pH of the zinc oxide composition decreased rapidly within 24 hours falling 
to between 5.6 and 5.7. The pH of the zinc containing glasses did not decrease as much as that of 
the zinc free composition by day 7.  
On the other hand, a negligible change in the pH was observed for the glasses in nutrient broth, 
synthetic urine and cell culture media. The pH values remained in the optimum range throughout 
the study for nutrient broth (6.30 - 6.97) and cell culture media (7.41 - 7.56), however due to the 
initial alkaline pH of synthetic urine (9.72) high pH values were observed. The results obtained 
were in agreement with the pH studies of cobalt doped glasses (section 2.4.1.3) 
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Distilled water 
 
Nutrient broth 
Day 0 1% 3% 5% 10% 0 1% 3% 5% 10% 
0 7.37±0.0 7.37±0.0 7.37±0.00 7.37±0.0 7.37±0.0 6.97±0.0 6.97±0.0 6.97±0.0 6.97±0.0 6.97±0.0 
1 5.24±0.19 5.74±0.10 5.70±0.03 5.56±0.0 5.47±0.30 6.94±0.01 6.86±0.02 6.81±0.01 6.79±0.0 6.81±0.02 
2 4.78±0.01 5.16±0.0 5.41±0.07 5.36±0.07 5.42±0.04 6.7±0.01 6.77±0.02 06.78±0.01 6.77±0.01 6.52±0.01 
3 4.20±0.19 4.58±0.27 4.62±0.02 4.61±0.03 4.52±0.26 6.69±0.0 6.69±0.0 6.60±0.0 6.55±0.0 6.41±0.0 
4 4.23±0.01 4.47±0.11 4.50±0.05 4.42±0.09 4.47±0.16 6.48±0.0 6.56±0.04 6.69±0.04 6.70±0.02 6.51±0.01 
5 3.96±0.04 4.28±0.12 4.31±0.02 4.25±0.02 4.185±0.02 6.57±0.06 6.41±0.06 6.50±0.02 6.48±0.01 6.51±0.11 
6 3.96±0.16 4.29±0.02 4.25±0.0 4.21±0.01 4.08±0.01 6.48±0.0 6.56±0.04 6.69±0.04 6.70±0.02 6.53±0.01 
7 3.80±0.07 4.23±0.09 4.28±0.04 4.14±0.02 4.04±0.01 6.28±0.0 6.3±0.01 6.48±0.01 6.48±0.02 6.38±0.08 
 
Continued next page 
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Synthetic urine 
 
Cell Culture media 
Day 0 1% 3% 5% 10% 0 1% 3% 5% 10% 
0 9.72±0.0 9.72±0.0 9.72±0.0 9.72±0.0 9.72±0.0 7.56±0.02 7.56±0.02 7.56±0.02 7.56±0.02 7.56±0.02 
1 9.80±0.01 9.82±0.0 9.65±0.14 9.86±0.04 972.±0.01 7.51±0.03 7.52±0.0 7.55±0.01 7.55±0.01 7.55±0.01 
2 9.82±0.03 9.88±0.04 9.66±0.12 9.71±0.09 9.71±0.04 7.55±0.01 7.52±0.02 7.51±0.03 7.56±0.04 7.54±0.04 
3 9.88±0.02 9.79±0.01 9.78±0.06 9.70±0.05 9.73±0.03 7.49±0.02 7.55±0.04 7.47±0.02 7.55±0.06 7.60±0.02 
4 9.72±0.06 9.73±0.05 9.71±0.05 9.71±0.02 9.70±0.05 7.47±0.04 7.58±0.06 7.58±0.06 7.51±0.03 7.54±0.01 
5 9.77±0.02 9.71±0.06 9.66±0.09 9.68±0.05 9.74±0.01 7.48±0.02 7.50±0.05 7.49±0.07 7.49±0.07 7.51±0.07 
6 9.51±0.09 9.79±0.05 9.72±0.05 9.61±0.07 9.69±0.03 7.45±0.06 7.47±0.04 7.51±0.01 7.47±0.06 7.49±0.05 
7 9.55±0.14 9.66±0.12 9.81±0.01 9.65±0.11 9.72±0.02 7.40±0.05 7.48±0.07 7.55±0.06 7.41±0.03 7.49±0.02 
 
Table 2.3: shows the pH values of zinc doped glasses (0, 3, 5 and 10 mol %), studied in distilled water, nutrient broth, synthetic urine and cell culture 
media (Mean ± SD for triplicate sample).
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2.4.2.4 Ion release study (ICP-OES) 
 
The ion release profile was conducted to monitor the release of cations and anions from the 
different glass compositions in water over the given period (Figure 2.8). The ion release reflected 
the degradation behaviour of the glass compositions. A linear increase in the release of anion 
(PO43-) from all compositions was observed for the period investigated. By day 7, the release was 
highest in zinc free glasses (1064 ppm) followed by 10% mol zinc glass (950 ppm). A linear 
increase in ion release was also observed for cations over the 7-day period. Cation release 
increased with increasing dissolution rates, the least ion leaching was seen for the least soluble 
glass that is 3 mol % zinc phosphate glass. The release trend of sodium was like that of anion 
(PO43-). There was no significant difference in the release rate of Na+ between the compositions, 
containing 200-300 ppm.  
 
On the other hand, calcium release was highest in glass without zinc oxide, followed by 1% zinc 
glass. This was expected as the glasses with highest CaO content were the most soluble. By day 
7, between 100-300 ppm of calcium ions were leached from the given glass compositions, least 
calcium ion leached from 3 mol % zinc glass composition. As with Zn+2 ion release, an increase 
in the quantity of zinc ions was observed with increasing zinc oxide content in the glass 
compositions. 
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Figure 2.8: Cumulative ion release (A) phosphorus, (B) calcium, (C) sodium and (D) zinc as a 
function of time for 0, 1, 3, 5 and 10 mol% cobalt doped glasses in distilled water. (Error bars = 
± SD for triplicate samples).
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2.5 Discussion  
 
Glass dissolution is a complex process which not only depends on the glass composition and 
structure but also on the other factors such as the surrounding environment i.e. ionic strength, 
temperature and the pH of the solution [11]. The aim of this study was to investigate the glass 
solubility with an increasing metal oxide content in different media, subsequent changes in the 
pH and ion release profile of the glasses.   
 
The degradation rate of cobalt and zinc doped glasses showed variation in trend with increasing 
metal oxide concentration. Delahaye et al. [5] studied the dissolution kinetics of sodium-calcium 
metaphosphate glasses, according to their investigation the dissolution of the glasses is governed 
by the ionic strength of the solution; an increase in ionic strength of the surrounding environment 
decreases the weight loss with time. They postulated that the glasses with higher CaO content 
release more calcium ions which are likely to increase the ionic strength of the solution and 
subsequently decrease the dissolution rate of the glasses. In the present investigation it was 
observed that the glasses with higher calcium ions leaching had higher dissolution rates. Cobalt 
free glass composition had the highest release rate of cations and anions compared to cobalt 
containing glasses. The similar effect was also demonstrated by Franks et al., [9] where a decrease 
in glass dissolution was observed with substitution of CaO with MgO.   
 
A decline in dissolution of cobalt doped glasses was observed to occur with an increasing amount 
of cobalt oxide at the expense of calcium oxide. The observed trend in dissolution pattern fits well 
with the literature available, several studies have demonstrated that addition of metallic species 
decreased the dissolution of glasses with an increasing metal oxide content. A decrease in 
dissolution of silver doped phosphate glasses was observed by Ahmed et al. [12-15]. Brauer et 
al., [16] investigated the effect of adding titanium oxide in phosphate glasses and showed that 
increasing the amount of titanium oxide decreased the solubility of glasses in water and simulated 
body fluid (SBF). Similar effect were seen by Moss et al., [17] where addition of titanium 
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increased the chemical durability compared to titanium free composition (P2O5)50 (CaO)30 
(Na2O)20. Ahmed et al., reported systematic increase in the cross-link density, hence the chemical 
durability of MgO doped glasses compared to magnesium free glasses. Increase in gallium oxide 
content in phosphate glasses has also been shown to increase glass durability and hence decreased 
dissolution [18, 19]. 
 
The authors of the above-mentioned studies provided various explanations of the decreased 
dissolution behaviour with structural analysis of the glasses. However, it is difficult to make a 
direct comparison of the given work due to compositional variations. Even though no 
experimental study was undertaken to elucidate the change in glass dissolution, nonetheless the 
possibilities are explained here.  
 
The dissolution of metaphosphate glasses is mainly controlled by the bonding of the phosphate 
chains to the modifier atoms [20]. As stated earlier in section 1.8, the basic structural unit of 
phosphate glasses is the orthophosphate tetrahedron surrounded by four oxygen atoms. Three of 
these oxygen atoms are available to form covalent bonds with phosphorus atom, P-O-P bonds. 
The addition of other components such as calcium or sodium breaks P-O-P bonds creating non-
bridging oxygen atoms. The resulting phosphate chains form crosslinks between modifier cations 
through ionic bonds making the network more compact [21] and hence chemically durable. The 
strength of the ionic bond depends on the charge to size ratio of modifier cations. Since the ionic 
radius of cobalt is smaller than that of calcium, i.e. the charge to size ratio of cobalt is more than 
that of calcium therefore the bonds formed by cobalt are stronger than calcium. This makes the 
cleavage of the bonds difficult when cobalt is replaced with calcium making the glasses less 
soluble in aqueous media. Thus, when cobalt content is increased, the weaker Ca-O bonds are 
replaced by stronger Co-O bonds thus the dissolution decreases with an increasing cobalt oxide 
content.  
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Zinc doped glasses showed a similar trend in weight loss up to 3% compositions however, 5% 
and 10% mol zinc doped glasses showed a considerable increase in dissolution compared to 3% 
mol composition. The substitution of calcium oxide with zinc means high charge to size ratio that 
makes the crosslinked bonds stronger and therefore makes 1 and 3 % mol glasses more durable 
compared to zinc free compositions. However, the glass composition with higher zinc oxide 
content had higher degradation rates. The change in the dissolution behaviour could be explained 
based on the network clustering of modifier cations. According to Christie et al., [20], clustering 
of modifier cations is more likely to occur at low concentrations which strengthens the network 
and vice versa. Therefore, it is postulated that higher zinc oxide content leads to open network 
therefore it is easy to ingress water and thus solubility increases. A similar trend in glass 
dissolution was observed by Salih and Mustafa [22, 23] where the highest zinc oxide containing 
glass showed significant weight loss compared to compositions containing lower zinc oxide 
content. A study conducted by Salih et al., [22] on zinc glasses showed a higher dissolution rate 
of glasses with less calcium oxide and more zinc content. A detailed structural analysis of the 
glasses, beyond the scope of this thesis, is required to capture the structural changes in the glass 
network that affects the dissolution of zinc oxide glasses.  
 
The dissolution rate of phosphate based glasses depends not only on their chemical stability but 
also on the nature of the media [3]. The difference in the dissolution rates in different media can 
be explained by the diverse composition of the media used. Nutrient broth contains sodium 
chloride whereas cell culture media contains various ions such as sodium, calcium, potassium, 
chloride and magnesium etc. along with amino acids, vitamins, growth factors and glucose. The 
components found in these formulations are also leached from glass. As the ionic strength of the 
solution is already higher than that of distilled water the dissolution of glasses is supressed. 
Similar effect was observed by Uo et al., [21] where the authors observed reduced dissolution 
rate of the glasses studied in SBF compared to distilled water. In media, such as nutrient broth 
and cell culture media which have neutral pH the system has sufficient capacity to neutralise the 
minimal changes occurring in surrounding environment due to glass leaching [2]. Since the pH 
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of the media also influences the rate of glass dissolution, the buffering capacity of nutrient broth 
and cell culture media suppress the glass dissolution. Bunker et al., [2] investigated the effect of 
pH buffered media on glass dissolution and found strong dependence of glass dissolution on the 
pH of the solution. In strongly acidic or alkaline solution rate of dissolution increases 
dramatically. This was observed when glasses were dissolved in synthetic urine, an increase in 
dissolution by a factor of seven occurred. Gao et al., [3] demonstrated a strong role of pH in the 
dissolution process as a dramatic increase in dissolution of the glasses was observed in extreme 
pH changes. 
 
The ion release and pH results of both cobalt and zinc doped glasses are concurrent with the 
weight loss data. Increase in the release rate of anion and cations was observed in the most soluble 
compositions compared to less soluble glasses. With an increasing cobalt or zinc oxide content 
less calcium and more cobalt/zinc ions were leached. The pH analysis in most media showed the 
buffering capacity of the systems which also explains the suppressed dissolution.   
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2.6 Conclusion  
A series of cobalt and zinc doped phosphate based glassed were successfully manufactured and 
characterised. The rate of dissolution of cobalt doped glasses was shown to decrease with an 
increasing cobalt oxide content whereas for zinc doped phosphate glasses, an increase in 
dissolution rate was seen with an increasing zinc oxide content. It was established that the glass 
solubility associated ion release is affected by several factors such as the glass structure, ionic 
strength and pH of media. A detailed structural analysis of the glasses is however required to 
capture the structural changes in the glass network that affects the dissolution of zinc doped 
glasses.  
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Chapter 3 
Study of antimicrobial efficacy of cobalt or zinc 
doped phosphate based glasses; alone. 
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3.1 Introduction 
The growth and attachment of microorganisms on surfaces leads to contamination and/or 
infections [1], therefore prevention of microbial adhesion and colonisation is the preeminent 
strategy to combat infections. In the last few decades many antimicrobial surfaces have been 
developed such as antibacterial plastics, ceramics and clothes [2-4] to prevent microbial 
colonisation. Likewise, recent attempts to coat or impregnate medical devices, such as urinary 
and central venous catheters, ventilators, dental and orthopaedic implants, with antimicrobials are 
gaining interest [5-7]. Microorganisms, like all living cells require trace elements such as Mn, 
Zn, Co, Mo, Ni and Cu for their growth and survival. However, a significant increase in the 
intracellular concentration of these metallic ions can be toxic. Heavy metals, therefore have long 
been used as antimicrobials. For example, in ancient times copper plates were used to sterilise 
drinking water and it has been recently used to coat door handles [8]. Silver nanoparticles have 
also been widely used in dental implants, catheters and burn wound dressings [9]. Thus, metal 
ions can act as antimicrobial agents and by using a controlled system can be delivered locally to 
prevent infections such as those caused by urinary catheterisation. 
 
Bioactive glasses are of great importance not only due to their ability to establish chemical bonds 
with soft and hard tissue but also due to their broad antimicrobial properties [10, 11]. Given the 
importance of bioactive glasses, various glass compositions have been prepared to investigate 
their antimicrobial efficacy, a number of studies demonstrated antimicrobial effects of silica 
based bioactive glasses against various pathogenic microorganisms [11-15]. 45S5 has been 
extensively investigated for its bone tissue regeneration as well as its antimicrobial potential [12, 
16-18]. Similarly, S53P4 bioactive glass has been shown to possess strong antimicrobial effect 
against four oral microorganisms [14]. The antimicrobial properties of these bioactive glasses 
have been attributed to the increase in the pH of the media that occurs due to leaching of ions, 
immersed in an aqueous environment [19-21]. However, an in vivo study conducted on the 
115 
 
antimicrobial effects of particulate 45S5 showed the lack of antimicrobial effect [13]. The human 
body, under normal physiological conditions, maintains a haemostatic state by keeping pH with 
in a specific range, thus the resulting pH change due to bioactive glasses diminishes due to body’s 
buffering capacity and hence lack of antimicrobial activity. Following the discovery of 45S5 and 
S53P4, different glass compositions have been investigated to modify bioactive properties or to 
give them new properties by incorporating antimicrobial ions.  
 
Silver and copper are the most widely studied metals for their broad and strong antimicrobial 
properties [4, 22-26], they have also been incorporated in bioactive glasses. Silver doped 
bioactive glasses have shown bacteriostatic and bactericidal properties against Escherichia coli, 
Pseudomonas aeruginosa, and Staphylococcus aureus. Knowles et al. [24, 26] investigated the 
antimicrobial effect of silver-doped phosphate-based glass on planktonic bacteria as well as the 
effect of increasing copper content in phosphate based glasses on biofilms of Streptococcus 
sanguinis. Similarly, silver and gallium doped phosphate glasses have been shown to possess 
antimicrobial properties against Gram negative and Gram positive bacteria including MRSA [27-
29]. Although silver and copper have been shown to exhibit antimicrobial properties, recent 
studies have documented emergence of resistance. McHugh et al. [30-35] reported the first silver 
resistant strain, Salmonella typhimurium and since then silver resistance has been described in 
members of the Enterobacteriaceae, P. aeruginosa, Candida albicans, Escherichia coli. 
Similarly copper resistant strains of Staphylococci, Kocuria palustris, Brachybacterium 
conglomeratum, Sphingomonas panni and Pseudomonas oleovorans have been reported [36]. 
Therefore, due to the emerging resistance it is essential to expand the range of antimicrobial 
glasses to combat existing infections and reduce the risk of developing resistant strains. 
 
The antimicrobial properties of silver and copper have received much attention in the literature 
and other heavy metals have been overlooked. To determine the antimicrobial efficacy of metals, 
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such as cobalt, copper, gallium, nickel, gallium and zinc, a pilot study was conducted against a 
Gram positive and a Gram negative strain over a 4-day period (A.1 – A.4). The data demonstrated 
a strong antimicrobial effect of copper, cobalt and zinc within 24 hours compared to gallium, 
nickel and silver. Due to the promising results shown by cobalt and zinc metal powders their 
metal oxides were used to dope a ternary phosphate glass system (P2O5-Na2O-CaO) and the 
potential antimicrobial efficacy was evaluated. Since catheter associated urinary tract infections 
are caused by a diverse range of microorganism from Gram positive and negative bacterial 
species to fungi therefore, in the present study Escherichia coli, Staphylococcus aureus and 
Candida albicans were used to study the antimicrobial efficacy of the manufactured glasses. 
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3.2 Aims 
The aims of this study were to: 
• Investigate the antimicrobial efficacy of cobalt and zinc doped phosphate based bio-
glasses (1, 3, 5 and 10 mol %) against Escherichia coli (NCTC 10538), Staphylococcus. 
aureus (ATCC 6538) and Candida. albicans (ATCC 76615).  
 
This was achieved by studying: 
• The effect on viability of microbial cells when in direct contact with cobalt or zinc doped 
phosphate based glasses using ISO-22196. 
• Live/Dead staining of the microorganisms following a 24 hours exposure to glass surface. 
• The effect of dissolution products (indirect contact) of cobalt or zinc doped phosphate 
based glasses using shaking flask method.   
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3.3 Materials and Methods 
 
3.3.1 Microbial strains 
Two bacterial strains; Escherichia coli (NCTC 10538) and Staphylococcus aureus (ATCC 6538) 
and a fungal strain, Candida albicans (ATCC 76615) were used in this study. These strains were 
maintained at -80°C stored on MicroBank beads (Pro-Lab Diagnostics Neston, Cheshire, UK). 
When required the beads were cultured in respective broth by incubating overnight at 37°C or 
30°C (depending upon the strain) in an aerobic atmosphere. The inoculum was sub-cultured onto 
agar plates for short term storage at 5°C and used for experiments. The culture was adjusted in 
sterile broth to achieve the desired cell density for antimicrobial studies. 
 
3.3.2 Microbiological media 
Nutrient agar (NA), Nutrient broth (NB), Mueller Hinton agar (MHA), Mueller Hinton broth 
(MHB), Sabouraud dextrose agar (SDA) and Sabouraud dextrose broth (SDB) were supplied by 
Oxoid Ltd (UK) and prepared by following manufacturer’s instructions and autoclaved at 121°C 
for 15 minutes. The agar was allowed to cool down to 55°C and poured into sterile Petri dishes 
(Sarstedt Ltd, Leicester,UK). Plates and broths were stored at 4°C. Dey/Engley (D/E) neutralizing 
broth (Fisher Scientific, Leicester, UK) was also prepared as per manufacturer’s instruction and 
stored at 4°C. Phosphate buffered saline (PBS) was purchased from Fisher Scientific (UK) and 
prepared by adding one tablet into 100 ml distilled water, this was then autoclaved for 15 minutes 
at 121°C to sterilize.  
 
3.3.3 Standard curve for colony forming units using optical density 
To determine the standard growth of the test microorganisms in the stationary phase, growth 
curves were plotted. Microorganisms were inoculated in respective broths (i.e. E. coli and S. 
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aureus in NB whereas C. albicans in SDB) and incubated overnight at 37°C and 30°C 
respectively. Following incubation serial dilutions were prepared in PBS in triplicates and the 
optical density (OD) of each dilution was determined at 570 nm using a spectrophotometer 
(Jenway 6305 UV/Visible Spectrophotometer). Cell viability was determined for each dilution 
using the spread plate method. The colony forming units of each dilution was then plotted against 
OD. 
 
3.3.4 Antimicrobial activity of cobalt or zinc doped phosphate based glasses individually, 
against microorganisms in planktonic growth mode 
 
3.3.4.1 Direct Contact – Surface testing  
To determine the antimicrobial potential of the different glass surface, the international standard 
protocol for testing non-porous surfaces; ISO-22196 [37] was used. To conduct experiments an 
overnight microbial culture was adjusted using fresh Muller Hinton or Sabouraud dextrose broth 
depending upon the microbial strain. The adjusted cultures were inoculated on the top surface of 
the glass discs to produce ~106 CFU microbial density. A thin sterile glass cover slip (Fisher 
scientific, UK) was placed on the top of the inoculum and pressed gently so that the test inoculum 
spreads to the edges. The cover slip not only helps to create a thin bacterial film on the glass discs 
but also prevents the bacterial death due to desiccation. Standard plastic coverslips with 12 mm 
diameter were used as the control. Inoculated glass discs and control samples were then placed 
in a Petri dish and incubated in 37°C and 30°C incubators. At each time point; 1, 2, 4, 6, 24 and 
48 hours two glass discs were removed from each set of glass composition along with untreated 
glass and washed with 5 ml of D/E broth (Becton Dickinson UK Ltd). This was achieved by 
placing the test glass discs with coverslips in 5 ml D/E broth and vortexed for two minutes. The 
viable bacterial count in the broth was determined by the spread plate method. In addition, 
immediately after inoculation, two untreated test specimens were processed and the viable count 
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determined was used as the recovery rate of the bacteria from the test specimens under 
investigation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: A schematic diagram showing the method for testing the antimicrobial activity of 
non-porous surfaces. The surface of sterilised test samples is inoculated with test microorganism 
and incubated for a period. Cell viability is determined to evaluate the antimicrobial efficacy of 
the material.    
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Treated sample - 24hrs 
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The antibacterial effect was evaluated according to the standard outlined in ISO-standard 22196. 
The number of viable bacteria for each specimen was determined using equation 3.1: 
N = (100 x C x D x V)/A  ……….  (3.1) 
where N is the number of viable microorganisms recovered per cm2 per test specimen; 
C is the average plate count for the duplicate plates; 
D is the dilution factor for the plates counted; 
V is the volume in ml of D/E broth added to the specimen;  
A is the surface area in mm2 of the cover film. 
 
The antibacterial activity, R was determined using the following equation 
R = (Ut – U0) – (At – U0) = Ut - At  …… (3.2) 
Where U0 is the average of the common logarithm of the number of viable bacteria, in cells/cm2 
recovered from the untreated test specimens immediately after inoculation  
Ut is the average of the common logarithm of the number of viable bacteria, in cells/cm2 recovered 
from the untreated test specimens after time t respectively. 
At is the average of the common logarithm of the number of viable bacteria, in cells/cm2 recovered 
from the treated test specimens after time t. 
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3.3.4.2 Determination of Viable Non Culturable Cells by Baclight staining 
Occasionally microorganisms under unfavourable conditions enter a state where they are 
metabolically active however cannot be cultured on media, because they do not reproduce and 
form colonies. Therefore, to confirm the findings of the direct contact experiment Live/Dead 
staining using fluorescent microscopy was undertaken to determine the viable but non culturable 
state of microorganisms. An overnight microbial inoculum was adjusted and inoculated on the 
top surface of the glass discs to produce ~106 CFU microbial density. A thin sterile glass cover 
slip was placed on the top of the inoculum and pressed gently so that the test inoculum spread to 
the edges. Following 24 hours incubation, fluorescent microscopy was conducted using the 
LIVE/DEAD® BacLight™ Bacterial Viability Kit purchased from Life Technologies (UK). 
 
The LIVE/DEAD® BacLight™ staining kit uses two stains; SYTO® 9 green-fluorescent nucleic 
acid stain and the red-fluorescent nucleic acid stain, propidium iodide. The stains differ in their 
ability to penetrate healthy cells, the SYTO® 9 penetrates all bacteria in a population, whereas 
propidium iodide penetrates only cells with damaged cell membranes. SYTO® 9 however when 
used with propidium iodide has reduced fluorescence when both dyes are present. Thus, live cells 
i.e. bacteria with intact cell membranes appear green whereas dead cells i.e. with damaged cell 
membranes stain red. 
 
The stain was stored in the – 20°C freezer and prior to use the stain was allowed to stand at room 
temperature for 30 minutes. Equal volumes (2 µl) of SYTO® 9 and propidium iodide were 
combined in a microfuge tube and mixed thoroughly by using a pipettor. 200 µl of sterile water 
was added to the microcentrifuge tube and mixed by vortexing for two minutes. The dye mixture 
was allowed to stand at room temperature for approximately 20 minutes. Following specimen’s 
incubation, coverslips were removed and the glass discs were fixed onto glass slides using 
specimen mounting wax. The samples were then placed in sterile Petri dishes, 20 µl of the dye 
mixture was added onto each glass disc and incubated for 30 minutes at 37°C. Following 
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incubation unbound dye was removed with a paper towel and a glass coverslip was mounted onto 
the glass disc using mounting oil. The cells were observed under the x40 objective of the Leica 
DM16000 B microscope. All images were saved as TIFF files. 
 
3.3.4.3 Indirect Contact – suspension analysis 
Indirect contact analysis was used to determine the effect of dissolution products of glasses on 
the growth and viability of microorganisms tested. In this method, sterilised glass discs (Ø 10   
mm, 2 mm thick) were placed in 25 ml of Mueller Hinton broth containing approximately 
106 CFU/ml of the test microorganism. The samples were then incubated in an aerobic incubator 
at 30°C and 37°C with a shaking speed of 200 rpm. Mueller Hinton broth without glass discs 
served as negative control. At various time intervals; 24, 48, 72, 96 and 120 hours, a 100µl sample 
was taken out from each test container and serially diluted to determine the viable count using 
spread plate method. All experiments were undertaken in triplicate. A logarithmic microbial 
reduction of less than 0.5 and 1 was regarded as slight, values greater than 1 or less and equal to 
3 as a significant and values greater than 3 as a strong antimicrobial activity [19, 38]. 
 
3.3.5 Statistical analysis 
Two-way analysis of variance was carried out to determine statistical significances (GraphPad 
Prism 7.0). If a significant difference was detected a Tukey test was carried out to determine 
which values were significantly different. Differences were considered statistically significantly 
at a level of P < 0.05. 
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3.4 Results 
 
3.4.1 Standard growth as determined by optical density 
The standard curves for cell suspension of each microorganism using optical density produced 
linear graphs with R2 values of 0.9203 for E. coli, 0.9604 for S. aureus and 0.9217 for C. albicans 
(Figures A5 - A7). 
 
3.4.2 Antimicrobial activity of cobalt doped phosphate based glasses 
 
3.4.2.1 Direct Contact – Surface testing  
Figures 3.2 - 3.4 show the antimicrobial activity of cobalt doped phosphate glasses against E. 
coli, S. aureus and C. albicans at 2, 4, 6 and 24-hour time intervals. According the ISO-22196, 
an antimicrobial activity greater than 2 demonstrates that the test specimen is antimicrobial.  
Figure 3.2 shows the antimicrobial efficacy of un-doped phosphate glass and 1, 3, 5 and 10 mol 
% cobalt doped phosphate glass against E. coli when cultured directly on glasses. Whilst 
minimum or no activity was seen in the initial hour (data not shown), all glass compositions 
demonstrated a strong antimicrobial activity within 2 hours when compared with non-treated 
control. At 2, 4 and 6 hours’ time points, significant difference in R value was observed for 1, 3, 
5 and 10 mol % cobalt doped phosphate glasses compared to un-doped phosphate glass samples 
(p < 0.0001). 
 
Whilst a sharp increase in the activity was observed against E. coli within 2 hours, a gradual 
increase in antimicrobial activity was seen against S. aureus. As seen in figure 3.3, the R value 
remained below 2 for the initial 4 hours, but at 6 hours time point all glass compositions showed 
an antimicrobial activity ≥ 2 except for un-doped phosphate glass, however the difference 
observed was statistically non-significant. A similar trend in R value was observed at 24 hours. 
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The R value of all glass compositions exhibited a non-significant increase when compared to un-
doped glass except for 10 mol % cobalt doped glass which showed a significant increase in R 
value when compared with un-doped phosphate glass (p < 0.001), 1 and 3 mol % cobalt doped 
glasses (p = 0.0027, p = 0.0044 respectively). Overall, whilst E. coli showed a higher 
susceptibility with a complete kill seen within 6 hours, complete killing of S. aureus was not seen 
within 24 hours. 
 
2  h o u rs 4  h o u rs 6  h o u rs
0
1
2
3
4
5
A
n
ti
m
ic
ro
b
ia
l 
a
c
ti
v
it
y
 R
0
1  m o l %
3  m o l %
5  m o l %
1 0  m o l %
***
***
***
***
***
***
***
*****
****
 
Figure 3.2: The antimicrobial efficacy of un-doped phosphate glass and 1, 3, 5 and 10 mol % 
cobalt doped phosphate glass against E. coli at 2, 4 and 6 hours. Data shown are expressed as 
mean ± SD (N=3) antibacterial activity as determined by ISO-22196. 
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Figure 3.3: The antimicrobial efficacy of un-doped phosphate glass and 1, 3, 5 and 10 mol % 
cobalt doped phosphate glass against S. aureus over a 24 hours period. Data shown are expressed 
as mean ± SD (N=3) antibacterial activity as determined by ISO-22196.  
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Figure 3.4 shows the antimicrobial activity of the glasses against C. albicans when inoculated 
directly on glass discs. The R value in the first 2 hours remained below 2, however at 4 hours 3, 
5 and 10 mol % cobalt doped glasses exhibited an antimicrobial activity ≥ 2, whereas un-doped 
glass value was less than 2 highlighting the importance of incorporating antimicrobial ions. A 
statistically significant difference in the activity was not seen until 6 hours, 10 mol % cobalt 
doped glass showed a strong antimicrobial effect when compared to un-doped phosphate glass (p 
= 0.0002). A complete kill of C. albicans was seen within 24 hours. 
 
 
2  h o u rs 4  h o u rs 6  h o u rs 2 4  h o u rs
0
1
2
3
4
5
A
n
ti
m
ic
ro
b
ia
l 
a
c
ti
v
it
y
 R
0
1  m o l %
3  m o l %
5  m o l %
1 0  m o l %
***
Figure 3.4: The antimicrobial efficacy of un-doped phosphate glass and 1, 3, 5 and 10 mol % 
cobalt doped phosphate glass against C. albicans over a 24-hour period. Data shown are 
expressed as mean ± SD (N=3) antibacterial activity as determined by ISO-22196.  
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3.4.2.2 Determination of Viable Non Culturable Cells by Baclight staining 
Figure 3.5 – 3.7 shows the fluorescent images taken using Baclight stain following 24 hours 
incubation of E. coli, S. aureus and C. albicans respectively. The live cells take up SYTO® and 
appear green whereas dead cells appear red due to penetration of propidium iodide. It is 
demonstrated from the figures that the microorganisms are not viable following 24 hours 
exposure to glass surfaces and thus confirms the killing effect shown in direct contact 
analysis. 
129 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5: Fluorescent images taken by using Baclight staining of E. coli following 24 hours incubation on A - untreated control, B - un-doped phosphate 
based glass C, D, E and F 1, 3, 5 and 10 mol % cobalt doped phosphate based glasses. Dead cells appear in red/yellow and live cells appear green. Scale bar 
represents 10 µm. 
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Figure 3.6: Fluorescent images taken by using Baclight staining of S. aureus following 24 hours incubation on A - untreated control, B - un-doped phosphate 
based glass C, D, E and F 1, 3, 5 and 10 mol % cobalt doped phosphate based glasses. Dead cells appear in red/yellow and live cells appear green. Scale bar 
represents 10 µm. 
A B C 
D E F 
131 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6: Fluorescent images taken by using Baclight staining of C. albicans following 24 hours incubation on A - untreated control, B - un-doped phosphate 
based glass C, D, E and F 1, 3, 5 and 10 mol % cobalt doped phosphate based glasses. Dead cells appear in red/yellow and live cells appear green. Scale bar 
represents 10 µm.
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3.4.2.3 Indirect contact 
 
Figures 3.8 – 3.10 show the effect of dissolution products of cobalt doped phosphate glasses over 
a 5-day period under an aerobic atmosphere at 37°C /200 rpm shaking speed. It was observed that 
the dissolution products of the glasses failed to demonstrate antibacterial effect against E. coli 
(Figure 3.8) over 5 days as the bacterial viability was approximately 100% when compared with 
microorganisms cultured in broth only. Similar results were seen against S. aureus (Figure 3.9) 
and C. albicans (Figure 3.10).   
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Figure 3.8: The effect of dissolution products of un-doped phosphate glass and 1, 3, 5 and 10 
mol % cobalt doped phosphate glass against E. coli over a 5 days period. Data shown are 
expressed as mean ± SD (N=3).  
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Figure 3.9: The effect of dissolution products of un-doped phosphate glass and 1, 3, 5 and 10 
mol % cobalt doped phosphate glass against S. aureus over a 5 days period. Data shown are 
expressed as mean ± SD (N=3).  
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Figure 3.10: The effect of dissolution products of un-doped phosphate glass and 1, 3, 5 and 10 
mol % cobalt doped phosphate glass against C. albicans over a 5 days period. Data shown are 
expressed as mean ± SD (N=3). 
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3.4.3 Antimicrobial activity of zinc doped phosphate based glasses 
3.4.3.1 Direct Contact – Surface testing  
The antimicrobial effect of 1, 3, 5 and 10 mol % zinc doped phosphate glasses compared to un-
doped phosphate glass against E. coli is illustrated in figure 3.11. Zinc doped phosphate glasses 
showed an antimicrobial activity of ≥ 2 within initial 2 hours, however only 10 mol % zinc doped 
phosphate glass exhibited a significant difference when compared un-doped phosphate glass (p = 
0.0322). Furthermore, at 4 hours, each zinc doped glass composition showed a significant 
difference in antimicrobial activity compared to un-doped phosphate glass (p = 0.0233).  
Figure 3.12 shows the antimicrobial activity of zinc doped glasses against S. aureus. In the initial 
2 hours, only 10 mol % zinc doped glass showed an antimicrobial activity of ≥ 2, however the 
difference was non-significant when compared to un-doped phosphate glass.  At 4 hours time 
point, zinc doped glass composition showed an antimicrobial activity greater than 2 and 10 mol 
% zinc doped glass exhibited a significant difference in comparison to un-doped phosphate glass 
(p < 0.001). A similar trend in antimicrobial activity was observed at 6 and 24 hours, however 
significant difference was only detected at 24 hours for 10 mol % zinc doped glass (p =0.0031).  
The antimicrobial activity of the un-doped and zinc doped phosphate glasses when tested against 
C. albicans can be seen in figure 3.13. It was found that at 4 hours 5 and 10 mol % zinc doped 
glasses demonstrated an antimicrobial activity above 2 which however was non-significant. A 
significant difference in the antimicrobial activity was not observed until 6 hours, 3, 5 and 10 mol 
% glasses showed a strong antimicrobial activity compared to un-doped phosphate glasses (p = 
0.0403, 0.0053, 0.0044 respectively).  
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Figure 3.11: The antimicrobial efficacy of un-doped phosphate glass and 1, 3, 5 and 10 mol % 
zinc doped phosphate glass against E. coli over a 24 hours period. Data shown are expressed as 
mean ± SD (N=3) antibacterial activity as determined by ISO-22196.  
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Figure 3.12: The antimicrobial efficacy of un-doped phosphate glass and 1, 3, 5 and 10 mol % 
zinc doped phosphate glass against S. aureus over a 24 hours period. Data shown are expressed 
as mean ± SD (N=3) antibacterial activity as determined by ISO-22196. 
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Figure 3.13: The antimicrobial efficacy of un-doped phosphate glass and 1, 3, 5 and 10 mol % 
zinc doped phosphate glass against C. albicans over a 24 hours period. Data shown are expressed 
as mean ± SD (N=3) antibacterial activity as determined by ISO-22196. 
 
3.4.3.2 Determination of Viable Non Culturable Cells by Baclight staining 
Figure 3.14 – 3.16 shows the fluorescent images taken using Baclight stain following 24 hours 
incubation of E. coli, S. aureus and C. albicans respectively. The live cells take up SYTO® and 
appear green whereas dead cells appear red due to penetration of propidium iodide. It is 
demonstrated from the figures that the microorganisms are not viable following exposure to 
various compositions of zinc doped glass surfaces and thus confirms the killing effect shown in 
direct contact analysis.   
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Figure 3.14: Fluorescent images taken using Baclight staining of E. coli following 24 hours incubation on A - untreated control, B - un-doped phosphate based 
glass C, D, E and F 1, 3, 5 and 10 mol % zinc doped phosphate based glasses. Dead cells appear in red/yellow and live cells appear green. Scale bar represents 
10 µm. 
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Figure 3.15: Fluorescent images taken using Baclight staining of S. aureus following 24 hours incubation on A - untreated control, B - un-doped phosphate 
based glass C, D, E and F 1, 3, 5 and 10 mol % zinc doped phosphate based glasses. Dead cells appear in red/yellow and live cells appear green. Scale bar 
represents 10 µm. 
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Figure 3.16: Fluorescent images taken using Baclight staining of C. albicans following 24 hours incubation on A - untreated control, B - un-doped phosphate 
based glass C, D, E and F 1, 3, 5 and 10 mol % zinc doped phosphate based glasses. Dead cells appear in red/yellow and live cells appear green. Scale bar 
represents 10 µm. 
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3.4.3.3 Indirect contact  
Figure 3.17 shows the antimicrobial effect of the dissolution products of un-doped phosphate 
glass and zinc doped glasses against E. coli over 5 days period. It was found that dissolution 
products did not exhibit antimicrobial action for 96 hours. At time 120 hours the dissolution 
products of 5 and 10 mol % zinc glasses demonstrated a significant antibacterial effect when 
compared to control culture (p = 0.0011 and p < 0.0001 respectively). Additionally, when 
compared to un-doped phosphate glass, the antibacterial effect of 5 and 10 mol % zinc doped 
glass was significant (p < 0.0001). Significant differences in the antimicrobial activity was also 
seen for 5 and 10 mol % glasses compared to 1 and 3 mol % zinc doped glasses (Figure 3.17).    
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Figure 3.17: The effect of dissolution products of un-doped phosphate glass and 1, 3, 5 and 10 
mol % zinc doped phosphate glass against E. coli over a 5 day period. Data shown are expressed 
as mean ± SD (N=3).  
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The antimicrobial effect of the dissolution product of the glasses when tested against S. aureus is 
shown in figure 3.18. During the initial 24 hours, the dissolution products of the glasses failed to 
show antibacterial effect, similarly all glass compositions exhibited a non-significant decrease in 
bacterial log reduction at 48 hours except for 10 mol % zinc doped glass (p < 0.0001). Both 5 and 
10 mol % zinc doped glasses exhibited a significant decrease in bacterial viability at 72, 96 and 
120 hours compared to control culture as well as un-doped phosphate glass dissolution products 
(p < 0.0001). Similarly, the dissolution products of 5 and 10 mol % zinc doped glasses exhibited 
a significant decrease in bacterial density compared to 1 and 3 mol % dissolution products of zinc 
doped glasses. Interestingly, dissolution products of un-doped phosphate glass seemed to improve 
bacterial viability compared to control S. aureus cultures. A significant difference (p = 0.0067) 
was detected at 24 and 48 hours.   
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Figure 3.18: The effect of dissolution products of un-doped phosphate glass and 1, 3, 5 and 10 
mol % zinc doped phosphate glass against S. aureus over a 5 days period. Data shown are 
expressed as mean ± SD (N=3).  
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The dissolution products of zinc doped glasses, unlike against E. coli and S. aureus showed a 
strong antimicrobial activity against C. albicans in the initial 24 hours. The dissolution products 
of both 5 and 10 mol % glasses exhibited a significant decrease in microbial load compared to 
control, un-doped and 1 mol % glass dissolution products within 24 hours (p < 0.001). 
Furthermore, 3 mol % zinc doped dissolution products also showed antimicrobial effect against 
C. albicans (p = 0.0133).  However, the antimicrobial effect seemed to diminish after 24 hours 
as the viability of C. albicans seemed to improve over the next two days and reached to the same 
density as the control cultures.  
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Figure 3.19: The effect of dissolution products of un-doped phosphate glass and 1, 3, 5 and 10 
mol % zinc doped phosphate glass against C. albicans over a 5 days period. Data shown are 
expressed as mean ± SD (N=3).  
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3.5 Discussion 
As stated in section 3.1, many studies have been undertaken to elucidate the antimicrobial 
potential of various silicate and phosphate glass systems. However, to date, none of the studies 
have evaluated the antimicrobial effect of cobalt and zinc doped glasses in the context of 
controlled ion release for treating catheter associated urinary tract infections. The present study, 
therefore investigated the antimicrobial effect of an un-doped and doped (with 1, 3, 5 and 10 mol 
% cobalt or zinc oxide) phosphate based bioactive glass (P2O5-Na2O-CaO) against clinically 
relevant microorganisms.  
 
The antimicrobial effect was determined using direct and indirect contact (dissolution products) 
method. The results of direct contact showed a strong antimicrobial activity exhibited by cobalt 
and zinc doped glasses compared to control specimens against E. coli, S. aureus and C. albicans. 
In addition, the effect was time dependent as a gradual decrease in microbial viability was 
observed over a period. Whilst an antimicrobial effect was seen against the three strains studied, 
E. coli showed higher susceptibility compared to S. aureus and C. albicans. Similar results were 
reported by Hu et al., [16] demonstrating a high kill against E. coli when treated with Bioglass® 
compared to S. aureus. This is also in agreement with a study conducted on antimicrobial effect 
of gallium doped phosphate glasses where the authors observed a larger zone of inhibition for E. 
coli and P. aeruginosa when compared to S. aureus [29]. Likewise, E. coli was shown to have a 
higher susceptibility compared to S. aureus when treated with 3 mol % silicate based gallium 
glass [19].  
 
The difference in the activity could be explained based on the differences in the outer cell wall of 
the Gram positive and Gram negative bacteria. Gram positive bacteria such as S. aureus contain 
a thick peptidoglycan layer in its cell wall along with teichoic and lipoteichoic acids. Teichoic 
acids are polyol phosphate polymers with a strong negative charge whereas in Gram negative 
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bacteria these are not present [39, 40]. These charged anionic clusters contribute to the binding 
of ions such as sodium, calcium, copper and cobalt etc. thus promote bacterial adhesion to the 
metallic surfaces. This cationic sequestering mechanism therefore confers resistance to bacterial 
killing in Gram positive bacteria. Furthermore, thick peptidoglycan layer protects bacteria from 
penetration of ions and reactive oxygen species generated by metallic ions [41], therefore confers 
stability to Gram positive cells. A thick peptidoglycan layer is believed to prolong the killing 
process as demonstrated by Espirito Santo et al., [42, 43] where it was shown that Staphylococcus, 
when exposed to metallic copper surface, takes seven times longer to kill compared to E. coli. On 
the other hand, Gram negative bacteria contain an outer membrane containing 
lipopolysaccharides (LPS) which acts as a barrier for transport of antimicrobials. The passage 
through the outer membrane is regulated through non-specific ion channels called porins. These 
channels are hydrophilic thus do not allow the passage of hydrophobic molecules such as 
antibiotics, however metal ions can easily pass through porins and thus bring about the cell death 
[44-46].  
 
Although the exact mechanism of action is not known, yet several factors have been shown to 
play a role in contact mediated killing by metallic surfaces. Direct contact of microbes with an 
antimicrobial surface damages the outer membrane by punching holes, such as shown by copper 
ions [8] which leads to loss of membrane potential. Additionally, reactive oxygen species are 
produced at the interface of bacterial cell wall and the bioactive glass surface causing further 
structural damage to the membrane. The loss of membrane integrity results in leakage of the cell 
contents and thus cell death occurs  [47]. Similar mechanism was proposed in a study conducted 
on metallic copper surface against S. aureus. The authors showed a reduced level of intracellular 
copper ions following a complete kill which suggested membrane leakage [43].  
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The indirect contact experiments were conducted to investigate the antimicrobial efficacy of 
metal ions leached from the given glasses. The results of the present study show that the optimum 
release of cobalt ions required to illicit a toxic effect was not achieved in the test media, as the 
dissolution products failed to exhibit bacteriostatic/bactericidal effect against any of the test 
strains. The ionic concentration of 1, 3, 5 and 10 mol % cobalt approximately reached up to 5, 
10, 14 and 17 ppm respectively.  Whilst 1, 3, 5 and 10 mol % cobalt glasses failed to exhibit any 
antimicrobial effect, 5 and 10 mol % zinc doped glasses (32 and 66 ppm respectively) produced 
a considerable kill at 120 hours against E. coli. Likewise, significant difference in the activity 
was seen against S. aureus within 48 hours which improved by 120 hours. C. albicans on the 
other hand, showed antimicrobial effect within 24 hours which appeared to diminish as the time 
progressed. The dissolution products therefore showed minimum or no activity compared to 
direct contact experiments.    
 
In indirect contact assays, the efficacy of bioactive glass depends on their solubility and release 
of constituent ions such as calcium, sodium, phosphorus, cobalt or zinc. These ions then enter the 
microbial cells via non-specific ion channels and can target various cell components directly and 
indirectly to bring about cell death. Metal ions produce reactive oxygen species that results in 
oxidative damage to DNA, mitochondria and proteins restricting cell growth and metabolism [48, 
49]. The ions can also affect bacteria indirectly by binding to enzymes and inducing 
conformational changes thus making them non-functional. Subsequently bacteria fail to 
synthesize their machinery to carry out metabolic processes and hence death occurs. Cobalt ions 
have been shown to produce hydroxyl radicals whereas zinc ions result in production of 
superoxide molecules that subsequently target various cell components. Zinc ions are also 
believed to inhibit glutathione reductase, an enzyme that prevents oxidative damage in cells. 
Several bacterial species require manganese for carrying out metabolic functions, however zinc 
ions have been shown to competitively bind to manganese receptors and inhibits its uptake and 
thus exerts toxic effect on bacteria [50, 51]. 
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Since the presence of metal ions is essential therefore the lack of antimicrobial activity could be 
due to reduction in the availability of free ions in solution. Microbiological media such as nutrient 
broth provides a complex environment with a number of ionic species that may reduce the 
concentration of free metal ions by precipitation or by the formation of soluble complexes [52]. 
Silver ions have been shown to form insoluble silver salts when in contact with large amounts of 
ions such as chlorides and amino acids present in broth, thus causing inactivation of silver ions 
[53]. Similarly, a study on zinc doped bioactive glasses showed that the amount of zinc ions 
leached from the glass was reduced by the formation of complexes between zinc ions and 
components of broth [54]. Contrary if the dissolution products are available as free ions, then the 
poor antimicrobial activity could be due to the neutralization mechanism deployed by the 
microorganism. Pathogenic microbes have evolved mechanisms to efflux heavy metals such as 
cobalt and zinc. E. coli for instance has efficient periplasmic efflux pumps that detoxify the 
bacterial cell in the presence of excess silver and copper [55, 56]. Therefore, it is reasonable to 
suggest that microorganisms have evolved similar mechanisms, such as efflux pumps, to remove 
excess cobalt and zinc ions. 
 
The lack of activity in the suspension experiments could also be due to the buffering capacity of 
nutrient broth as demonstrated in the pH analysis. One of the most widely accepted mode of 
action of glasses in solution is via a rapid change in the pH of the surrounding medium. A study 
by Brown et al., [57] confirmed that a rapid change in the pH causes reduction in bacterial 
viability. Similar results were also reported by Stoor et al. and Allan et al. [12, 14] therefore we 
can argue that the lack of activity of the glasses observed in the indirect contact study is likely 
due to the neutralization of the pH to near optimal range, as shown previously. 
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3.6 Conclusion 
An antimicrobial activity was demonstrated by all glass compositions particularly by 5 and 10 
mol % cobalt and zinc doped glasses when in direct contact with microorganisms. The killing 
effect was not only time dependent but also strain specific. The significant difference in the 
antimicrobial activity of un-doped and doped phosphate glasses suggests the additional benefit 
of adding cobalt and zinc ions as antimicrobials. The lack of activity in shaking flask experiment 
is either because the number of antimicrobial ions released was well below the concentration 
needed for killing microbes or due to inactivation of antimicrobial ions. The pH buffering and 
inactivation of metal ions raises concerns over use of these glasses in vivo.   
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Chapter 4 
Study of antimicrobial efficacy of 5 mol % 
copper, cobalt and zinc doped phosphate based 
glasses; alone and in combination 
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4.1 Introduction 
Everyday many patients are prescribed antibiotics to treat bacterial infections which in some cases 
can prove effective, but inappropriate and overuse of broad spectrum antibiotics has led to a 
drastic increase in antibiotic resistance. The emergence of resistant strains and decline in 
discovery of new antibiotics has led to the idea of combining various antimicrobials to treat 
resistant strains and/or polymicrobial infections. Two or more antibiotics can work 
simultaneously to give additive, synergistic, antagonistic effect or without any effect on each 
other [1]. The interaction between any two antibiotics is considered synergistic if the combined 
effect is stronger than an additive expectation and antagonistic if it is weaker [2]. 
 
The idea of combining antibiotics to enhance their effect is not new; clinical interest started in 
the 1950s when streptomycin was added with penicillin G to treat enterococcal endocarditis [3]. 
Since then several antimicrobials have been combined and resulted in synergism [4], 
demonstrating beneficial effect in clinical medicine. Antibiotic combinations that inhibit cell wall 
and protein synthesis, beta-lactamase inhibitors with beta-lactam antibiotics and combination 
agents that inhibit sequential metabolic or synthetic pathways have been shown to exhibit 
synergistic effects [5]. Extensive in vitro data is available on antibiotic synergism, for instance, 
aztreonam is often used with clindamycin or another beta-lactam antibiotic [4]. Similarly, 
amdinocillin has demonstrated synergism when combined with other penicillins and 
cephalosporins [5]. A study conducted by Stephanie et al. [6] compared the effects of different 
combinations of a beta-lactam, vancomycin, and/or an aminoglycoside against 32 clinical strains 
of MRSA and demonstrated synergistic effects of vancomycin combined with imipenem or 
cefazolin, and even with netilmicin in a triple combination. 
 
The antimicrobial combinations are not only limited to antibiotics but many other compounds 
with antimicrobial potential have been combined with antibiotics to enhance their activity. For 
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instance, antimicrobial peptides have potent antimicrobial action and have been combined with 
conventional antibiotics. Zhou and Peng investigated the interaction between polycationic 
peptides and clinically used antimicrobial agents in the treatment of clinical isolates of Gram-
positive and Gram-negative aerobic bacteria [7]. A synergistic effect was shown between 
ranalexin and polymyxin E, doxycycline and clarithromycin. Similarly, magainin II was 
demonstrated to be synergistic with ceftriaxone, amoxicillin clavulanate, ceftazidime, 
meropenem, piperacillin and β-lactam antibiotics.   
 
Similarly lactic acid, an effective antimicrobial agent, has shown enhanced activity when 
combined with copper. A study undertaken by Gyawali and Ibrahim [8] investigated the effect of 
adding low doses of copper to lactic acid to prevent growth of foodborne pathogens. Various 
combination treatments showed synergistic effect against Salmonella and E. coli O157:H7 on 
different food products. Copper has also been shown to exhibit a synergistic effect against 
biofilms of Pseudomonas aeruginosa when combined with quaternary ammonium cations [9]. 
Since transition metals exhibit antimicrobial properties, they have also been investigated for their 
combined effect. Silver has demonstrated enhanced antimicrobial effect against E. coli and B. 
subtilis when combined with other transition metals such as zinc, cobalt, cadmium, nickel and 
copper [10]. 
 
As stated in earlier chapters, transition metals have also been used to dope bioactive glasses for 
many biomedical applications. However, to date there has been no study undertaken on the 
antimicrobial effect of combining two or more metal oxides in a bioactive glass system. The aim 
of this chapter was to determine if cobalt, copper and/or zinc can work in combination and 
whether doping the phosphate based glass with synergistic combinations will retain the 
antimicrobial effect.  
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4.2 Aims 
The aim of the given investigation was 
• Investigate the effect of combining metal oxides such as cobalt, copper or zinc on growth 
and viability of Escherichia coli (NCTC 10538), S. aureus (ATCC 6538) and C. albicans 
(ATCC 76615).  
 
This was achieved by  
• Evaluate the minimum inhibitory or bactericidal concentrations of 5 mol % cobalt, 
copper or zinc doped phosphate glass powders using broth microdilution assay. 
•  Determine the antimicrobial activity by checkerboard and time kill assays 
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4.3 Methods and Materials 
4.3.1 Microbial strains 
See section 3.3.1 
4.3.2 Microbiological media  
See section 3.3.2 
4.3.3 Standard Growth curve 
See section 3.3.3 
4.3.4 Antimicrobial activity of 5 mol % cobalt, zinc and copper phosphate based glasses; 
alone and in combination against microorganisms in planktonic growth mode 
 
4.3.4.1 Determination of Minimum inhibitory and bactericidal concentration using Broth 
Macrodilution  
Broth macrodilution was performed in accordance with CLSI guidelines to determine minimum 
inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of the glass 
particles. Double dilutions of each stock solution (100 mg/ml) were performed in the range from 
50 – 0.2 mg/ml by adding 1 ml sterile PBS and 1 ml Mueller Hinton Broth (Oxoid Ltd, UK.). To 
maintain equal volumes throughout the procedure, 1 ml of solution was discarded from the last 
dilution. Triplicate samples were prepared in sterile Bijoux bottles (Thermo Scientific, UK.), 
inoculated with 105 CFU/ml and incubated overnight in shaking incubator at 200 rpm at 37 ºC; 
C. albicans at 30 ºC in an aerobic environment. Solution devoid of glass dissolution products, 
under the same growth condition, was used as a control. To avoid potential misinterpretation of 
turbidity due to coloured solution of glasses, liquid medium without microorganisms, but 
containing the same concentration of glass dissolution products were used as standard solutions 
for comparison.  
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After overnight incubation, the turbidity of the test solutions was checked against glass standard 
solutions. MIC was determined as the lowest concentration which showed no turbidity on visual 
inspection. One hundred µl of the lowest concentration that was not visually turbid i.e. MIC and 
higher concentrations than MIC along with the controls were plated onto Mueller Hinton agar 
and incubated overnight at 37°C; C. albicans at 30°C on SDA in an aerobic environment. MBC 
was determined as the lowest concentration which yielded three log reductions i.e. a 99.9% 
reduction in CFU/ml compared to control. Tests were performed in triplicate and repeated three 
times. 
 
4.3.4.2 Checkerboard assay to assess the antimicrobial efficacy in combination 
To determine the effect of the glasses in combination, a checkerboard assays were performed as 
explained here. To evaluate the effect of copper (Cu) and cobalt (Co), for instance, double 
dilutions of Cu dissolution products and Co dissolution products were prepared in MHB or SDB 
ranging from 50 – 0.2 mg/ml. For each microorganism 96 wells plates (Fisher Scientific, 
Leicester, UK) were set up, in duplicate, by adding 100 µl of Cu glass dissolution products and 
100 µl of Co glass dissolution products. Thus, for each plate, the dissolution products of Cu were 
serially diluted along the ordinate and those of Co were diluted along the abscissa. Cu and Co 
glass dissolution products alone were set up as the controls, along with MHB or SDB. All wells 
were inoculated with 10 µl of a 106 CFU/ml of test microorganism and incubated overnight in an 
aerobic environment at 37°C or 30°C as appropriate. Similar procedure was repeated with other 
combinations i.e. cobalt and zinc; copper and zinc.  
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Figure 4.1: shows schematic representation of checkerboard assay. Reducing concentrations of 
bioactive glass, A or B are added in rows and columns respectively. Ten µl of a 106 CFU/ml 
inoculum of each microorganism was added to determine synergism, indifference or antagonism. 
 
The MIC of each metal alone and in combination was determined as the lowest concentration of 
metal dissolution product that completely inhibited the growth of the organism as detected with 
the naked eye. The effects of the combinations were then determined as synergistic, indifferent 
or antagonistic by calculating the fractional inhibitory concentration (FIC), and then the fractional 
inhibitory concentration indices (FICI) value for each combination [11].  
FIC = MIC of metal in combination 
MIC of metal alone 
FICI = FIC of metal A + FIC of metal B 
Where FICI ≤ 0.5 shows synergism 
FICI > 0.5 or < 4.0 shows indifference 
FICI > 4.0 shows antagonism 
4.3.4.3 Time kill assay to determine the antimicrobial efficacy in combination 
The time kill of the glass dissolution products alone and in combination along with synergy 
determination was also assessed using a suspension method time-kill assay as described by White 
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et al. [11]. Three experimental suspensions were prepared at twice the MIC concentration, for 
each combination: Cu only suspension, Co only suspension and a combination Cu/Co suspension. 
All experimental tubes; each metal alone and in combination (Cu/Co, Cu/Zn and Co/Zn) were 
seeded with an initial microbial density of 105 cfu/ml. In addition, a control containing Mueller-
Hinton broth seeded with a microbial inoculum and a control containing broth only, were 
prepared. All tubes were incubated aerobically at 37°C or 30°C for 24 hours in a shaking 
incubator at 200 rpm. At time periods, 0, 2, 6 and 24 hours, 100 µl aliquots were diluted 1:10 in 
D/E neutralization buffer to prevent antimicrobial carry-over. Diluted samples were sub-cultured 
on Mueller-Hinton agar and incubated overnight at 37°C or 30°C under aerobic conditions after 
which cfu were determined. 
 
Synergy was defined as a ≥ 2 log10 reduction in the colony count between the combination and 
the most active agent at 24 hour. Additive or indifference was a < 2 log10 decrease in the colony 
count at 24 hr by the combination compared with the most active single agent whereas antagonism 
was a ≥ 2 log10 increase in colony after 24 hour between the combination and the most active 
agent [12-14]. 
 
4.3.5 Evaluation of antimicrobial activity of phosphate based glasses containing 50/50 
mol % of metal oxides 
The effect of glasses manufactured with 5 mol % of two different metal oxides was determined 
on the growth of microorganism studied. 5 mg/ml suspension of 5 mol % copper, cobalt, zinc 
alone and in combinations were prepared in relevant microbiological media. Each test sample 
was inoculated with 105 cfu/ml of the test microorganism. The samples were then incubated in an 
aerobic incubator at 37°C or 30°C with a shaking speed of 200 rpm, broth without glass discs 
served as negative control. At various time intervals; 0, 2, 6 and 24 hours, a 100 µl sample was 
taken out from each test container and serially diluted 1:10 in D/E neutralization buffer to 
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determine the viable count using spread plate method. All experiments were undertaken in 
triplicate. Since the pH of the aqueous media is likely to change upon glass dissolution therefore 
pH was also assessed at time 0, 2, 6 and 24 hours (See Appendix – Table A1). 
 
Synergy was defined as a ≥ 2 log10 reduction in the colony count between the combination and 
the most active agent at 24 hour. Additive or indifference was a < 2 log10 decrease in the colony 
count at 24 hr by the combination compared with the most active single agent whereas antagonism 
was a ≥ 2 log10 increase in colony after 24 hour between the combination and the most active 
agent [12-14].  
 
4.3.6 Statistical analysis 
Two-way analysis of variance was carried out to determine statistical significances (GraphPad 
Prism). If a significant difference was detected a Tukey test was carried out to determine which 
values were significantly different. Differences were considered statistically significantly at a 
level of P < 0.05. 
 
 
 
 
 
4.4 Results 
4.4.1 Minimum Inhibitory and Bactericidal concentrations of cobalt, zinc and copper 
doped glasses using broth microdilution 
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The results demonstrated a greater antimicrobial activity of cobalt doped phosphate glass 
compared to zinc and copper doped phosphate glasses, as the MIC and MBC values are ≤ 3.13 
mg/ml for cobalt, 1.5 – 6.25 mg/ml for zinc and 3.13 – 25 mg/ml for copper doped glass (Figure 
4.2). C. albicans demonstrated reduced susceptibility to copper compared to the other 
microorganisms tested, where the highest concentration tested (25 mg/ml) of copper exhibited 
bactericidal effect.    
 
 
Figure 4.2: MICs and MBCs media value (N=3) of 5 mol % metal (cobalt, zinc, copper) doped 
phosphate glasses against E. coli, S. aureus and C. albicans determined using the broth 
microdilution assay. 
 
 
 
 
4.4.2  Checkerboard assay to assess the antimicrobial efficacy in combination 
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All three combinations; cobalt and copper, cobalt and zinc, zinc and copper failed to demonstrate 
synergistic antimicrobial activity against the microorganisms tested except for cobalt and copper 
against E. coli with and FICI value of 0.5 (Table 4.1).    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Microorganism Combination tested MIC alone/Combination 
Mean 
FIC 
Mean 
FICI Result 
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E. coli Co/Cu Co 3.13/0.78, 3.13/0.78 0.25, 0.25 
0.5 Synergy 
  Cu 12.50/3.13, 12.50/3.13 0.25, 0.25 
 Co/Zn Co 3.13/1.56, 3.13/3.13 0.5, 1.0 
1.75 Indifference 
  Zn 6.25/6.25, 6.25/6.25 1.0, 1.0 
 Cu/Zn Cu 12.50/12.50, 12.50/6.25 0.125, 0.5 
1.375 Indifference 
  Zn 6.25/3.13, 6.25/6.25 0.5, 1.0 
S. aureus Co/Cu Co 1.56/1.56, 1.56/0.78 1.0, 0.5 
0.94 Indifference 
  Cu 6.25/1.56, 6.25/0.78 
0.25, 
0.125 
 Co/Zn Co 1.56/3.13, 1.56/3.13 2.0, 2.0 
3.0 Indifference 
  Zn 6.25/6.25, 6.25/6.25 1.0, 1.0 
 Cu/Zn Cu 6.25/6.25, 6.25/1.56 1.0, 0.25 
1.87 Indifference 
  Zn 6.25/12.5, 6.25/1.56 2.0, 0.25 
C. albicans Co/Cu Co 3.13/1.56, 6.25/3.13 0.5, 0.25 
1.0 Indifference 
  Cu 12.5/6.25, 25.0/6.25  0.25, 0.25 
 Co/Zn Co 3.13/1.56, 3.13/1.56 0.5, 0.5 
2.0 Indifference 
  Zn 6.25/12.5, 12.5/12.5 2.0, 1.0 
 Cu/Zn Cu 12.5/6.25, 25.0/6.25 0.5, 0.25 
0.95 Indifference 
  Zn 3.13/3.13, 12.5/3.13 1.0, 0.25 
 
Table 4.1: Antimicrobial efficacy of 5 mol % cobalt, zinc and copper doped phosphate based 
glasses against planktonic growth of E. coli, S. aureus and C. albicans, using a checkerboard 
assay. The results are shown in duplicate and expressed as Fractional Inhibitory Concentration 
(FIC) and FIC Index (FICI), where FICI ≤ 0.5 shows synergy, FICI > 0.5 or ≤ 4.0 shows 
indifference, and FICI > 4.0 shows antagonism. 
 
4.4.3 Evaluation of synergistic effect of glasses using time kill assay 
166 
 
Time kill curves of 5 mol % cobalt, zinc or copper doped phosphate glasses alone and in 
combination against E. coli are shown in Figure 4.3. A significant antimicrobial effect of the 
glasses tested and their combinations was not observed until 6 hours. At 6 hours cobalt showed a 
significant reduction (p = 0.0089) in the bacterial count compared to copper and zinc doped 
glasses. Similarly, significant results were observed for all three glass combinations at 6 hours (p 
< 0.0001). At 24 hours, the antimicrobial effect of cobalt and copper was enhanced (p < 0.0001) 
while zinc failed to exhibit antimicrobial effect. When considering the effect of combining two 
different glasses, a synergistic activity between Co/Cu, Co/Zn and Cu/Zn was observed, as there 
is a visible reduction in colony count at 24 hours below single agents. 
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Figure 4.3: shows time kill curves of 5 mol % cobalt, zinc and copper doped phosphate glass 
powders alone and in combination, at 2×MIC concentration, against E. coli. The combinations 
investigated were (A) Co/Cu, (B) Co/Zn and (C) Cu/Zn.  Microbial viability is presented as log 
CFU/ml. Data shown are expressed as mean ± SD (N=3). 
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The antimicrobial effect of 5 mol % cobalt, copper or zinc doped glasses against S. aureus is 
shown in the figure 4.4. A non-significant decrease in bacterial count was seen at 2 hours, and at 
6 hours except for cobalt doped glass and Co/Zn glass combination. Whilst significant activity 
was observed at 24 hours by copper and cobalt against S. aureus zinc failed to exhibit 
antimicrobial activity. While all glass combinations exhibited a synergistic effect against E. coli, 
only two combinations i.e. Co/Cu and Co/Zn showed synergistic effect against S. aureus (Figure 
4.3). A significant difference (p < 0.001) in the bacterial count was observed at 24 hours by cobalt, 
copper, Co/Cu and Co/Zn when compared to S. aureus control.  
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Figure 4.4: shows time kill curves of 5 mol % cobalt, zinc and copper doped phosphate g glass 
powders alone and in combination, at 2×MIC concentration, against S. aureus. The combinations 
investigated were (A) Co/Cu, (B) Co/Zn and (C) Cu/Zn. Microbial viability is presented as log 
CFU/ml. Data shown are expressed as mean ± SD (N=3). 
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The antimicrobial effect of 5 mol % cobalt, copper or zinc doped glasses against C. albicans is 
shown in the figure 4.5. A non-significant decrease in microbial count was seen at 2 and 6 hours. 
A significant decrease in colony count was observed at 24 hours by copper (p < 0.001), cobalt (p 
= 0.002) and zinc (p = 0.0298) when compared to non-treated cultures (control). Similarly, 
combinations tested showed significant antimicrobial effect (p < 0.001). Whilst significant 
activity was observed at 24 hours by glasses alone and combinations, synergistic effect was not 
seen. 
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Figure 4.5: shows time kill curves of 5 mol % cobalt, zinc and copper doped phosphate glass 
powders and in combination, at 2×MIC concentration, against C. albicans. The combinations 
investigated were (A) Co/Cu, (B) Co/Zn and (C) Cu/Zn. Microbial viability is presented as log 
CFU/ml. Data shown are expressed as mean ± SD (N=3).  
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4.4.4 Evaluation of antimicrobial activity of phosphate based glasses containing 50/50 
mol % of metal oxides 
Time kill curves of cobalt, copper and zinc doped glasses alone and in combination (50/50 mol 
%) against E. coli are shown in Figure 4.6. A significant antimicrobial effect was seen for cobalt 
at 6 and 24 hours when compared to untreated control (p < 0.0001) and un-doped phosphate based 
glass (p < 0.0001), whereas copper and zinc failed to demonstrate a significant decrease in 
microbial count. When considering the effect of combining two different glasses (5 mol % of 
each dopant), a synergistic activity was only seen for Cu/Zn, as there is > 2 log reduction in 
colony count at 24 hours compared to copper and zinc alone. 
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Figure 4.6: shows time kill curves of 50/50 mol % cobalt, zinc and copper doped phosphate glass 
powders alone and in combination against E. coli. The combinations investigated were (A) 
Co/Cu, (B) Co/Zn and (C) Cu/Zn.  Microbial viability is presented as log CFU/ml. Data shown 
are expressed as mean ± SD (N=3). 
 
// 
// 
B 
C 
174 
 
Figure 4.7 shows the antimicrobial effect of combining two metal oxides in the given phosphate 
glass system against S. aureus. A significant decrease in bacterial count was seen at 2 hours for 
5 mol % cobalt doped glass (p = 0.0376), whereas a non-significant difference was observed for 
5 mol % copper or zinc doped glasses demonstrating lack of antimicrobial activity. Similar effect 
was seen at 6 and 24 hours. The combined effect of glasses showed Cu/Zn have synergistic effect 
against S. aureus whereas Co/Cu and Co/Zn showed indifference.  
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Figure 4.7: shows time kill curves of 50/50 mol % cobalt, zinc and copper doped phosphate glass 
powders alone and in combination against S. aureus. The combinations investigated were (A) 
Co/Cu, (B) Co/Zn and (C) Cu/Zn.  Microbial viability is presented as log CFU/ml. Data shown 
are expressed as mean ± SD (N=3). 
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Figure 4.8 shows the time kill curves of cobalt, copper or zinc doped phosphate based glasses; 
alone and in combination against C. albicans. Significant decrease in growth of C. albicans was 
seen at 24 hours when treated with cobalt, copper or zinc doped glasses alone (p < 0.0001). 
However, the antimicrobial effect was less pronounced against C. albicans compared to E. coli 
or S. aureus (Figure 4.5 – 4.6). Combination of Co/Cu resulted in synergistic activity for C. 
albicans, whereas ‘Indifference’ was observed for Co/Zn and Cu/Zn combinations (Figure 4.7). 
 
 
 
0 2 6 2 4
0
2
4
6
8
1 0
T im e  (H o u rs )
lo
g
 c
fu
/m
l
C o n tro l
C o
C u
C o /C u
0
 
 
 
 
 
 
 
// 
A 
177 
 
 
0 2 6 2 4
0
2
4
6
8
1 0
T im e  (H o u rs )
lo
g
 c
fu
/m
l
C o n tro l
C o
Z n
C o /Z n
0
 
 
0 2 6 2 4
0
2
4
6
8
1 0
T im e  (H o u rs )
lo
g
 c
fu
/m
l
C o n tro l
C u
Z n
C u /Z n
0
 
Figure 4.8: shows time kill curves of 50/50 mol % cobalt, zinc and copper doped phosphate glass 
powders alone and in combination against C. albicans. The combinations investigated were (A) 
Co/Cu, (B) Co/Zn and (C) Cu/Zn.  Microbial viability is presented as log CFU/ml. Data shown 
are expressed as mean ± SD (N=3). 
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4.5 Discussion 
The polymicrobial nature of various infections and development of resistant strains over the past 
few decades have become a huge clinical problem. Therefore, researchers are striving not only to 
gain comprehensive knowledge about drug resistant strains but also assessing the alternative 
treatments such as combination prospects. This study not only adds to the current knowledge of 
antimicrobial potential of bioactive glasses but also provides an insight to the effect of combining 
metal oxides within a glass system. The purpose of this chapter was to identify metal doped glass 
compositions with synergistic antimicrobial effect against microorganisms such as E. coli, S. 
aureus and/or C. albicans.   
 
Five mol % cobalt, copper or zinc doped phosphate glasses were tested alone and in combination 
against clinically relevant microorganism. The synergistic effect was studied using two different 
methods; checkerboard and time kill assays to attain comprehensive results. The results of this 
study demonstrated that 5 mol % cobalt, copper or zinc doped phosphate glass systems possess 
antibacterial and antifungal activity proving effective against E. coli, S. aureus and C. albicans 
in planktonic form. The lack of antimicrobial activity seen for un-doped phosphate based glass 
demonstrates that the antimicrobial efficacy of the doped glasses is derived from the cobalt, 
copper or zinc ions. Additionally, this study is the first to report a synergistic antimicrobial effect 
of metal oxides against E. coli, S. aureus and C. albicans (discussed below).  
 
Variable results were seen with both methods, most combinations showed indifference in 
checkerboard except for Co/Cu against E. coli, Time kill analysis was performed using two 
slightly different methods. In method 1 (Time Kill 1 – TK1), conventional assay was used where 
single metal oxide doped glasses were separately used to test synergy. Whereas, in method 2 
(Time kill 2 – TK2), glasses were prepared with a combination of two metal oxides within the 
same glass system. Whilst no synergistic effect was seen against C. albicans, in TK1, Co/Cu and 
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Co/Zn showed a synergetic antimicrobial effect against E. coli and S. aureus whereas Cu/Zn 
showed only against E. coli. On the other hand, in TK2, Cu/Co and Cu/Zn showed synergistic 
effect against E. coli whereas, only Cu/Zn against S. aureus with no synergism against C. 
albicans. 
 
A considerable variation in the combination results was observed when checkerboard and time 
kill results were compared, nonetheless there was no major categoric difference i.e. from 
synergism to antagonism or vice versa. The difference in the data could be attributed to the 
methodologies used. In checkerboard studies, the microtiter plates were incubated in static 
incubator and the results demonstrated an ‘indifference’ whereas time kill studies were 
undertaken in a shaker at 200 rpm and few combinations showed synergism. Unlike checkerboard 
assay (static conditions), in time kill studies metal ions are more likely to come in contact with 
microorganisms due to continuous agitation and penetrate cells therefore exhibiting an enhanced 
antimicrobial effect. Furthermore, in checkerboard assay the slightly coloured solution of glasses 
makes it difficult to interpret the visible growth and could have contributed to incorrect FICI 
calculations.    
 
Several studies have been undertaken to compare the accuracy and sensitivity of the two methods. 
Petrou & Rogers conducted a comparative study on the efficacy of polyene and azole 
combinations against fungal strains and noted better sensitivity and reproducibility with time kill 
analysis [15]. Similarly, Lewis et al., indicated that E-test and time kill assays yield better results 
compared to checkerboard tests [16]. The rates of synergy detected by time kill assay on MDR 
Acinetobacter baumannii were higher than the rates detected by checkerboard assay [17]. A 
systematic review conducted by Zusman et al., concluded that synergy rates are higher in studies 
using time kill method than the checkerboard or E-test method [18]. Thus, the data presented here 
on combination analysis using time kill assays is likely to be more accurate.     
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Time kill assays were performed using two different approaches. In method 1 glasses prepared 
with one metal oxide were combined to evaluate synergistic potential whereas for method 2, two 
metal oxides were incorporated within the glass system at 5 mol % ratio of each component. The 
results from the two methods showed a slight variation for E. coli and S. aureus however no 
synergism was detected against C. albicans. All combinations demonstrated a synergistic 
antimicrobial effect using method 1 but only Cu/Zn showed synergism in method 2. The lack of 
synergism in method 2 compared to method 1 could be attributed to the glass dissolution 
behaviour. As discussed in section 2.5, glass dissolution is a complex process which depends on 
several factors such as glass composition, structure, dissolving media, pH and temperature. The 
incorporation of an additional metal oxide in the glass system is likely to change the structure of 
the glass network and subsequently the dissolution behaviour and ion release profile. 
Furthermore, microbiological media such as nutrient broth provides a complex environment with 
a number of ionic species that may reduce the concentration of a free metal ion by precipitation 
or by the formation of soluble complexes [19]. Therefore, a direct comparison between the two 
methods cannot be made due to different release profile of the antimicrobial ions from glasses.  
 
Despite the variation in time kill results from two methods, the present study has established that 
metal doped bioactive glasses can be used in combination as they possess a synergistic 
antimicrobial activity. Some drug combinations with different modes of actions can produce 
synergistic effect against multidrug resistant strains. Bioactive glasses are generally believed to 
have a broad spectrum antimicrobial action; however, various metal ions have also been shown 
to target specific cell component or process. For instance, copper ions are believed to target the 
cell membrane [20] whereas cell death due to cobalt ions is brought about due to hypoxic 
conditions [21, 22]. Nonetheless, the full mechanism of action of combining metal oxides is not 
yet fully understood.  
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In line with the results of chapter 3, the synergistic antimicrobial action appeared organism 
specific, with E. coli being the most sensitive whereas C. albicans was least susceptible. This 
could be attributed to the outer cell wall structure of the strains tested. Gram negative bacteria 
unlike Gram positive bacteria have ion channels that allow penetration of metallic ions through 
the outer membrane which subsequently bring about cell death. Furthermore, in addition to thick 
peptidoglycan, cationic sequestering due to anionic metal binding sites occurs on the surface of 
Gram positive bacteria which contributes to resistance of S. aureus killing [23-26] 
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4.6 Conclusion 
Five mol % cobalt and copper doped phosphate glass demonstrated an antimicrobial activity 
against Gram positive and negative bacteria, as well as C. albicans. Combination studies using 
time kill assays showed synergism. The synergistic antimicrobial efficacy possessed by Cu/Co 
and Cu/Zn against E. coli and Cu/Zn against S. aureus may be used to coat/impregnate urinary 
catheters for preventing device related infections. A better understanding of the active 
concentration of metallic ions needed to kill microbes can be achieved by performing elemental 
analysis.  
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Chapter 5 
Cytotoxic evaluation of cobalt or zinc doped 
bioactive glasses with human uroepithelial cells 
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5.1 Introduction  
Urinary catheters, part of the catheter coated with bioactive glasses or glass beads injected in to 
the bladder lining will come in contact with body environment and therefore should be 
biocompatible. Bioactive glasses have been extensively investigated for bone repair and 
regeneration as well as in dental field. Biocompatibility of bioactive glasses is a key element 
when it comes to their in vivo applications. The composition of bioactive glasses has a significant 
effect on their ability to support cell growth and proliferation. For instance, calcium ions in 
Bioglass® play a key role in stimulating osteoblast-like cell proliferation and differentiation. It is 
therefore important that glasses should release an optimum level of ions which are sufficient to 
elicit a desired response with minimal detrimental effects to the living tissues. Several studies 
have found bio-glasses to be safe materials that allow adhesion, proliferation and differentiation 
of cells [1-7]. 
 
Several phosphate glass systems have been developed and studied for their biocompatibility. In 
a study conducted by Uo et al., cytocompatibility of a phosphate glass system (P2O5-CaO-Na2O) 
was evaluated against dental pulp cells. It was found that the glass was not very cytotoxic when 
P2O5 content was 50% or below, whereas glasses with P2O5 content greater than 50% were 
rendered cytotoxic due to high pH [8]. Similar findings were reported by Navarro et al. that 
showed a non-toxic effect of a titanium doped P2O5-CaO-Na2O system on Saos-2 cells [9]. Salih 
et al, studied the biological response of a similar ternary glass system against two human 
osteoblast cell lines; MG63 and HOS and showed enhanced cell growth with dissolution products 
of the glasses studied [10]. Biocompatibility studies of sodium phosphate glasses showed low 
levels of peroxide and interleukin-1β released by macrophages which maintained a round non-
activated morphology. The study established that the glass produced a very low inflammatory 
response [3]. 
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In vivo studies have also been conducted on bioactive glasses to investigate bonding of bioglass 
to bone. The glasses have been implanted not only in mice but also in mammals such as monkeys, 
dogs and baboons with no evidence of toxicity [11-14]. Several studies have been performed to 
understand the inflammatory response of the body to bioactive glasses. Walker et al., reported 
the effect of injecting Bioglass®, in bladder tissues of rabbits, to correct urinary incontinence. 
The surrounding tissue was found not to contain increased calcium and silicon, no histological 
changes and inflammatory response were observed [15]. Rectenwald and co-workers injected 
glass intraperitoneally into mice and found it attenuated a proinflammatory response due to 
endotoxicosis [16]. Similarly bioactive glasses containing CaO–SiO2–P2O5 have been shown to 
bind with hard and soft tissue without causing local or systemic toxicity and any signs of 
inflammation [17, 18]. 
 
Whilst a growing body of research is available on lack of toxicity of bioactive glasses, nonetheless 
a few studies have reported detrimental effects on living tissue. For instance, Luo et al., conducted 
in vitro analysis of cytotoxicity of silver containing borate glasses and found the glasses had toxic 
effects on cell viability [19]. In some other studies, cytotoxicity of borate glasses has been shown, 
however this has been attributed to be a consequence of high pH due to the faster degradation 
rate of the borate glasses [20-22]. 
 
From the above-mentioned studies it is evident that glasses are safe for use in vivo, however a 
large number of the studies have been conducted on osteoblasts and limited or no data is available 
on the effect of bioactive glasses on epithelial cells such as uroepithelium. Since the aim of the 
research is to develop novel glass coatings or glass beads that can be injected in to the bladder 
lining to treat urinary tract infections, hence the cytotoxic effect of the given glasses needs to be 
evaluated on the cells lining the urinary tract. Therefore, the focus of the present work was to 
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investigate the cytotoxic effects, if any, of the cobalt or zinc doped glasses on human epithelial 
cells. 
 
The urinary tract is lined by transitional epithelium which is a type of tissue containing multiple 
layers of epithelial cells. The tissue is found in renal pelvis, urinary bladder, ureters and urethra. 
Therefore, for this study normal human uroepithelial cells (HUCs) and a cancer cell line (T24) 
were used. These cells exhibit a characteristic cobblestone morphology in culture (Figure 5.1). 
 
 
Figure 5.1a: Normal human uroepithelial cells. Scale bar indicates 100 µm. 
 
Figure 5.1b: Bladder cancer cells – T24. Scale bar indicates 100 µm. 
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5.2 Aims 
The aims of this study were to: 
• Investigate the cytotoxic effects of cobalt and zinc doped phosphate based bio-glasses 
(0, 3, 5 and 10% mol) on uroepithelial cells; normal human uroepithelial cells (HUC) 
and transitional carcinoma cells (T24).  
 
This was achieved by studying: 
• The effect of dissolution products of cobalt and zinc doped glasses on HUC and T24 
cells 
o The effect of pH buffering 
• The effect on viability of cells when in direct contact with cobalt and zinc doped 
glasses. 
 
 
 
 
 
 
 
 
 
 
5.3 Methods and Materials 
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5.3.1 Glass preparation 
See section 2.3.1 
 
 
5.3.2 Cell culture 
 
All cell culture work was undertaken in a class II biosafety cabinet with HEPA filtration units. 
Before and after use, the cabinet was cleaned with 70% (v/v) ethanol (Fisher Scientific, UK) and 
UV light was also used to disinfect the cabinet prior to use each day. Once every two weeks, the 
cabinet and incubators were cleaned with 10% Distel (Fisher Scientific, UK). Waste media and 
cells were disposed of using Virkon® (Sigma Aldrich, Dorset, UK). 
 
 
5.3.1.1 Maintenance of Human uroepithelial cells 
 
Human uroepithelial cells (HUC) were purchased from ScienCell laboratories, USA and cultured 
in a T75 flask (Fisher Scientific, UK) coated with poly L-lysine (ScienCell laboratories) at 
concentration of 2µg/cm2. Before seeding cells, flasks were rinsed twice with sterile water and 
maintained in recommended uroepithelial cell media (UCM, ScienCell laboratories) 
supplemented with uroepithelial cell growth supplement (UCGS, ScienCell laboratories) and 1% 
penicillin/streptomycin (Fisher Scientific, UK) at 37°C and 5% CO2 incubator. The media was 
changed every three days until the culture reached 70% confluency, thereafter the media was 
changed every other day until the culture was approximately 90% confluent.  
 
Once 80- 90% confluent, cells were subcultured. First cells were washed twice with sterile 
Dulbecco’s Phosphate Buffered Saline (DPBS) (Sigma Aldrich, Dorset, UK). To harvest cells 8 
ml of sterile DPBS was added to the flask along with 2 ml of 0.25% trypsin/EDTA solution 
(ScienCell laboratories) and incubated at 37°C for 2 minutes. At the end of incubation, the flask 
was gently tapped to dislodge cells. The contents of the flask were then transferred into a 
centrifuge tube containing 5 ml of fetal bovine serum (FBS). Ten ml of trypsin neutralising 
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solution (ScienCell laboratories) was used to collect remaining cells from the flask and transferred 
into the centrifuge tube. Cells were then centrifuged at 1000 rpm for 5 minutes and resuspended 
in culture medium and seeded into a new flask and/or used for experiments.  
 
5.3.1.2 Maintenance of T24 cells – Bladder transitional cell carcinoma  
 
 
T24 (ATCC® HTB-4™) the human bladder carcinoma cells were purchased from the American 
Tissue Culture Collection and cultured in McCoy’s 5A medium (ATCC) supplemented with 1% 
penicillin/streptomycin and 10% fetal bovine serum (FBS). Cells were maintained in a humidified 
atmosphere of 5% CO2 and at 37°C. When 80 - 90% confluent cells were harvested using 0.25% 
trypsin, 0.03% EDTA solution. Culture media was removed, cells were washed with sterile DPBS 
(Sigma Aldrich, Dorset, UK) and 2 ml of trypsin-EDTA solution was added. The flask was 
incubated at 37°C for one minute. Following incubation 3 ml of complete media were added to 
neutralise the effect of trypsin-EDTA solution. The contents of the flask were added in a 15 ml 
centrifuge tube and spun at 1000 rpm for 3 minutes to harvest cells. After removing the supernant, 
the pellet was re-suspended in 1 ml of culture media and the cell count was performed as 
explained in section 4.3.2.3. The cells were then seeded into new flasks at a density of 1000 
cells/cm2 or used for experiments. 
 
5.3.1.3 Viable cell counts using the trypan blue exclusion method 
The viability of the cells in suspension was performed using the trypan blue exclusion method. 
The technique is based on the fact that viable cells have intact cell membranes whereas the dead 
cells have damaged i.e. perforated cell membranes which allows penetration of certain dyes such 
as trypan blue. Therefore, dead cells take up the dye and appear blue when looked under light 
microscope, whereas live cells have clear cell body.  
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To perform a viable cell count, 10 µl of cell suspension was added in 40 µl of trypan blue solution 
(Fisher Scientific, UK). The suspension was mixed thoroughly and loaded onto a 
haemocytometer (Fisher Scientific, Leicester, UK). Live cells were counted in four sets of 16 
corner squares and number of viable cells were counted as under: 
Viable cells/ml = Average cell count x 10, 000 x 5  
(Multiplied by 5 to correct for 1:5 dilution from trypan blue addition). 
 
5.3.2 Determination of cytotoxic effect of cobalt doped and zinc doped phosphate 
based glasses  
 
 
5.3.2.1 Direct contact 
 
Direct contact assay allows both qualitative as well as quantitative assessment of cytotoxicity. 
The test material is placed on the cultured mammalian cells in vitro and the cytotoxic effect can 
be evaluated by observing the changes in the cell morphology and by quantifying the number of 
viable cells after exposure to the test material. The test was performed in accordance with ISO-
10993-5 for testing in vitro cytotoxicity of medical devices [23]. To evaluate the effect of cobalt 
doped or zinc doped phosphate glasses cells were cultured in 6 wells plate. A known aliquot of 
continuously stirred cell suspension was added in each well and cells were evenly distributed by 
gentle horizontal rotation of the plates. Cells were then incubated in a humidified atmosphere of 
5% CO2 and at 37°C until the culture had grown to 90 – 100% confluency.   
 
Before placing glass discs on the cells monolayer, cell morphology and confluency was verified 
under the light microscope. Culture medium was removed and 2 ml of fresh culture media was 
added. Heat sterilised glass discs (Ø 10 mm) were then placed on the cell layer, care was taken 
to avoid mechanical damage to cells while placing samples, in triplicates. It was ensured that the 
glass discs cover approximately 1/30th of the cell monolayer. Following 24, 48 and 72 hours 
194 
 
incubation at optimum conditions cell viability was performed using MTT reagent as described 
in 5.3.3.2. 
 
5.3.2.2 Indirect contact 
 
Medical devices when in vivo are subject to degradation, therefore it is vital to evaluate the 
cytotoxic effect of the dissolution products of the test specimen on the growth and proliferation 
of mammalian cells. To test the cytotoxic effect of dissolution products, conditioned media was 
prepared as described in ISO-10993-5. Sterile glass discs were incubated in 25 ml of respective 
complete cell media at 37ºC for 24 hours. Since phosphate glasses have uniform dissolution over 
a period and the glass products are likely to get flushed out of the body within 24 hours, hence 
the time chosen for the extraction of glass products. After 24 hours incubation, conditioned media 
was filtered through 0.2µ Ministart syringe filter (Sartorius Biotech, Germany) and pH readings 
were taken using an accumet® pH meter (Fisher Scientific, UK). The conditioned media from 
each sample was then divided in two parts; one set of the media was not neutralised whereas the 
other was neutralised. The pH neutralisation was achieved by keeping the universals in 5% CO2 
incubator for one hour. pH readings were recorded before and after incubation.  
 
Cells were harvested and seeded, in quadruplicate, into 96 wells plates at a density of 6 x 103 cells 
per well in 100 µl media. The plates were then incubated overnight to allow cells to attach. 
Following incubation, media was removed and cells were treated with 100 µl conditioned media 
for 24, 48 and 72 hours. Two plates were prepared for each time point, one was treated with 
conditioned media without pH buffering and the other treated with pH buffered media. During 
incubation, cells were treated with fresh conditioned media every 24 hours. Ethanol was used as 
positive control whereas cells grown in complete cell media served as negative control. At each 
time point cell viability was determined using MTT test as described below and the treatments 
were cytotoxic if the cell viability was less than 70% compared to the negative control.   
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An MTT viability assay (Thermo Fisher, UK) was used as to determine the cytotoxic effect of 
glass dissolution products. The assay works on the principle that metabolically active cells have 
NAD(P)H dependent cellular oxidoreductase enzymes which reduces the yellow tetrazolium 
MTT (3-(4, 5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide) into insoluble formazan 
crystals. The crystals can be solubilised using detergents such as SDS or DMSO and the optical 
density of the solution gives direct measure of cell viability. A 12 mM stock solution of 3 - (4.5-
dimethylthiazol-2-yl) - 2.5-diphenyltetrazolium bromide (MTT) was prepared by adding 1 ml 
PBS to 5 mg MTT reagent. At each time point, conditioned media was removed from each well 
and MTT reagent, diluted 1/10 in phenol free media, was added to the cells. The plates were then 
incubated in the dark for 3 hours at 37ºC/5% CO2. Following incubation, the solution was 
removed from the wells and 100 µl of DMSO (Sigma – Aldrich, UK) was added to each well and 
left to incubate at 37ºC for 10 minutes. The optical density was measured using an Ascent 
MultiScan GO spectrophotometer (Fisher Scientific, Leicester, UK) at 570 nm (test) and 675 nm 
(reference).  
 
5.3.2.3 Cytotoxic evaluation using Live/Dead staining 
 
To evaluate the cytotoxic effect of conditioned media on cells, live/dead staining was performed. 
Conditioned media was prepared as explained in section 4.3.3.2. A cell suspension containing 
10,000 cells in complete media was added in each well of a 24 well plate. Cells were incubated 
overnight to allow adherence of the cells onto the well surface. Following incubation, media was 
discarded and cells were treated with conditioned media for 24, 48 and 72 hours. At each time 
point, a positive control was established by incubating cells with 70% ethanol for 45 minutes. 
Cells treated with complete media served as negative control. 100 µl staining solution containing 
0.5 µM calcein-green and 2.5 µM ethidium homodimer - 1 was added to T24 cells and 2.0 µM 
calcein-green and 2.5 µM ethidium homodimer-1 was added to HUC. The cells along with 
staining solution was incubated for 45 minutes. Fluorescence microscopy was used to photograph 
the cells at 100X.  
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Live cells are distinguished by the presence of intracellular esterase; the enzyme converts non-
fluorescent cell-permeant calcein AM to the intensely fluorescent calcein. The polyanionic dye 
calcein-green is well retained within live cells, producing an intense uniform green fluorescence. 
On the other hand, dead cells have damaged cell membrane that allows EthD-1 to enter the cell 
and undergo a 40-fold enhancement of fluorescence upon binding to nucleic acids, thus producing 
a bright red fluorescence in dead cells.  
 
5.3.3 Statistical analysis  
Each experiment was performed in triplicates or quadruplicates and repeated three times, data are 
represented as the mean ± standard deviation. Statistical analysis was undertaken using Graphpad 
Prism 7.0. Two-way ANOVA was used to test significance, if significance was detected a 
Tukey’s multiple comparisons test was conducted. Levels of significance are given in the text 
and considered statistically significant at a level of P < 0.05. 
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5.4 Results 
 
5.4.1 Determination of cytotoxic effect of cobalt doped phosphate based glasses on 
normal uroepithelial cells 
 
5.4.1.1 Indirect Contact 
Figure 5.2 shows the viability of normal HUCs when exposed to media conditioned with various 
mol % of cobalt glasses. The pH of the conditioned media was recorded before and after 
conditioning time, and was within the optimum range. (Appendix Table A.1). The MTT assay 
was performed to assess the cytotoxic effects, cell viability was calculated as percentage of 
respective negative control.  
 
As seen in Figure 5.2, the viability of HUCs was compromised with an increasing concentration 
of cobalt in media. Dissolution products of 10 mol % cobalt glass showed a significant cytotoxic 
effect against HUCs (p < 0.0001) when compared to negative control at 24, 48 and 72 hours. 
Similar effect was observed for dissolution products of 5 mol % cobalt glass, however the 
cytotoxic effect was less pronounced compared to 10 mol % cobalt glass dissolution products but 
significant compared to negative control (p < 0.0001). The least cytotoxic effect was seen when 
HUCs were treated with dissolution products of 3 mol % cobalt glass as the cell viability was 
60%. Nonetheless, the result shows a significant (p < 0.0001) decrease in cell viability when 
treated for 24 hours, with further reduction in cell viability at 48 and 72 hours compared to the 
negative control.  
 
Cytotoxic effect of un-doped phosphate glass was also studied along with cobalt doped phosphate 
glasses. It can be seen in figure 5.2, a reduction in cell viability was observed within 24 and 48 
hours exposure to the dissolution products, 72.9% and 69.7% respectively (p < 0.001). However, 
a significant (p < 0.0001) decrease in cell viability was observed when the cells were treated for 
72 hours with the dissolution products of un-doped phosphate glass.     
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The changes in the cell morphology following incubation with conditioned media were also 
observed using phase contrast microscopy. The cells maintained a cobbled shaped morphology 
for 24 and 48 hours for 3 and 5 mol % glass compositions, however appeared round when 
incubated 72 hours. Whereas, in 10 mol % glass cells appeared round after 24 hours (Figure A.7)  
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Figure 5.2: The effect of the dissolution products of cobalt doped phosphate based glasses (3%, 
5% and 10 mol %) and un-doped phosphate glass on normal human uroepithelial cells. MTT 
assay was used to determine the cell viability following 24, 48 and 72 hours incubation with 
conditioned media. The data is represented as Mean ± SD (N=3).  
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5.4.1.2 Evaluation of cell viability by Live/Dead staining 
 
The cytotoxic effect of glass dissolution products was also assessed using Live/Dead staining, 
live cells are shown in green whereas dead cells in red. As seen in Figure 5.3, cells treated with 
dissolution products of 3 and 5 mol % cobalt glass for 24 hours showed similar viability as the 
cells cultured in urothelial cell media i.e. negative control. However, after 48 hours in culture, 
cells showed reduced viability compared to the 48 hours negative control and respective 24 hours 
dissolution products as a high number of cells were stained with EthD-1 (red - dead). HUCs 
treated with dissolution products of 10 mol % cobalt glass showed significant cytotoxic effects 
as none of the cells were stained with Calcein-AM (green – live), all cells lost viability within 24 
hours of incubation with dissolution products.  
 
Live/Dead staining of the un-doped phosphate glass showed that the dissolution products were 
non-toxic as similar proportion of live cells and very few dead cells were observed when 
compared to the cells grown in urothelial cell media. However, a decrease in live cells was 
observed when cells were exposed to the dissolution products for 48 hours. It was also observed 
that the live cells were clustered together.    
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Figure 5.3: Fluorescence images of Live/dead staining of Human uroepithelial cells cultured for 
24, 48 and 72 hours in dissolution products of cobalt doped phosphate based glasses. Cells grown 
in (A) complete media, media conditioned with (B) un-doped phosphate glass, (C) 3% cobalt 
glass, (D) 5% cobalt glass (E) 10% cobalt glass and (F) cells treated with 70% (v/v) ethanol. 
Images were taken using a fluorescent microscope at 100x magnification. Live cells are shown 
in green whereas red represents dead cells. Scale bar indicates 100 µm. 
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5.4.2 Determination of the cytotoxic effect of cobalt doped phosphate based glasses 
on T24 cells 
 
 
5.4.2.1 Direct Contact 
 
 
The cytotoxic effect of the glasses was determined by placing the glass discs on the cell 
monolayer. Following incubation for 24, 48 and 72 hours MTT assays were performed to evaluate 
the effect of glasses on the viability of T24 cells, which was calculated as the percentage of 
respective controls. As shown in Figure 5.4, the un-doped glass discs exhibited a non-significant 
decrease in the cell viability at all time points (p > 0.9999). According to the ISO-10993-5 
guidelines no cytotoxic effect was observed with the cell viability of 94.9%, 88.4% and 77.8% at 
24, 48 and 72 hours respectively. Similarly, for cobalt doped glasses a non-significant (p > 
0.9937) decrease in cell viability was observed for 24 hours. The cell viability of 94.3%, 95.3% 
and 96.4% was observed for 3, 5 and 10 mol % glass discs.  
 
The cell viability significantly reduced when cells were exposed to glass discs for 48 and 72 hours 
(p < 0.0001). At 48 hours, the cell viability reduced to 49.4% for 3 mol %, 49.0% for 5 mol % 
and 43.5% for 10 mol % cobalt glass, in comparison to the negative control. Moreover, at 72 
hours the cytotoxic effect was even higher with cell viability of approximately 20% for all cobalt 
glass compositions. The changes in the cell morphology following incubation with glass discs 
were also observed using phase contrast microscopy. The cells maintained a cobbled shaped 
morphology for 24 and 48 hours, however appeared round when incubated with glass discs for 
72 hours (Figure 5.5).  
 
 
 
 
 
 
 
202 
 
 
 
 
 
 
 
 
c o n tro l 0 3 % 5 % 1 0 % E th a n o l
0
5 0
1 0 0
1 5 0
%
 C
e
ll
 V
ia
b
il
it
y
2 4  h o u r s
4 8  h o u r s
7 2  h o u r s
n s
* * * * * * * * * * * *
* * * *
n s n s n s
 
 
Figure 5.4: Cytotoxic evaluation, when in direct contact, of cobalt doped phosphate based glasses 
(3, 5 and 10 mol %) and un-doped phosphate glass on T24 cells. Glass discs were placed on cell 
monolayer and the MTT assay was used to determine the cell viability following 24, 48 and 72 
hours incubation. The data is represented as Mean ± SD (N=3).  
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Figure 5.5: Phase contrast images of Human uroepithelial cells cultured for 24, 48 and 72 hours 
in dissolution products of cobalt doped phosphate based glasses. Cells grown in (A) complete 
media, media conditioned with (B) un-doped phosphate glass, (C) 3% cobalt glass, (D) 5% cobalt 
glass (E) 10% cobalt glass and (F) cells treated with 70% (v/v) ethanol. Scale bar indicates 100 
µm. 
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5.4.2.2 Indirect contact 
 
Cytotoxic effect was determined both with and without buffering the pH of the conditioned 
media. pH readings of the media before and after buffering are given in Table A.2. The cell 
viability after treating the cells with conditioned media, for 24, 48 and 72 hours, was quantified 
using MTT assay.   
 
According to the international standard protocol for testing medical devices for cytotoxicity, if 
the cell viability is less than 70% compared to the negative control then the test material is 
considered cytotoxic. As seen in Figure 5.6A, the cell viability significantly reduced for most of 
the glasses at each time point except for 3% and 5% glass compositions at 24 hour. The cell 
viability for 3% glass reduced to approximately half within 24 hours (p < 0.0001) and further 
reduction was observed for 48 and 72 hours (< 15%), with statistical significance of p < 0.0001. 
Similar data was obtained for 5% glass; however, the highest effect was seen for 10% glass where 
percentage cell viability was less than 5 even after 24 hours, significantly reduced in comparison 
to control media (p < 0.0001). Since human body has evolved mechanisms to buffer pH changes 
and maintain it within optimum range therefore pH of the conditioned media was buffered to 
represent in vivo conditions.  
 
The pH buffered analysis was undertaken to rule out the effect of pH on the cell viability, if any. 
The cell viability improved for 3 mol % glass composition at 24 hours as the reduction in viability 
was non-significant. However, at 48 and 72 hours significant decrease in cell viability was 
observed (p < 0.001). Between 24 hours and 48 hours, the percentage cell viability increased from 
50 to 85 suggesting lack of cytotoxicity of 3% cobalt glass. On the other hand, even though the 
cell viability improved for 5 mol % glass composition however it remained below 70% hence 
cytotoxic. Contrary to 3 and 5 mol % glasses no effect of pH buffering was observed for 10 mol 
% cobalt glass (Figure 5. 6B) which suggests toxicity due to cobalt ions rather than the pH.   
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Figure 5.6: The effect of the dissolution products of cobalt doped phosphate based glasses (3%, 
5% and 10 mol %) and un-doped phosphate glass on T24 cells. MTT assay was used to determine 
T24 cell viability following 24, 48 and 72 hours incubation with conditioned media without pH 
buffering (A) and with pH buffering (B). The data is represented as Mean ± SD (N=3). 
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5.4.2.3 Evaluation of cell viability by Live/Dead staining  
 
Figure 5.7 and 5.8 show the fluorescent microscopy of T24 cells following incubation with 
dissolution products of cobalt doped glasses along with controls for 24, 48 and 72 hours stained 
with Calcein-AM and Ethidium homodimer-1. Micrographs are representative of two replicates. 
The data obtained corresponded the results from indirect contact experiment. As it can be seen in 
the Figure 5.7 and 5.8, cells in negative control (A) and un-doped glass conditioned media (B) 
were stained green (live) whereas very few were stained red (dead). On the other hand, when pH 
buffered and non-buffered results were compared, the viability was seen to improve for 3 and 5 
mol % buffered conditioned media, as the number of live cells increased (Figure 5.8) compared 
to non-buffered conditioned media (Figure 5.7). However, as seen from Figure 5.7 and 5.8, no 
live cells were seen for 10 mol % cobalt glass composition, even when the pH was buffered which 
is indicative of high toxicity of the glass due to metal ions.   
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Figure 5.7: Live/dead staining of T24 cells cultured with media conditioned with cobalt doped 
phosphate based glasses at 24, 48 and 72 hours; without pH buffering. Cells grown in (A) 
complete media, media conditioned with (B) undoped phosphate glass, (C) 3% cobalt glass, (D) 
5% cobalt glass (E) 10% cobalt glass and (F) cells treated with 70% v/v ethanol, at time point 24, 
48 and 72 hours. Images were taken using a fluorescent microscope at 100x magnification. Live 
cells are shown in green whereas red represents dead cells. Scale bar indicates 100 µm.    
208 
 
 
 
Figure 5.8: Live/dead staining of T24 cells cultured with media conditioned with cobalt doped 
phosphate based glasses at 24, 48 and 72 hours; with pH buffering. Cells grown in (A) complete 
media, media conditioned with (B) un-doped phosphate glass, (C) 3% cobalt glass, (D) 5% cobalt 
glass (E) 10% cobalt glass and (F) cells treated with 70% v/v ethanol, at time point 24, 48 and 72 
hours. Images were taken using a fluorescent microscope at 100x magnification. Live cells are 
shown in green whereas red represents dead cells. Scale bar indicates 100µm.   
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5.4.3 Determination of the cytotoxic effect of zinc doped phosphate based glasses on 
normal uroepithelial cells 
 
 
5.4.3.1 Indirect Contact 
 
The effect of dissolution products of zinc doped phosphate based glasses on normal human 
uroepithelial cells was evaluated. pH measurements of the media and media with dissolution 
products were determined prior to and after conditioning time, both readings were within the 
physiological pH range acceptable for cell growth and maintenance (Table A.1).  Figure 5.9 
shows the viability of normal HUCs when exposed dissolution products of various mol % of zinc 
glasses. MTT assay was performed to assess the cytotoxic effects, cell viability was calculated as 
percentage of respective negative control.  
 
The viability of HUCs was compromised when treated with dissolution products of zinc doped 
glasses compared to negative control as well as the un-doped phosphate based glass. A significant 
decrease (p < 0.0001) in the cell viability was seen when treated with dissolution products of 3 
mol % zinc doped glass. Cell viability reduced to 24.0%, 19.8% and 19.8% at 24, 48 and 72 hours 
respectively. Furthermore, dissolution products of 5 and 10 mol % zinc doped glasses exerted a 
greater cytotoxic effect with cell viability of less than 5% at 24, 48 and 72 hours (p < 0.0001) 
compared to respective negative control. On the other hand, dissolution products from un-doped 
phosphate glass exhibited a reduction in cell viability within 24 and 48 hours exposure to the 
dissolution products, 72.9% and 69.7% respectively (p < 0.001). However, a significant (p < 
0.0001) decrease in cell viability was observed when the cells were treated for 72 hours with the 
dissolution products of un-doped phosphate glass.     
 
Changes in cell morphology following exposure to the dissolution products were also observed 
under a light microscope. As the concentration of dissolution products increased in media, the 
typical cobblestone shape of the HUCs changed into a round shape. A large number of the cells 
detached from the surface of the well i.e. lost viability (Figure A.9).   
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Figure 5.9: The effect of the dissolution products of zinc doped phosphate based glasses (3%, 
5% and 10 mol %) and un-doped phosphate glass on normal human uroepithelial cells. MTT 
assay was used to determine the cell viability following 24, 48 and 72 hours incubation with 
conditioned media. The data is represented as Mean ± SD (N=3). 
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5.4.3.2 Evaluation of cell viability by Live/dead staining  
 
Live/Dead staining of HUCs was also performed to assess the cytotoxic effects of glass 
dissolution products. Figure 5.10 shows fluorescent images of HUCs where live cells are shown 
in green and dead cells in red. The un-doped phosphate glass showed that the dissolution products 
were non-toxic as similar proportion of live cells and very few dead cells were observed when 
compared to the cells grown in urothelial cell media. However, a slight decrease in live cells was 
observed when cells were exposed to the dissolution products for 48 hours. Whilst no or very few 
dead cells were observed for un-doped glass dissolution products, a considerable cytotoxic effect 
was observed when cells were cultured with dissolution products of zinc doped glasses as no live 
(green) cells were seen at any time point studied compared to negative control.  
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Figure 5.10: Fluorescence images of Live/dead staining of Human uroepithelial cells cultured 
for 24, 48 and 72 hours in dissolution products of zinc doped phosphate based glasses. Cells 
grown in (A) complete media, media conditioned with (B) un-doped phosphate glass, (C) 3% 
zinc glass, (D) 5% zinc glass (E) 10% zinc glass and (F) cells treated with 70% (v/v) ethanol. 
Images were taken using a fluorescent microscope at 100x magnification. Live cells are shown 
in green whereas red represents dead cells. Scale bar indicates 100 µm. 
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5.4.4 Determination of the cytotoxic effect of zinc doped phosphate based glasses on 
T24 cells 
 
 
5.4.4.1 Direct Contact 
 
The effect of placing glass discs on the surface of cell monolayer was assessed. This was achieved 
by performing MTT assay after exposing cells to glass discs for 24, 48 and 72 hours and the cell 
viability was calculated as the percentage of respective controls. The changes in cell morphology 
was also determined under light microscope. 
 
Cell viability significantly (p < 0.0001) decreased when cell monolayers were exposed to zinc 
doped glasses. Figure 5.11 shows that 3, 5 and 10 mol % zinc doped glasses had pronounced 
cytotoxic effect with viability reduced to 12.9%, 10.5% and 2.2% respectively within 24 hours. 
Cell viability was less than 2% at 48 and 72 hours for all glass compositions. This was also seen 
in phase contrast microscopy of the cells when exposed to glass discs. Cells lost their 
characteristic shape within 24 hours, appeared round and detached themselves from the surface 
of the well (Figure 5.12). On the other hand, the un-doped glass discs exhibited a non-significant 
(p > 0.9907) decrease in cell viability at all time point (94.9%, 88.4% and 77.8% at 24, 48 and 72 
hours respectively). 
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Figure 5.11: Cytotoxic evaluation, when in direct contact, of zinc doped phosphate based glasses 
(3, 5 and 10 mol %) and un-doped phosphate glass on T24 cells. Glass discs were placed on cell 
monolayer and MTT assay was used to determine the cell viability following 24, 48 and 72 hours 
incubation. The data is represented as Mean ± SD (N=3).  
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Figure 5.12: Phase contrast images of Human uroepithelial cells cultured for 24, 48 and 72 hours 
in dissolution products of zinc doped phosphate based glasses. Cells grown in (A) complete 
media, media conditioned with (B) un-doped phosphate glass, (C) 3% zinc glass, (D) 5% zinc 
glass (E) 10% zinc glass and (F) cells treated with 70% (v/v) ethanol. Images were taken at 100x 
magnification. Scale bar indicates 100 µm. 
 
216 
 
5.4.4.2 Indirect contact 
 
The cytotoxic effect was determined both; with and without buffering the pH of the conditioned 
media. pH readings of the media before and after buffering are given in Table A.2. The cell 
viability after treating the cells with conditioned media, for 24, 48 and 72 hours, was quantified 
using MTT assay.   
 
Figure 5.13 shows non-cytotoxic effects of dissolution products of zinc doped phosphate glasses 
on viability of T24 cells. A non-significant decrease in the cell viability was seen for 3, 5 and 10 
mol % zinc glasses compared to negative control as well as the un-doped phosphate based glass. 
For 3 mol % glass dissolution products the viability was 93.5%, 96.6% and 88.9% at 24, 48 and 
72 hours respectively, which was comparable even after pH buffering of the conditioned media.  
For 5 and 10 mol % zinc glasses a slight cytotoxic effect was observed with viability of 87.2%, 
86.5% and 73.5% for 5 mol %; 79.5%, 71.6% and 66.7% for 10 mol % zinc doped glass 
dissolution products. However, unlike 3 mol % zinc glass products the viability improved 
following pH neutralisation of the conditioned media; 94.2%, 88.2% and 85.0% for 5 mol %; 
95.9%, 81.4% and 67.6% for 10 mol % zinc doped glass dissolution products. 
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Figure 5.13: The effect of the dissolution products of zinc doped phosphate based glasses (3%, 
5% and 10 mol %) and un-doped phosphate glass on T24 cells. MTT assay was used to determine 
T24 cell viability following 24, 48 and 72 hours incubation with conditioned media without pH 
buffering (A) and with pH buffering (B). The data is represented as Mean ± SD (N=3). 
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5.4.4.3 Evaluation of cell viability by Live/dead staining  
 
The cytotoxic effects of dissolution products were also assessed by Live/Dead staining of the 
cells with Calcein-AM green and EthD-1. The effect of dissolution products was evaluated on 
cell viability with and without pH buffering of the conditioned media. As seen in Figure 5.14, 3 
mol % zinc glass dissolution products, a large number of cells were stained with Calcein-AM 
(green – live) and a very few or none with EthD-1 (red – dead), when compared with respective 
negative control and un-doped glass. However, quite a few cells were stained with EthD-1 in 5 
and 10 mol % zinc doped glasses. When compared to buffered dissolution products (Figure 5.15) 
the cell viability appeared to improve for 5 and 10 mol % zinc glass dissolution products, as none 
of the cells were stained with EthD-1. Overall, by looking at the confluency of the culture in 
Figure 5.15 shows that the pH buffered conditioned media appeared to enhance the cell growth. 
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Figure 5.14: Live/Dead staining of T24 cells cultured with media conditioned with zinc doped 
phosphate based glasses at 24, 48 and 72 hours; without pH buffering. Cells grown in (A) 
complete media, media conditioned with (B) undoped phosphate glass, (C) 3% zinc glass, (D) 
5% zinc glass (E) 10% zinc glass and (F) cells treated with 70% (v/v) ethanol at time point 24, 
48 and 72 hours. Images were taken using a fluorescent microscope at 100x magnification. Live 
cells are shown in green whereas red represents dead cells. Scale bar indicates 100µm. 
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Figure 5.15: Live/dead staining of T24 cells cultured with media conditioned with zinc doped 
phosphate based glasses at 24, 48 and 72 hours; with pH buffering. Cells grown in (A) complete 
media, media conditioned with (B) un-doped phosphate glass, (C) 3% zinc glass, (D) 5% zinc 
glass (E) 10% zinc glass and (F) cells treated with 70% (v/v) ethanol at time point 24, 48 and 72 
hours. Images were taken using a fluorescent microscope at 100x magnification. Live cells are 
shown in green whereas red represents dead cells. Scale bar indicates 100µm. 
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5.5 Discussion 
 
Phosphate glasses have been extensively investigated for their biocompatibility as discussed in 
section 5.1. The aim of the study was to investigate the cytotoxic effects of 3, 5 and 10 mol % 
cobalt doped and zinc doped phosphate glasses on the growth and viability of normal HUCs and 
T24 cells. This was achieved by assessing the effect of dissolution products of the glasses and by 
placing the glass discs directly on cell monolayers i.e. direct contact test. The dissolution products 
of cobalt doped glasses were found to exhibit a strong cytotoxic effect against normal HUCs, a 
concentration dependent decrease in cell viability was observed which was also shown by 
Live/Dead staining of the cells (Figure 5.2 and 5.3). Whilst the pH of glass dissolution products 
remained within optimum range in UCM, it was slightly higher than the optimum range in 
McCoy’s 5A medium, hence pH buffered and un-buffered studies were performed with T24 cells. 
Overall, viability of T24 cells was compromised in a dose dependent manner in both pH buffered 
and un-buffered analysis. Thus, a reduced cell viability of both cell types was demonstrated with 
dissolution products of cobalt doped glasses where 10 mol % glass was the most toxic 
composition. The data obtained was supported by the fluorescent and phase contrast microscopy.  
 
The decrease in cell viability could be attributed to the ionic strength of the conditioned media. 
Many studies have demonstrated that the cytotoxicity occurs due to glass degradation and 
associated change in the ionic strength as well as the pH of the solution. Bioactive glasses when 
immersed in an aqueous media degrade and release ionic products, such as phosphorus, calcium 
and sodium in the present case, which if higher than the optimum range are detrimental to cells. 
The human body requires these elements to perform various functions. For instance, calcium is 
required for membrane permeability, muscle contraction whereas phosphorus plays a role in the 
synthesis of phospholipids and phosphoproteins. Similarly, sodium is present in plasma and help 
regulate nerve impulse and maintain fluid balance in the body [24]. 
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Epithelial cells, like all other cells, have several mechanisms to tightly regulate the calcium levels, 
according to Joost et al., [25], optimum calcium tolerance level of epithelial cells is approximately 
2.5mM/100ppm, similarly sodium in plasma is 3200 ppm [26]. A study conducted by Franchini 
et al., [27] on gallium phosphate glasses reported 101 ppm and 3490 ppm concentration of 
calcium and sodium ions respectively, in 24 hours, as non-toxic. Additionally, 88-100 ppm of 
calcium ions is reported as the concentration needed for the up regulation of several osteogenic 
genes [7, 28, 29]. In the present analysis, the most soluble glass i.e. un-doped phosphate glass 
(P2O5-CaO-Na2O) released 64 ppm of calcium and 50 ppm of sodium within 24 hours of 
immersing in distilled water, therefore the cell toxicity observed in the study is unlikely due to 
calcium or sodium ions. Additionally, in vitro cytotoxic evaluation of 50 mol % phosphate based 
glasses have shown the non-toxic effects of glasses [8]. The non-toxic nature of the un-doped 
glass (P2O5-CaO-Na2O) has also been shown here as the un-doped glass shows proliferative 
effect on cell viability when compared to doped glasses (Figure 5.2 - 5.14). Therefore, the 
decrease in cell viability reported here is likely due to the cobalt ions. 
 
Whilst biocompatibility of glasses has been extensively studied, there is limited literature 
available on cobalt doped bioactive glasses. The available work covers the angiogenic potential 
of cobalt doped silicate glasses in bone tissue engineering [30]. While no data is available on 
cytotoxic effect of cobalt doped phosphate glasses on epithelial cells, some of the studies have 
stated the possible optimum range of the cobalt ions. Hoppe et al. , has reported 12, 24 and 48 
ppm of cobalt ion as therapeutically active range that stimulated migration, promoted 
proliferation and tubule like structure formation of umbilical cord blood derived CD133(+) cells 
[31]. In another study 12 ppm CoCl2 was shown to upregulate endothelin-1 gene in human 
microvascular endothelial cells [32]. Similarly, Lucas et al., found that cobalt ions < 10 µg/ml 
(10 ppm) were well tolerated by osteoblast as the effect of the ions on cell proliferation and 
function was non-significant. However, cobalt ions > 10 ppm has shown cytotoxic effects on 
osteoblast like MG63 cells [33] and bone marrow derived stem cells [30]. In the present study, 
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the ionic concentration of cobalt ion was less than 10 ppm which per the above studies is within 
therapeutic range. Nevertheless, a significant cytotoxic effect of the cobalt ions was seen on 
uroepithelial cells studied, even though the ionic concentration was within an acceptable range. 
The cytotoxic effect of cobalt exhibited in this study could be attributed to the fact that various 
cells are likely to have different tolerance level for ions. To date no studies have been conducted 
on cytotoxicity of cobalt ions on uroepithelial cells. Therefore, this study is the first to evaluate 
and report cytotoxic effect of cobalt ions on human uroepithelial cells.   
 
It is evident form the data that the un-doped glass dissolution products have non-significant effect 
on cells compared to cobalt doped samples. High cobalt doses have been shown to induce cell 
death via a variety of mechanisms. Cobalt ions act as antagonist for calcium channels therefore 
inhibit the calcium signalling pathways [34]. Once inside the cell, cobalt ions can inhibit crucial 
enzymes due to their high affinity for sulfhydral groups and hinder metabolic processes [35, 36]. 
Cobalt ions also induce oxidative stress by producing reactive oxygen species that cause DNA, 
proteins and lipid damage [34, 37]. Lucas et al., reported that the DNA synthesis in human 
osteoblasts like cells was inhibited by cobalt ions in a dose dependent manner [38]. Similarly, 
cobalt has been shown to inhibit enzymes involved in DNA repair and synthesis thus leading to 
chromosome aberrations [39, 40]. Xie et al., [41] reported chromosomal aberrations in normal 
primary human lung epithelial cells due to soluble and particulate cobalt. Most importantly cobalt 
ions induce hypoxia (low oxygen pressure) and severe and prolonged hypoxia initiates cell death 
by apoptosis [37, 42].   
 
Whilst high cobalt concentrations have been shown to be cytotoxic in various studies, several 
other studies have shown the controlled release of cobalt ions can promote cell growth by 
inducing hypoxia. Certain metal ions such as cobalt, copper, nickel and vanadium have been 
shown to induce oxidative stress by mimicking hypoxia conditions [43]. Whilst severe and 
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prolonged hypoxia has been shown to induce cell death in vitro, however under acute hypoxic 
conditions cells may adapt to the stress by initiating a survival mechanism. One of the mechanism 
is increased vascularization, by expressing genes that are related to angiogenesis. In vivo hypoxia 
stabilizes hypoxia inducible factor 1 alpha (HIF-1α) and stimulate expression of Vascular 
Endothelial Growth Factor (VEGF) and erythropoietin (EPO) genes, which subsequently activate 
the cascade affecting vascularization and angiogenesis [30, 43]. Therefore, it is difficult to 
translate the in vitro cytotoxic effect of cobalt to in vivo conditions. 
 
Many studies have reported the cytotoxic effect of bioactive glasses is due to the change in pH as 
the glasses degrade. The pH of the conditioned media for HUCs was neutral however the pH of 
the conditioned media for T24 cells was neutralised to investigate if the cell viability is influenced 
by the pH of the conditioned media. Cell viability of T24, following pH neutralisation, was 
similar for all compositions except as a dose dependent decrease in viability was observed except 
for 3 mol % cobalt doped glass. It was found that the cell viability improved following pH 
neutralisation by 40%, 37% and 27% at 24, 48 and 72 hours respectively (Figure 5.6). The 
reduced cell viability observed in 3 mol % glasses is an in vitro phenomenon and the viability 
following pH neutralisation is more representative of in vivo conditions as human body has 
naturally buffering system where pH is maintained within an optimum range, approximately 7.0. 
Nevertheless, these findings suggest that the cytotoxic effect observed against HUCs and T24 
cells is due to the presence of dissolution products of cobalt glass. 
 
Whilst dissolution products of cobalt doped phosphate glasses showed a concentration dependent 
effect on cell viability, dissolution products of zinc doped phosphate glasses showed a significant 
decrease in HUCs viability at all concentrations (Figure 5.9). Zinc has been shown to play a key 
role in various biological process such as development of skeletal system, DNA replication and 
protein synthesis [44-46]. However, higher concentration of zinc has detrimental effects of cells. 
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Aina et al., [47] showed that zinc concentrations in the range of 2-8 ppm are cytotoxic to human 
osteoblasts. Similar results were seen against endothelial cells where zinc concentration of 2.7 
ppm caused cell death, whereas 1.1 ppm showed cell proliferation [48]. In the present study, the 
glass composition containing the lowest mol % of zinc oxide (3 mol %) had approximately release 
rate of 9 ppm which per above studies is cytotoxic.    
 
Whilst cytotoxic effect was observed against primary HUCs, a proliferative effect on viability of 
transitional carcinoma T24 was observed both with and without buffering the pH of the 
dissolution products (Figure 5.13). Zinc has been shown to selectively kill cancer cells due to 
high susceptibility of cancer cells to ROS. A study conducted on ZnO nanoparticles showed cell 
death in breast and prostate cancer cells while no major effect was observed in the respective 
normal cells [49]. The lack of cytotoxic effect observed in the present study against T24 cells 
could be attributed to the fact that different cell types have different tolerance for a given ion. 
Additionally, the two cell types were cultured in different media and each medium has a diverse 
range of components containing ions such as Cl־, HCO3־, CO3־ P and proteins which makes it 
difficult to maintain the ionic form of zinc. It is likely that the zinc ions in McCoy’s 5A media 
form soluble or insoluble complexes thus depleting the media of zinc ions and thus no cytotoxic 
effect was observed.  
 
The effect of direct contact of cobalt doped phosphate based glasses with cell monolayer showed 
a non-significant effect on cell viability for 24 hours, whereas a significant reduction (p < 0.001) 
in cell viability was observed at time point 48 and 72 hours (Figure 5.4). On the other hand, T24 
viability significantly reduced when the cells were exposed to zinc doped phosphate based glasses 
directly. The reduction in cell viability in direct contact experiment is likely due to the drastic 
change in the pH of the cell culture media when cell monolayer was exposed to glass discs. 
Several studies have reported that the decrease in cell viability following exposure to bioactive 
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glasses is due to the associated pH changes. The experiment was conducted in 6 wells plate where 
the volume of the media was two millilitres compared to indirect contact experiments where 25 
ml media was used. Small volume of cell culture media is unlikely to buffer the pH changes, 
therefore high pH reduces cell growth and proliferation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
227 
 
5.6 Conclusion 
The dissolution products of 3, 5 and 10 mol % cobalt or zinc doped phosphate based glasses 
showed a significant cytotoxic effect on primary human uroepithelial cells. However, a 
proliferative effect of dissolution products of zinc doped glasses was observed against T24 cells, 
whereas dissolution products of cobalt doped glasses demonstrated cytotoxic effect even when 
the pH was neutralised. The results from direct contact experiments show that cobalt or zinc 
doped glasses did not promote cell growth when tested against T24 cells.  
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6.1 Conclusion 
The aim of the current research was to develop novel antimicrobial bioactive glasses to prevent 
catheter associated urinary tract infections (UTI). UTIs affect significant proportions of the 
population, being particularly prevalent in older adults. Up to 40 % of healthcare associated 
infections are UTIs and 80% of those are associated with catheter use [1]. Studies have shown 
that about 15-25% of the patients admitted in hospital require urinary catheterisation [2] which 
increases their risk of developing urinary tract infection by 5% per day [3, 4]. The financial 
implications are enormous as the high complication rate arising from catheterisation requires 
significant time and cost. More than a million cases are reported each year accounting for annual 
economic burden of approximately £125 million [4, 5]. UTIs are predicted to increase 
dramatically in the future in line with the rise in average life expectancy. The current study 
focused on incorporating antibacterial metal ions (Co, Cu and Zn); alone and in combination 
within a phosphate based glass (P2O5-Na2O-CaO) to prevent CAUTI’s.  
 
The objectives of the chapter 2 were to manufacture and study the dissolution behaviour and 
related aspects such as pH and ion release profile of un-doped and cobalt or zinc doped phosphate 
glasses. The results can be summarised as follows: 
 
1. The incorporation of metal oxides (cobalt and zinc oxide), alters the dissolution 
behaviour of the doped glasses compared to un-doped phosphate based glass. The rate 
of dissolution of cobalt doped glasses was shown to decrease with an increasing cobalt 
oxide content whereas for zinc doped phosphate glasses, an increase in dissolution rate 
was seen with an increasing zinc oxide content. This is due to the charge to size ratio 
of the dopant metal oxide replacing CaO content [6, 7]. When cobalt content is 
increased, the weaker Ca-O bonds are replaced by stronger Co-O bonds, making the 
bond cleavage difficult thus the dissolution decreases with an increasing cobalt oxide 
235 
 
content. Whereas, the increase in dissolution of zinc doped glasses with an increasing 
zinc oxide content is due to opening of network which makes it easier to ingress water 
and thus more solubility. Further studies on structural changes occurring due to dopants 
could strengthen the understanding of the changes in glass dissolution behaviour.  
 
2. A variation in glass dissolution rate was observed in different media, with a decreased 
dissolution in nutrient broth and cell culture media and an increased solubility in 
synthetic urine. Various biological media vary greatly in composition, as the ionic 
strength of the media plays a considerable role in glass dissolution, hence the variation 
in glass degradation in different media. Significantly high dissolution rate in synthetic 
urine is likely due to its high pH as the dissolution increases dramatically in highly 
acidic or alkaline pH. This has also been demonstrated in studies by Bunker et al, [8] 
and Gao 2004 et al. [9], where authors demonstrated a strong relationship between pH 
and glass dissolution.  
 
3. The ion release and pH results of both cobalt and zinc doped glasses are concurrent 
with the weight loss data. Increase in the release rate of anion and cations was observed 
in the most soluble compositions compared to less soluble glasses. 
 
The objectives of the chapter 3 were to evaluate the antimicrobial efficacy of cobalt or zinc doped 
(1, 3, 5 and 10 mol %) phosphate based glasses by testing the surface as well as the dissolution 
products in aqueous media. The results are summarised below: 
 
1. A strong antimicrobial effect was demonstrated by cobalt and zinc doped phosphate 
glass surfaces against E. coli, S. aureus and C. albicans compared to un-doped 
phosphate and control specimens. The antimicrobial effect was time dependent as a 
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gradual decrease in microbial viability was observed over a period. Furthermore, a 
concentration dependent effect was also exhibited in the initial hours, as enhanced 
killing was observed for higher mol % glasses, however the effect plateaued after 24 
hours.     
 
2.  The dissolution products of cobalt doped phosphate based glasses failed to exhibit 
bacteriostatic/bactericidal effect against any of the test strains, however dissolution 
products of 5 and 10 mol % zinc doped glasses showed a kill at 120 hours against E. 
coli. Likewise, significant difference in the activity was seen against S. aureus within 
48 hours which improved by 120 hours. C. albicans on the other hand, showed an 
antimicrobial effect within 24 hours which appeared to diminish as the time 
progressed. The dissolution products therefore showed minimum or no activity 
compared to direct contact experiments. The lack of activity was attributed to the fact 
that media such as nutrient broth provides a complex environment with many ionic 
species that may reduce the concentration of free metal ions by precipitation or by the 
formation of soluble complexes [10, 11]. This could be further investigated by 
performing inductively coupled plasma optical emission spectrometry (ICP-OES).  
 
 
3. Whilst an antimicrobial effect was seen against the three strains studied, E. coli 
showed higher susceptibility compared to S. aureus and C. albicans. As discussed 
earlier, the cell wall is a primary target in contact mediated killing therefore, the 
difference in the efficacy against each strain could be due to the difference in outer 
cell wall. The thick peptidoglycan in S. aureus not only confers stability but also has 
charged anionic clusters which contribute to the binding of ions such as sodium, 
calcium, copper and cobalt thus promote bacterial adhesion to the metallic surfaces. 
Whereas in E. coli the presence of outer membrane with porins allows passage of 
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metallic ions which subsequently bring about cell death by inhibiting DNA and 
proteins.  
 
 
4. Several studies have been conducted to understand the antimicrobial mode of action 
of bio-glasses and pH has been shown to play a key role. The pH analysis exhibited 
that nutrients broth has sufficient capacity to neutralise the minimal changes occurring 
in surrounding environment due to glass leaching. Therefore, in the present analysis, 
it can be argued that the antimicrobial effect seen is due to the doped metallic ions, 
cobalt or zinc.  
 
The emergence of resistant strains and decline in discovery of new antibiotics has led to the idea 
of combining various antimicrobials to treat resistant strains and/or polymicrobial infections. The 
study presented in chapter 4 was therefore undertaken to investigate the effect of combining two 
metal oxide i.e. to determine if the bioactive glasses can be combined to achieve synergistic 
antimicrobial effect. The results are summarised below: 
 
1. It was shown that 5 mol % cobalt, copper or zinc doped phosphate glass systems possess 
antibacterial and antifungal activity proving effective against E. coli, S. aureus and C. 
albicans in planktonic form. The un-doped phosphate based glass did not possess an 
antimicrobial activity which shows antimicrobial efficacy of the doped glasses is derived 
from the cobalt, copper or zinc ions.  
 
2. The present study has established that metal doped bioactive glasses can be used in 
combination as they possess a synergistic activity. A synergistic antimicrobial activity 
was observed for Cu/Co and Cu/Zn against E. coli and Cu/Zn against S. aureus.  
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The aim of the chapter 5 was to study the cytotoxicity of the given glasses (3, 5 and 10 mol % 
cobalt or zinc doped phosphate glasses) against human cells as biocompatibility of bioactive 
glasses is significant when considering their in vivo applications. Therefore, direct and indirect 
exposure of glasses to primary Human Uroepithelial Cells and T24 bladder cancer cells was 
investigated. The results were as follows: 
 
1. The effect of dissolution products of un-doped phosphate glass and the direct contact 
assay shows reduced viability of HUCs and T24 after 24 and 48 hours respectively.     
Dissolution products of cobalt doped glasses demonstrated a strong cytotoxic effect 
against normal HUCs, in a concentration dependent manner. Due to a difference in the 
pH of McCoy’s media, pH buffered and non-buffered analysis was undertaken. Apart 
from the dissolution products of 3 mol % cobalt doped glass (pH buffered), the viability 
of T24 cells was compromised in a dose dependent manner in both pH buffered and non-
buffered analysis. Thus, a reduced cell viability of both cell types was demonstrated with 
dissolution products of cobalt doped glasses where 10 mol % glass was the most toxic 
composition.    
 
2. Like the dissolution products of cobalt doped glasses, zinc doped phosphate based glasses 
also showed a significant cytotoxic effect on primary human uroepithelial cells. However, 
a proliferative effect was observed against T24 cells. The decrease in cell viability could 
be attributed to the ionic strength of the conditioned media. Bioactive glasses when 
immersed in an aqueous media degrade and release ionic products, which if higher than 
the optimum range are detrimental to cells.  
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3. The direct contact experiments were only conducted against T24 cells. The results from 
direct contact experiment show that cobalt or zinc doped glasses did not promote cell 
growth when tested against T24 cells. The significant cytotoxicity is attributed to the fact 
that the experiments were conducted in a 6 wells plate, which can accommodate a 
maximum of 2 ml of cell culture media. The small quantity of media means an increased 
ionic strength and considerable changes in the pH which proved detrimental to cells. 
Therefore, further investigation in larger vessel such as T25 or T75 flask could provide a 
better insight into the effect of direct contact of uroepithelial cells with the given bioactive 
glasses.  
 
The given study demonstrates that doping phosphate glass with cobalt, copper, zinc or their 
combinations confer antimicrobial properties to the glass system. However, the antimicrobial 
properties of the glasses are significantly modulated by the glass degradation behaviour in 
aqueous media. Whilst in vitro studies undertaken here are useful to assess the antimicrobial and 
cytotoxic behaviour of the glasses, it is difficult to generalise the results to the in vivo behaviour 
of the glasses. A biological fluid such as urine is a complex environment which contains 
constituents that broth or cell culture media lack, therefore the dissolution and ion leaching of the 
glasses is likely to vary and thus their antimicrobial and cytotoxic effect.  
 
Nevertheless, even though the glasses, due to their cytotoxicity, cannot be used inside the bladder 
they can still be used to prevent the catheter associated infections. As mentioned in section 1.4.2.5, 
34% microorganisms enter the urinary tract due to intraluminal migration associated with 
manipulation of collecting systems or due to contamination of the drainage bag or disruption of 
the catheter tubing junction, therefore the preventing microorganisms from this route can reduce 
the infection rate. This can be achieved by introducing a cartridge containing with 5 mol % cobalt 
or copper doped phosphate glass individually or glass doped with combination of 5 mol % cobalt, 
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copper or zinc in collecting bag which can dissolve slowly over a period and thus prevent 
microbial adhesion.  
 
Since the cell study has demonstrated a concentration dependent toxic effect the glasses, therefore 
coating a catheter (internally and externally) with a decreasing gradient of cobalt or zinc doped 
phosphate glasses is likely to prevent the occurrence of infection with minimal cytotoxicity. This 
can be achieved by coating the distal part of the catheter with the highest possible mol % of the 
doped glass and decreasing the concentration towards the drainage port (the part inserted inside 
the bladder). The use of phosphate based glasses as a delivery system will not only provide a 
controlled sustained release of antimicrobial ions but also will have additional benefit of low pH. 
The acidic pH will prevent formation of calcium and magnesium crystals which eventually will 
minimize the risk of catheter encrustation and blockage. 
 
6.2 Further work 
Whilst this thesis has shown the potential use of phosphate based glasses doped with divalent 
metallic ions for preventing catheter associated urinary tract infections, nonetheless certain 
limitations remain. The given section explores the limitations and opportunities for extending the 
scope of this thesis.  
1. The weight loss data (section 2.4.1.2 and 2.4.2.2) was conducted in four different media; 
distilled water, nutrient broth, cell culture media and synthetic urine. As discussed 
previously in section 2.5, the pH of the media plays a key role in determining the rate of 
glass dissolution. Since the initial pH of Surine ™ was highly alkaline therefore a 
considerably higher dissolution rate (by a factor of seven) was observed in comparison 
to the other aqueous media tested. Therefore, it is highly desirable to repeat the 
dissolution rate in simulated urine that is more representative of the physiological 
conditions more specifically within an optimum pH range (5.5 - 7.0). 
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2. An exceptional trend in the dissolution behaviour of zinc doped phosphate glasses was 
observed. As discussed in section 2. 5, glass dissolution is governed by the glass structural 
therefore a detailed structural analysis of zinc doped phosphate glasses is required to 
capture the changes in the glass network that affect the dissolution of zinc doped glasses. 
Since zinc behaves as an intermediate oxide and can act as network former or modifier 
therefore it is required to understand the role of zinc oxide in the present glass system. 
This can be achieved by performing neutron diffraction analysis along with X-ray 
absorption spectroscopy to determine the coordination environment of zinc with other 
elements. This will provide an insight into whether zinc act as the network former and/or 
modifier in the glass system studied. 
 
3. The antimicrobial studies were performed in standard laboratory broths and media which 
does not essentially mirror the urinary environment, therefore it would be ideal to perform 
antimicrobial assays in artificial urine that is capable of growing urinary pathogens. A 
simple artificial urine recipe for growth of urinary pathogen can be found in the reference 
[12].  
 
4. The findings of cell studies showed a proliferative effect of the dissolution products of 
zinc doped phosphate glasses against T24 cell, however a significant cytotoxic effect was 
observed on the viability of HUCs. As proposed earlier this is likely due to the presence 
albumin in the media used to grow T24 cells. It has been reported [13-15] that albumin 
forms soluble complexes with zinc ions, therefore once bound to albumin zinc ions are 
not available and thus the lack of cytotoxic effect was seen. Therefore it is desirable to 
quantify the free ions in different media to support the above statement. This could be 
achieved by performing elemental analysis i.e. ICP-OES.  
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Determination of antimicrobial efficacy of six pure metals against Escherichia coli 
and Staphylococcus aureus 
 
A pilot study was conducted to determine antimicrobial efficacy of pure metals; silver, copper, 
cobalt, zinc, nickel and gallium at the given concentrations of  2.5, 5.0, 10.0 and 20.0% w/v 
against Gram negative (Escherichia coli NCTC 10538) and Gram positive bacteria 
(Staphylococcus aureus ATCC 6538).  
Method: 50 mg, 100 mg, 200 mg and 400 mg of each metal powder was added in 2 ml of 106 
CFU/ml bacterial culture to make 2.5%, 5%, 10% and 20% w/v solutions respectively. Each 
sample along with a control was incubated for a period at 37°C in a shaking incubator with a 
shaking speed of 100 rpm. Following incubation for 24, 48, 72 and 96 hours, tenfold dilutions 
were prepared for each sample. 10-2, 10-4 and 10-6 dilutions were plated in duplicates on to nutrient 
agar to estimate viable count. The reduction in bacterial density was measured as reduction in log 
CFU/ml. 
Results:  
Figure A.1 shows reduction in log CFU/ml for E. coli when incubated with the metal powders 
for 24 hours. 5% copper shows a considerable decrease, 4 log reductions, in bacterial cell density 
compared to the control whereas, 10% copper shows almost seven logs reduction. 2.5% and 5.0% 
cobalt both demonstrated 4 logs reduction and 10% cobalt showed a 9-log reduction compared to 
the control. Nickel showed a trivial reduction in bacterial number following 24 hours exposure. 
Gallium and silver the number of bacteria raised to a level above enumeration.  
 
The viable counts of S. aureus following direct contact exposure, for 24 hours, are shown in 
Figure A.2. Except for gallium and silver all metals showed antimicrobial effects. The bacterial 
numbers showed a considerable decrease within 24 hours for copper, cobalt and zinc compared 
to the control. 10% copper and cobalt showed a seven-log reduction i.e. complete kill compared 
247 
 
to the control. Whereas the growth of microorganism was very high for gallium and silver 
samples and reached a level above enumeration limit.    
 
 
Figure A.1: showing antimicrobial action of Cu, Co, Zn, Ni, Ga and Ag against E. coli following 
24 hours exposure.  
 
 
 
Figure A.2: showing antimicrobial action of Cu, Co, Zn, Ni, Ga and Ag against S. aureus 
following 24 hours exposure. 
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Metal powders that did not show any considerable antimicrobial effect in 24 hours; nickel, silver, 
gallium (against E. coli and S. aureus) and zinc (against E. coli), were studied for longer hours. 
The results of long interval sampling showed a considerable reduction in bacterial number for 
nickel and zinc. Antimicrobial effect of metals when observed against E. coli (Figure A.3), 
showed a rapid decrease in bacterial number by zinc and nickel within 48 hours. A significant 
decrease, 7 logs reduction, was observed for zinc within 24 hours and a complete kill was seen in 
the next 24 hours compared to the control. While nickel did not show any antibacterial effect in 
24 hours; a complete kill, 8 logs reduction, was observed by the end of 48 hours. Figure A.3 
illustrates a 2 logs reduction in bacterial density compared to the control in case of silver however 
no noticeable decrease was observed for gallium. 
According to Figure A.4, showing antimicrobial effect against S. aureus, nickel showed a gradual 
decrease in bacterial density over 96 hours compared to the control. By the end of the assay period 
a complete kill was observed which was approximately six logs less. When incubated for longer 
hours, silver and gallium did not show any bacterial reduction compared to the control or original 
number of bacteria.  
 
 
Figure A.3: showing antimicrobial action of Zn, Ni, Ga and Ag against E. coli following 96 hours 
exposure to metals.  
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Figure A.4: showing antimicrobial action of Zn, Ni, Ga and Ag against S. aureus following 96 
hours exposure to metals. 
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Standard curve for colony forming units using optical density 
 
 
Figure A.5: Mean colony forming units of E. coli (NCTC 10538) correlated to turbidity measured 
at an absorbance of 570 nm. 
 
 
 
 
Figure A.6: Mean colony forming units of S. aureus (ATCC 6538) correlated to turbidity 
measured at an absorbance of 570 nm. 
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Figure A.7: Mean colony forming units of C. albicans (ATCC 76615) correlated to turbidity 
measured at an absorbance of 570 nm. 
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Table A.1: The pH readings of broth taken at 0, 2, 6, and 24 hours incubation with glass particles 
at 37°C and 200 rpm.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Glass composition  0 2 hour 6 hour 24 hour 
0% 7.03±0.11 6.79±0.14 6.18±0.12 6.04±0.21 
5% Co 7.03±0.11 6.73±0.17 6.34±0.45 5.96±0.08 
5% Cu 7.03±0.11 6.52±0.12 6.0±0.01 4.79±0.16 
5% Zn 7.03±0.11 6.39±0.12 6.04±0.11 5.26±0.01 
Co/Cu 7.03±0.11 6.38±0.39 6.12±0.37 4.83±0.14 
Co/Zn 7.03±0.11 6.45±0.34 6.18±0.42 5.93±0.08 
Cu/Zn 7.03±0.11 6.23±0.20 5.98±0.11 4.83±0.25 
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Table A.2: The pH readings of conditioned media taken after 24 hours incubation with discs at 
37°C and 200 rpm in Urothelial cell media (UCM). 
 
 
 
 
 
 
 
 
 
 
 
Table A.2 shows the pH readings of conditioned media taken after 24 hours incubation with discs 
at 37°C and 200 rpm in McCoy’s 5A media. pH readings were also taken after media 
acclimatization in 5% CO2 incubator.  
 
 
 
 
 
Glass composition  pH  
0% 7.59 
3% Cobalt 7.62 
5% Cobalt 7.61 
10% Cobalt 7.67 
3% Zinc 7.71 
5% Zinc 7.73 
10% Zinc 7.58 
Glass composition Before pH buffering After pH buffering 
0% 8.22 7.60 
3% Cobalt 8.24 7.58 
5% Cobalt 8.32 7.56 
10% Cobalt 8.25 7.55 
3% Zinc 8.14 7.70 
5% Zinc 8.33 7.68 
10% Zinc 8.24 7.69 
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Figure A.8: Phase contrast images of Human uroepithelial cells cultured for 24, 48 and 72 hours 
in dissolution products of cobalt doped phosphate based glasses. Cells grown in (A) complete 
media, media conditioned with (B) un-doped phosphate glass, (C) 3% cobalt glass, (D) 5% cobalt 
glass (E) 10% cobalt glass and (F) cells treated with 70% (v/v) ethanol. Images were taken at 
100x magnification. 
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Figure A.9: Phase contrast images of Human uroepithelial cells cultured for 24, 48 and 72 hours 
in dissolution products of cobalt doped phosphate based glasses. Cells grown in (A) complete 
media, media conditioned with (B) un-doped phosphate glass, (C) 3% zinc glass, (D) 5% zinc 
glass (E) 10% zinc glass and (F) cells treated with 70% (v/v) ethanol. Images were taken at 100x 
magnification. 
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